{
 "cells": [
  {
   "cell_type": "markdown",
   "id": "<YOUR_JOB_ID>",
   "metadata": {},
   "source": [
    "## Create Genomics Store Supervisor Agent\n",
    "\n",
    "**Updated Version - With Quality-Based Filtering**"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "<YOUR_JOB_ID>",
   "metadata": {},
   "source": [
    "In this notebook we create the Genomics Store Supervisor Agent that will interact with **genomicsvariantstore** and **genomicsannotationstore** directly using AWS HealthOmics APIs and Athena queries. This version includes comprehensive quality filtering and uses real HealthOmics store queries with dynamic SQL generation capabilities.\n",
    "\n",
    "### Key Features:\n",
    "- Direct queries to genomicsvariantstore and genomicsannotationstore\n",
    "- Dynamic SQL query generation using AI\n",
    "- Proper VEP and ClinVar annotation handling\n",
    "- **Quality-based filtering**: All variant analyses automatically apply:\n",
    "  - `v.qual > 30 AND contains(v.filters, 'PASS')` for standard quality\n",
    "  - `v.qual > 50 AND contains(v.filters, 'PASS')` for high quality\n",
    "- No DynamoDB pipeline tracking dependency\n",
    "- Real genomic variant analysis functions\n",
    "- No LIMIT clauses - complete result sets"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "<YOUR_JOB_ID>",
   "metadata": {},
   "source": [
    "#### Install required packages for genomics store analysis"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "<YOUR_JOB_ID>",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Requirement already satisfied: boto3 in /home/ec2-user/anaconda3/envs/pytorch_p310/lib/python3.10/site-packages (1.40.27)\n",
      "Requirement already satisfied: botocore<1.41.0,>=1.40.27 in /home/ec2-user/anaconda3/envs/pytorch_p310/lib/python3.10/site-packages (from boto3) (1.40.27)\n",
      "Requirement already satisfied: jmespath<2.0.0,>=0.7.1 in /home/ec2-user/anaconda3/envs/pytorch_p310/lib/python3.10/site-packages (from boto3) (1.0.1)\n",
      "Requirement already satisfied: s3transfer<0.15.0,>=0.14.0 in /home/ec2-user/anaconda3/envs/pytorch_p310/lib/python3.10/site-packages (from boto3) (0.14.0)\n",
      "Requirement already satisfied: python-dateutil<3.0.0,>=2.1 in /home/ec2-user/anaconda3/envs/pytorch_p310/lib/python3.10/site-packages (from botocore<1.41.0,>=1.40.27->boto3) (2.9.0.post0)\n",
      "Requirement already satisfied: urllib3!=2.2.0,<3,>=1.25.4 in /home/ec2-user/anaconda3/envs/pytorch_p310/lib/python3.10/site-packages (from botocore<1.41.0,>=1.40.27->boto3) (2.5.0)\n",
      "Requirement already satisfied: six>=1.5 in /home/ec2-user/anaconda3/envs/pytorch_p310/lib/python3.10/site-packages (from python-dateutil<3.0.0,>=2.1->botocore<1.41.0,>=1.40.27->boto3) (1.17.0)\n",
      "Requirement already satisfied: pandas in /home/ec2-user/anaconda3/envs/pytorch_p310/lib/python3.10/site-packages (2.3.0)\n",
      "Requirement already satisfied: numpy in /home/ec2-user/anaconda3/envs/pytorch_p310/lib/python3.10/site-packages (1.26.4)\n",
      "Requirement already satisfied: python-dateutil>=2.8.2 in /home/ec2-user/anaconda3/envs/pytorch_p310/lib/python3.10/site-packages (from pandas) (2.9.0.post0)\n",
      "Requirement already satisfied: pytz>=2020.1 in /home/ec2-user/anaconda3/envs/pytorch_p310/lib/python3.10/site-packages (from pandas) (2025.2)\n",
      "Requirement already satisfied: tzdata>=2022.7 in /home/ec2-user/anaconda3/envs/pytorch_p310/lib/python3.10/site-packages (from pandas) (2025.2)\n",
      "Requirement already satisfied: six>=1.5 in /home/ec2-user/anaconda3/envs/pytorch_p310/lib/python3.10/site-packages (from python-dateutil>=2.8.2->pandas) (1.17.0)\n"
     ]
    }
   ],
   "source": [
    "!pip install --upgrade boto3\n",
    "!pip install pandas numpy"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "<YOUR_JOB_ID>",
   "metadata": {},
   "source": [
    "#### Import required libraries and initialize AWS clients"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "<YOUR_JOB_ID>",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "✅ AWS configuration detected - Region: <YOUR_REGION>, Account: <YOUR_ACCOUNT_ID>\n",
      "✅ Athena client initialized\n",
      "✅ Bedrock client initialized\n",
      "✅ HealthOmics client initialized\n",
      "✅ Glue client initialized\n",
      "Region: <YOUR_REGION>\n",
      "Account ID: <YOUR_ACCOUNT_ID>\n",
      "Variant Store: genomicsvariantstore\n",
      "Annotation Store: genomicsannotationstore\n",
      "Database: default\n",
      "✅ Genomics store agent tools defined\n",
      "✅ Configured for:\n",
      "   - Variant Store: genomicsvariantstore\n",
      "   - Annotation Store: genomicsannotationstore\n",
      "   - Database: default\n",
      "   - Region: <YOUR_REGION>\n",
      "   - Tools: 5\n",
      "AWS Account: <YOUR_ACCOUNT_ID>\n",
      "Region: <YOUR_REGION>\n",
      "Variant Store: genomicsvariantstore\n",
      "Annotation Store: genomicsannotationstore\n",
      "Database: default\n",
      "\n",
      "✅ No DynamoDB dependency - using direct store queries\n",
      "✅ Quality-based filtering enabled\n"
     ]
    }
   ],
   "source": [
    "import boto3\n",
    "import json\n",
    "import time\n",
    "from datetime import datetime\n",
    "import pandas as pd\n",
    "import numpy as np\n",
    "\n",
    "# Import genomics store modules\n",
    "from genomics_store_interpreters import (\n",
    "    genomics_store_agent_name,\n",
    "    genomics_store_agent_description,\n",
    "    genomics_store_agent_instruction,\n",
    "    genomics_store_agent_tools,\n",
    "    model\n",
    ")\n",
    "\n",
    "from genomics_store_functions import (\n",
    "    REGION,\n",
    "    ACCOUNT_ID,\n",
    "    VARIANT_STORE_NAME,\n",
    "    ANNOTATION_STORE_NAME,\n",
    "    LAKE_FORMATION_DATABASE,\n",
    "    get_stores_information,\n",
    "    get_available_samples_from_variant_store,\n",
    "    execute_dynamic_query\n",
    ")\n",
    "\n",
    "# Initialize AWS clients\n",
    "session = boto3.Session()\n",
    "region = session.region_name or '<YOUR_REGION>'\n",
    "sts_client = boto3.client('sts')\n",
    "account_id = sts_client.get_caller_identity()['Account']\n",
    "\n",
    "print(f\"AWS Account: {account_id}\")\n",
    "print(f\"Region: {region}\")\n",
    "print(f\"Variant Store: {VARIANT_STORE_NAME}\")\n",
    "print(f\"Annotation Store: {ANNOTATION_STORE_NAME}\")\n",
    "print(f\"Database: {LAKE_FORMATION_DATABASE}\")\n",
    "print(\"\\n✅ No DynamoDB dependency - using direct store queries\")\n",
    "print(\"✅ Quality-based filtering enabled\")"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "<YOUR_JOB_ID>",
   "metadata": {},
   "source": [
    "#### Initialize Bedrock AgentCore client"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "<YOUR_JOB_ID>",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "✅ Bedrock AgentCore clients initialized\n"
     ]
    }
   ],
   "source": [
    "# Initialize Bedrock AgentCore client\n",
    "bedrock_agent_client = boto3.client('bedrock-agent', region_name=region)\n",
    "bedrock_runtime_client = boto3.client('bedrock-agent-runtime', region_name=region)\n",
    "\n",
    "print(\"✅ Bedrock AgentCore clients initialized\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "id": "<YOUR_JOB_ID>",
   "metadata": {},
   "outputs": [],
   "source": [
    "from magic_helper import register_cell_magic"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "e1f7g5d4-5678-7890-1234-567890123456",
   "metadata": {},
   "source": [
    "#### Create Strands Agent for Genomics Store Analysis"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "<YOUR_JOB_ID>",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Successfully created orchestrator agent: vcf-agent-supervisor\n"
     ]
    }
   ],
   "source": [
    "%%write_and_run vcf_agent_supervisor.py\n",
    "\n",
    "import boto3\n",
    "import json\n",
    "import uuid\n",
    "import requests\n",
    "from typing import Dict, Any\n",
    "from strands import Agent, tool\n",
    "from strands.models import BedrockModel\n",
    "\n",
    "from genomics_store_interpreters import *\n",
    "\n",
    "# 1: vcf_interpreter_agent tool\n",
    "\n",
    "@tool\n",
    "def vcf_supervisor_agent(query: str) -> str:\n",
    "    \"\"\"\n",
    "    Create vcf interpreter agent with lake formation tables using Strands framework\n",
    "\n",
    "    Args:\n",
    "        query: An information request from the vcf database\n",
    "\n",
    "    Returns:\n",
    "        A summary of the understanding of the user's query and the response.\n",
    "    \"\"\"\n",
    "    try:\n",
    "        vcf_sup_agent = Agent(\n",
    "            model=model,\n",
    "            tools=genomics_store_agent_tools,\n",
    "            system_prompt=genomics_store_agent_instruction\n",
    "        )\n",
    "        vcf_agent_response = vcf_sup_agent(query)\n",
    "        print(\"VCF Supervisor agent Response:\")\n",
    "        print(vcf_agent_response)\n",
    "        return vcf_agent_response\n",
    "    except Exception as e:\n",
    "        print(f\"Error creating agent: {e}\")\n",
    "        raise\n",
    "\n",
    "# Define orchestrator agent configuration below\n",
    "\n",
    "agent_name = \"vcf-agent-supervisor\"\n",
    "agent_description = \"VCF supervisor agent for cinical insights disocvery\"\n",
    "agent_instruction = \"\"\"You are an advanced genomics analysis assistant specialized in clinical variant interpretation using AWS HealthOmics genomicsvariantstore and genomicsannotationstore.\n",
    "\n",
    "Your primary focus is on clinically actionable genomic analysis with these specialized capabilities:\n",
    "\n",
    "CORE CLINICAL TOOLS:\n",
    "1. **Gene-Specific Analysis** (query_variants_by_gene): For targeted gene panels, cancer genes (BRCA1/2, TP53), pharmacogenes (CYP2D6, CYP2C19)\n",
    "2. **Chromosomal Analysis** (query_variants_by_chromosome): For chromosomal abnormalities, CNV analysis, specific genomic regions\n",
    "3. **Population Frequency Analysis** (analyze_allele_frequencies): For rare disease variants, population genetics, allele frequency comparisons with 1000 Genomes\n",
    "4. **Sample Comparison** (compare_sample_variants): For family studies, cohort analysis, population stratification\n",
    "5. **Dynamic Queries** (execute_dynamic_genomics_query): For complex clinical questions requiring custom SQL\n",
    "\n",
    "CLINICAL DECISION SUPPORT:\n",
    "- Always apply quality filtering (qual > 30 AND PASS filters)\n",
    "- Prioritize variants by clinical significance and functional impact\n",
    "- Include 1000 Genomes frequency data for population context\n",
    "- Provide actionable clinical interpretations\n",
    "\n",
    "TOOL SELECTION STRATEGY:\n",
    "1. **For specific genes**: Use query_variants_by_gene (e.g., \"BRCA1 variants\", \"CYP2D6 pharmacogenomics\")\n",
    "2. **For chromosomal regions**: Use query_variants_by_chromosome (e.g., \"chromosome 17 variants\", \"chr13:32000000-33000000\")\n",
    "3. **For frequency analysis**: Use analyze_allele_frequencies (e.g., \"rare variants\", \"population frequencies\")\n",
    "4. **For cohort studies**: Use compare_sample_variants (e.g., \"compare samples\", \"family analysis\")\n",
    "5. **For complex queries**: Use execute_dynamic_genomics_query\n",
    "\n",
    "Remember: Focus on clinically actionable insights that can inform patient care, genetic counseling, and treatment decisions.\n",
    "\"\"\"\n",
    "\n",
    "# Define the model\n",
    "bedrock_model = BedrockModel(\n",
    "    model_id=\"us.anthropic.claude-3-7-sonnet-20250219-v1:0\", \n",
    "    region_name=region,\n",
    "    temperature=0.1,\n",
    "    streaming=False\n",
    ")\n",
    "\n",
    "# Instantiate the orchestrator agent\n",
    "try:\n",
    "    orchestrator = Agent(\n",
    "        model=bedrock_model,\n",
    "        system_prompt=agent_instruction,\n",
    "        callback_handler=None,\n",
    "        # associate sub-agents to supervisor\n",
    "        tools=[vcf_supervisor_agent]\n",
    "    )\n",
    "    print(f\"Successfully created orchestrator agent: {agent_name}\")\n",
    "except Exception as e:\n",
    "    print(f\"Error creating agent: {e}\")\n",
    "    raise"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "id": "<YOUR_JOB_ID>",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Testing orchestrator agent with query: Find all pathogenic variants in BRCA1 and BRCA2 genes for patient NA21144\n",
      "================================================================================================================\n",
      "I'll help you find pathogenic and likely pathogenic variants in BRCA1 and BRCA2 genes for patient NA21144. Let me query these genes specifically for this patient.\n",
      "Tool #1: query_variants_by_gene\n",
      "Executing query on database '<YOUR_AWS_PROFILE>': \n",
      "        WITH variant_annotations AS (\n",
      "            SELECT \n",
      "                v.sampleid,\n",
      "                v.contigname,\n",
      "                v.start,\n",
      "                v.referenceallele,\n",
      "                v.alternatealleles[1] as alternate_allele,\n",
      "                v.qual,\n",
      "                v.depth,\n",
      "                v.information['af'] as allele_frequency_1000g,\n",
      "                v.filters[1] as filter_status,\n",
      "                \n",
      "                CASE WHEN cardinality(v.annotations.vep) > 0 THEN v.annotations.vep[1].symbol END as vep_gene,\n",
      "                CASE WHEN cardinality(v.annotations.vep) > 0 THEN v.annotations.vep[1].impact END as vep_impact,\n",
      "                CASE WHEN cardinality(v.annotations.vep) > 0 AND cardinality(v.annotations.vep[1].consequence) > 0 \n",
      "                     THEN v.annotations.vep[1].consequence[1] END as vep_consequence,\n",
      "                \n",
      "                a.attributes['CLNSIG'] as clinvar_significance,\n",
      "                a.attributes['CLNDN'] as associated_disease,\n",
      "                split_part(a.attributes['GENEINFO'], ':', 1) as clinvar_gene\n",
      "                \n",
      "            FROM genomicsvariantstore v\n",
      "            LEFT JOIN genomicsannotationstore a ON (\n",
      "                REPLACE(v.contigname, 'chr', '') = REPLACE(a.contigname, 'chr', '')\n",
      "                AND v.start = a.start\n",
      "                AND v.referenceallele = a.referenceallele\n",
      "                AND v.alternatealleles[1] = a.alternatealleles[1]\n",
      "            )\n",
      "            WHERE v.qual > 30 \n",
      "                AND contains(v.filters, 'PASS')\n",
      "                AND (\n",
      "                    (cardinality(v.annotations.vep) > 0 AND UPPER(v.annotations.vep[1].symbol) IN ('BRCA1', 'BRCA2'))\n",
      "                    OR UPPER(split_part(a.attributes['GENEINFO'], ':', 1)) IN ('BRCA1', 'BRCA2')\n",
      "                )\n",
      "                AND v.sampleid IN ('NA21144')\n",
      "        )\n",
      "        \n",
      "        SELECT \n",
      "            sampleid,\n",
      "            CONCAT(contigname, ':', CAST(start as VARCHAR), ':', referenceallele, '>', alternate_allele) as variant_id,\n",
      "            COALESCE(clinvar_gene, vep_gene) as gene_symbol,\n",
      "            vep_consequence as consequence,\n",
      "            vep_impact as impact,\n",
      "            clinvar_significance,\n",
      "            associated_disease,\n",
      "            qual,\n",
      "            depth,\n",
      "            allele_frequency_1000g,\n",
      "            \n",
      "            CASE \n",
      "                WHEN clinvar_significance = 'Pathogenic' AND vep_impact = 'HIGH' THEN 10\n",
      "                WHEN clinvar_significance = 'Pathogenic' AND vep_impact = 'MODERATE' THEN 9\n",
      "                WHEN clinvar_significance = 'Likely_pathogenic' AND vep_impact = 'HIGH' THEN 8\n",
      "                WHEN clinvar_significance = 'Likely_pathogenic' AND vep_impact = 'MODERATE' THEN 7\n",
      "                WHEN clinvar_significance = 'Uncertain_significance' AND vep_impact = 'HIGH' THEN 6\n",
      "                WHEN vep_impact = 'HIGH' THEN 5\n",
      "                WHEN clinvar_significance = 'Uncertain_significance' AND vep_impact = 'MODERATE' THEN 4\n",
      "                ELSE 1\n",
      "            END as priority_score\n",
      "\n",
      "        FROM variant_annotations\n",
      "        ORDER BY priority_score DESC, qual DESC\n",
      "        \n",
      "====================================================================================\n",
      "Executing query on database '<YOUR_AWS_PROFILE>': \n",
      "        \n",
      "        WITH variant_annotations AS (\n",
      "            SELECT \n",
      "                v.sampleid,\n",
      "                v.contigname,\n",
      "                v.start,\n",
      "                v.referenceallele,\n",
      "                v.alternatealleles[1] as alternate_allele,\n",
      "                v.qual,\n",
      "                v.depth,\n",
      "                v.information['af'] as allele_frequency_1000g,\n",
      "                v.filters[1] as filter_status,\n",
      "                \n",
      "                CASE WHEN cardinality(v.annotations.vep) > 0 THEN v.annotations.vep[1].symbol END as vep_gene,\n",
      "                CASE WHEN cardinality(v.annotations.vep) > 0 THEN v.annotations.vep[1].impact END as vep_impact,\n",
      "                CASE WHEN cardinality(v.annotations.vep) > 0 AND cardinality(v.annotations.vep[1].consequence) > 0 \n",
      "                     THEN v.annotations.vep[1].consequence[1] END as vep_consequence,\n",
      "                \n",
      "                a.attributes['CLNSIG'] as clinvar_significance,\n",
      "                a.attributes['CLNDN'] as associated_disease,\n",
      "                split_part(a.attributes['GENEINFO'], ':', 1) as clinvar_gene\n",
      "                \n",
      "            FROM genomicsvariantstore v\n",
      "            LEFT JOIN genomicsannotationstore a ON (\n",
      "                REPLACE(v.contigname, 'chr', '') = REPLACE(a.contigname, 'chr', '')\n",
      "                AND v.start = a.start\n",
      "                AND v.referenceallele = a.referenceallele\n",
      "                AND v.alternatealleles[1] = a.alternatealleles[1]\n",
      "            )\n",
      "            WHERE v.qual > 30 \n",
      "                AND contains(v.filters, 'PASS')\n",
      "                AND (\n",
      "                    (cardinality(v.annotations.vep) > 0 AND UPPER(v.annotations.vep[1].symbol) IN ('BRCA1', 'BRCA2'))\n",
      "                    OR UPPER(split_part(a.attributes['GENEINFO'], ':', 1)) IN ('BRCA1', 'BRCA2')\n",
      "                )\n",
      "                AND v.sampleid IN ('NA21144')\n",
      "        )\n",
      "        \n",
      "        SELECT \n",
      "            sampleid,\n",
      "            CONCAT(contigname, ':', CAST(start as VARCHAR), ':', referenceallele, '>', alternate_allele) as variant_id,\n",
      "            COALESCE(clinvar_gene, vep_gene) as gene_symbol,\n",
      "            vep_consequence as consequence,\n",
      "            vep_impact as impact,\n",
      "            clinvar_significance,\n",
      "            associated_disease,\n",
      "            qual,\n",
      "            depth,\n",
      "            allele_frequency_1000g,\n",
      "            \n",
      "            CASE \n",
      "                WHEN clinvar_significance = 'Pathogenic' AND vep_impact = 'HIGH' THEN 10\n",
      "                WHEN clinvar_significance = 'Pathogenic' AND vep_impact = 'MODERATE' THEN 9\n",
      "                WHEN clinvar_significance = 'Likely_pathogenic' AND vep_impact = 'HIGH' THEN 8\n",
      "                WHEN clinvar_significance = 'Likely_pathogenic' AND vep_impact = 'MODERATE' THEN 7\n",
      "                WHEN clinvar_significance = 'Uncertain_significance' AND vep_impact = 'HIGH' THEN 6\n",
      "                WHEN vep_impact = 'HIGH' THEN 5\n",
      "                WHEN clinvar_significance = 'Uncertain_significance' AND vep_impact = 'MODERATE' THEN 4\n",
      "                ELSE 1\n",
      "            END as priority_score\n",
      "\n",
      "        FROM variant_annotations\n",
      "        ORDER BY priority_score DESC, qual DESC\n",
      "        \n",
      "Retrieved 255 total rows from Athena query\n",
      "## Clinical Analysis: BRCA1 and BRCA2 Variants in Patient NA21144\n",
      "\n",
      "Based on my analysis of the BRCA1 and BRCA2 genes for patient NA21144, I have important clinical findings to report:\n",
      "\n",
      "### Key Finding: No Pathogenic or Likely Pathogenic Variants Detected\n",
      "\n",
      "After examining all 255 variants in the BRCA1 and BRCA2 genes for patient NA21144, I found:\n",
      "\n",
      "- **No pathogenic variants** were identified in either gene\n",
      "- **No likely pathogenic variants** were identified in either gene\n",
      "- The majority of variants (218) were classified as \"Benign\" in ClinVar\n",
      "- 35 variants had no clinical significance classification\n",
      "- 1 variant was classified as \"Uncertain significance\" (VUS)\n",
      "- 1 variant was classified as \"Benign/Likely benign\"\n",
      "\n",
      "### Variant Distribution\n",
      "- BRCA1: 202 variants (all benign or unclassified)\n",
      "- BRCA2: 53 variants (all benign or unclassified)\n",
      "\n",
      "### Impact Assessment\n",
      "- Most variants (249) have MODIFIER impact (non-coding regions)\n",
      "- 3 variants have LOW impact (synonymous variants)\n",
      "- 3 variants have MODERATE impact (missense variants, but classified as benign)\n",
      "\n",
      "### Clinical Interpretation\n",
      "\n",
      "The absence of pathogenic or likely pathogenic variants in BRCA1 and BRCA2 suggests that this patient does not have an increased hereditary risk for breast and ovarian cancer associated with these specific genes. However, this analysis is limited to BRCA1 and BRCA2 only, and other cancer predisposition genes were not evaluated.\n",
      "\n",
      "### Follow-up Recommendations\n",
      "\n",
      "1. If there is a strong family history of breast, ovarian, or related cancers, consider:\n",
      "   - Testing additional cancer predisposition genes beyond BRCA1/2\n",
      "   - Evaluating for large genomic rearrangements not detected by this analysis\n",
      "   - Genetic counseling to discuss other risk factors\n",
      "\n",
      "2. Standard cancer screening based on age and personal risk factors should be followed according to current guidelines.\n",
      "\n",
      "Would you like me to provide more details about any specific variants found in this patient?VCF Supervisor agent Response:\n",
      "## Clinical Analysis: BRCA1 and BRCA2 Variants in Patient NA21144\n",
      "\n",
      "Based on my analysis of the BRCA1 and BRCA2 genes for patient NA21144, I have important clinical findings to report:\n",
      "\n",
      "### Key Finding: No Pathogenic or Likely Pathogenic Variants Detected\n",
      "\n",
      "After examining all 255 variants in the BRCA1 and BRCA2 genes for patient NA21144, I found:\n",
      "\n",
      "- **No pathogenic variants** were identified in either gene\n",
      "- **No likely pathogenic variants** were identified in either gene\n",
      "- The majority of variants (218) were classified as \"Benign\" in ClinVar\n",
      "- 35 variants had no clinical significance classification\n",
      "- 1 variant was classified as \"Uncertain significance\" (VUS)\n",
      "- 1 variant was classified as \"Benign/Likely benign\"\n",
      "\n",
      "### Variant Distribution\n",
      "- BRCA1: 202 variants (all benign or unclassified)\n",
      "- BRCA2: 53 variants (all benign or unclassified)\n",
      "\n",
      "### Impact Assessment\n",
      "- Most variants (249) have MODIFIER impact (non-coding regions)\n",
      "- 3 variants have LOW impact (synonymous variants)\n",
      "- 3 variants have MODERATE impact (missense variants, but classified as benign)\n",
      "\n",
      "### Clinical Interpretation\n",
      "\n",
      "The absence of pathogenic or likely pathogenic variants in BRCA1 and BRCA2 suggests that this patient does not have an increased hereditary risk for breast and ovarian cancer associated with these specific genes. However, this analysis is limited to BRCA1 and BRCA2 only, and other cancer predisposition genes were not evaluated.\n",
      "\n",
      "### Follow-up Recommendations\n",
      "\n",
      "1. If there is a strong family history of breast, ovarian, or related cancers, consider:\n",
      "   - Testing additional cancer predisposition genes beyond BRCA1/2\n",
      "   - Evaluating for large genomic rearrangements not detected by this analysis\n",
      "   - Genetic counseling to discuss other risk factors\n",
      "\n",
      "2. Standard cancer screening based on age and personal risk factors should be followed according to current guidelines.\n",
      "\n",
      "Would you like me to provide more details about any specific variants found in this patient?\n",
      "\n"
     ]
    }
   ],
   "source": [
    "# ---------------------------- Sample Question Bank --------------------------------------------\n",
    "\n",
    "# VCF Agent Questions\n",
    "vcf_agent_query_1 = \"Find all pathogenic variants in BRCA1 and BRCA2 genes for patient NA21144\"\n",
    "vcf_agent_query_2 = \"Analyze pathogenic variants in chromosome 17 in patient NA21144 and let me know any clinical followup need to be carried out\"\n",
    "vcf_agent_query_3 = \"What are the rare variants (frequency < 0.01) in patient NA21144?\"\n",
    "vcf_agent_query_4 = \"Compare variant profiles between samples NA21144 and NA21135\"\n",
    "vcf_agent_query_5 = \"Find pharmacogenomic variants in CYP2D6 gene for all samples\"\n",
    "vcf_agent_query_6 = \"Howmany patients are in present cohort?\"\n",
    "\n",
    "# -----------------------------------------------------------------------------------------\n",
    "test_query = vcf_agent_query_1 # Change value here to test different questions\n",
    "\n",
    "print(f\"Testing orchestrator agent with query: {test_query}\")\n",
    "print(\"=\" * (39 + len(test_query)))\n",
    "\n",
    "try:\n",
    "    # Run the agent\n",
    "    response = orchestrator(test_query)\n",
    "    \n",
    "except Exception as e:\n",
    "    print(f\"Error during agent execution: {e}\")\n",
    "    import traceback\n",
    "    traceback.print_exc()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "id": "<YOUR_JOB_ID>",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "I'll compare the pathogenicity profiles of patients NA21135 and NA21144 to analyze their genetic risk burden. Let me use the sample comparison tool to get a comprehensive analysis of their variants.\n",
      "Tool #1: compare_sample_variants\n",
      "Executing query on database '<YOUR_AWS_PROFILE>': \n",
      "        WITH sample_variants AS (\n",
      "            SELECT \n",
      "                v.sampleid,\n",
      "                v.qual,\n",
      "                v.depth,\n",
      "                v.referenceallele,\n",
      "                v.alternatealleles[1] as alternate_allele,\n",
      "                v.filters[1] as filter_status,\n",
      "                \n",
      "                CASE WHEN cardinality(v.annotations.vep) > 0 THEN v.annotations.vep[1].symbol END as vep_gene,\n",
      "                CASE WHEN cardinality(v.annotations.vep) > 0 THEN v.annotations.vep[1].impact END as vep_impact,\n",
      "                \n",
      "                a.attributes['CLNSIG'] as clinical_significance,\n",
      "                split_part(a.attributes['GENEINFO'], ':', 1) as clinvar_gene\n",
      "                \n",
      "            FROM genomicsvariantstore v\n",
      "            LEFT JOIN genomicsannotationstore a ON (\n",
      "                REPLACE(v.contigname, 'chr', '') = REPLACE(a.contigname, 'chr', '')\n",
      "                AND v.start = a.start\n",
      "                AND v.referenceallele = a.referenceallele\n",
      "                AND v.alternatealleles[1] = a.alternatealleles[1]\n",
      "            )\n",
      "            WHERE v.filters[1] = 'PASS'\n",
      "                AND v.sampleid IN ('NA21135', 'NA21144')\n",
      "        )\n",
      "\n",
      "        SELECT \n",
      "            sampleid,\n",
      "            COUNT(*) as total_variants,\n",
      "            \n",
      "            COUNT(CASE WHEN clinical_significance = 'Pathogenic' THEN 1 END) as pathogenic_count,\n",
      "            COUNT(CASE WHEN clinical_significance = 'Likely_pathogenic' THEN 1 END) as likely_pathogenic_count,\n",
      "            COUNT(CASE WHEN clinical_significance = 'Uncertain_significance' THEN 1 END) as vus_count,\n",
      "            COUNT(CASE WHEN clinical_significance IN ('Benign', 'Likely_benign') THEN 1 END) as benign_count,\n",
      "            \n",
      "            COUNT(CASE WHEN vep_impact = 'HIGH' THEN 1 END) as high_impact_count,\n",
      "            COUNT(CASE WHEN vep_impact = 'MODERATE' THEN 1 END) as moderate_impact_count,\n",
      "            COUNT(CASE WHEN vep_impact = 'LOW' THEN 1 END) as low_impact_count,\n",
      "            COUNT(CASE WHEN vep_impact = 'MODIFIER' THEN 1 END) as modifier_impact_count,\n",
      "            \n",
      "            ROUND(AVG(CAST(qual as DOUBLE)), 2) as avg_quality,\n",
      "            ROUND(AVG(CAST(depth as DOUBLE)), 2) as avg_depth,\n",
      "            MIN(qual) as min_quality,\n",
      "            MAX(qual) as max_quality,\n",
      "            \n",
      "            COUNT(DISTINCT COALESCE(clinvar_gene, vep_gene)) as unique_genes_affected,\n",
      "            \n",
      "            COUNT(CASE \n",
      "                WHEN LENGTH(referenceallele) = 1 AND LENGTH(alternate_allele) = 1 \n",
      "                THEN 1 \n",
      "            END) as snv_count,\n",
      "            \n",
      "            COUNT(CASE \n",
      "                WHEN LENGTH(referenceallele) > LENGTH(alternate_allele) \n",
      "                THEN 1 \n",
      "            END) as deletion_count,\n",
      "            \n",
      "            COUNT(CASE \n",
      "                WHEN LENGTH(referenceallele) < LENGTH(alternate_allele) \n",
      "                THEN 1 \n",
      "            END) as insertion_count,\n",
      "            \n",
      "            ROUND(\n",
      "                COUNT(CASE WHEN clinical_significance IN ('Pathogenic', 'Likely_pathogenic') THEN 1 END) * 100.0 / COUNT(*), \n",
      "                2\n",
      "            ) as pathogenic_percentage\n",
      "\n",
      "        FROM sample_variants\n",
      "        GROUP BY sampleid\n",
      "        ORDER BY sampleid\n",
      "        \n",
      "====================================================================================\n",
      "Executing query on database '<YOUR_AWS_PROFILE>': \n",
      "        \n",
      "        WITH sample_variants AS (\n",
      "            SELECT \n",
      "                v.sampleid,\n",
      "                v.qual,\n",
      "                v.depth,\n",
      "                v.referenceallele,\n",
      "                v.alternatealleles[1] as alternate_allele,\n",
      "                v.filters[1] as filter_status,\n",
      "                \n",
      "                CASE WHEN cardinality(v.annotations.vep) > 0 THEN v.annotations.vep[1].symbol END as vep_gene,\n",
      "                CASE WHEN cardinality(v.annotations.vep) > 0 THEN v.annotations.vep[1].impact END as vep_impact,\n",
      "                \n",
      "                a.attributes['CLNSIG'] as clinical_significance,\n",
      "                split_part(a.attributes['GENEINFO'], ':', 1) as clinvar_gene\n",
      "                \n",
      "            FROM genomicsvariantstore v\n",
      "            LEFT JOIN genomicsannotationstore a ON (\n",
      "                REPLACE(v.contigname, 'chr', '') = REPLACE(a.contigname, 'chr', '')\n",
      "                AND v.start = a.start\n",
      "                AND v.referenceallele = a.referenceallele\n",
      "                AND v.alternatealleles[1] = a.alternatealleles[1]\n",
      "            )\n",
      "            WHERE v.filters[1] = 'PASS'\n",
      "                AND v.sampleid IN ('NA21135', 'NA21144')\n",
      "        )\n",
      "\n",
      "        SELECT \n",
      "            sampleid,\n",
      "            COUNT(*) as total_variants,\n",
      "            \n",
      "            COUNT(CASE WHEN clinical_significance = 'Pathogenic' THEN 1 END) as pathogenic_count,\n",
      "            COUNT(CASE WHEN clinical_significance = 'Likely_pathogenic' THEN 1 END) as likely_pathogenic_count,\n",
      "            COUNT(CASE WHEN clinical_significance = 'Uncertain_significance' THEN 1 END) as vus_count,\n",
      "            COUNT(CASE WHEN clinical_significance IN ('Benign', 'Likely_benign') THEN 1 END) as benign_count,\n",
      "            \n",
      "            COUNT(CASE WHEN vep_impact = 'HIGH' THEN 1 END) as high_impact_count,\n",
      "            COUNT(CASE WHEN vep_impact = 'MODERATE' THEN 1 END) as moderate_impact_count,\n",
      "            COUNT(CASE WHEN vep_impact = 'LOW' THEN 1 END) as low_impact_count,\n",
      "            COUNT(CASE WHEN vep_impact = 'MODIFIER' THEN 1 END) as modifier_impact_count,\n",
      "            \n",
      "            ROUND(AVG(CAST(qual as DOUBLE)), 2) as avg_quality,\n",
      "            ROUND(AVG(CAST(depth as DOUBLE)), 2) as avg_depth,\n",
      "            MIN(qual) as min_quality,\n",
      "            MAX(qual) as max_quality,\n",
      "            \n",
      "            COUNT(DISTINCT COALESCE(clinvar_gene, vep_gene)) as unique_genes_affected,\n",
      "            \n",
      "            COUNT(CASE \n",
      "                WHEN LENGTH(referenceallele) = 1 AND LENGTH(alternate_allele) = 1 \n",
      "                THEN 1 \n",
      "            END) as snv_count,\n",
      "            \n",
      "            COUNT(CASE \n",
      "                WHEN LENGTH(referenceallele) > LENGTH(alternate_allele) \n",
      "                THEN 1 \n",
      "            END) as deletion_count,\n",
      "            \n",
      "            COUNT(CASE \n",
      "                WHEN LENGTH(referenceallele) < LENGTH(alternate_allele) \n",
      "                THEN 1 \n",
      "            END) as insertion_count,\n",
      "            \n",
      "            ROUND(\n",
      "                COUNT(CASE WHEN clinical_significance IN ('Pathogenic', 'Likely_pathogenic') THEN 1 END) * 100.0 / COUNT(*), \n",
      "                2\n",
      "            ) as pathogenic_percentage\n",
      "\n",
      "        FROM sample_variants\n",
      "        GROUP BY sampleid\n",
      "        ORDER BY sampleid\n",
      "        \n",
      "Retrieved 2 total rows from Athena query\n",
      "Now, let me get more detailed information about the pathogenic and likely pathogenic variants in each patient by querying their variants separately:\n",
      "Tool #2: execute_dynamic_genomics_query\n",
      "Executing query on database '<YOUR_AWS_PROFILE>': SELECT \n",
      "    v.contigname,\n",
      "    v.start,\n",
      "    v.end,\n",
      "    v.referenceallele,\n",
      "    v.alternatealleles[1] as alt_allele,\n",
      "    CASE WHEN cardinality(v.annotations.vep) > 0 THEN v.annotations.vep[1].symbol END as gene_name,\n",
      "    a.attributes['CLNSIG'] as clinical_significance,\n",
      "    a.attributes['CLNDN'] as disease_name,\n",
      "    a.attributes['GENEINFO'] as gene_info,\n",
      "    a.attributes['CLNREVSTAT'] as review_status\n",
      "FROM \n",
      "    genomicsvariantstore v\n",
      "INNER JOIN \n",
      "    genomicsannotationstore a ON\n",
      "    REPLACE(v.contigname, 'chr', '') = a.contigname\n",
      "    AND v.start = a.start\n",
      "    AND v.referenceallele = a.referenceallele\n",
      "    AND v.alternatealleles[1] = a.alternatealleles[1]\n",
      "WHERE \n",
      "    v.sampleid = 'NA21135'\n",
      "    AND contains(v.filters, 'PASS')\n",
      "    AND v.qual > 30\n",
      "    AND a.attributes['CLNSIG'] IN ('Pathogenic', 'Likely_pathogenic')\n",
      "ORDER BY \n",
      "    v.contigname, \n",
      "    v.start\n",
      "====================================================================================\n",
      "Executing query on database '<YOUR_AWS_PROFILE>': \n",
      "        SELECT \n",
      "    v.contigname,\n",
      "    v.start,\n",
      "    v.end,\n",
      "    v.referenceallele,\n",
      "    v.alternatealleles[1] as alt_allele,\n",
      "    CASE WHEN cardinality(v.annotations.vep) > 0 THEN v.annotations.vep[1].symbol END as gene_name,\n",
      "    a.attributes['CLNSIG'] as clinical_significance,\n",
      "    a.attributes['CLNDN'] as disease_name,\n",
      "    a.attributes['GENEINFO'] as gene_info,\n",
      "    a.attributes['CLNREVSTAT'] as review_status\n",
      "FROM \n",
      "    genomicsvariantstore v\n",
      "INNER JOIN \n",
      "    genomicsannotationstore a ON\n",
      "    REPLACE(v.contigname, 'chr', '') = a.contigname\n",
      "    AND v.start = a.start\n",
      "    AND v.referenceallele = a.referenceallele\n",
      "    AND v.alternatealleles[1] = a.alternatealleles[1]\n",
      "WHERE \n",
      "    v.sampleid = 'NA21135'\n",
      "    AND contains(v.filters, 'PASS')\n",
      "    AND v.qual > 30\n",
      "    AND a.attributes['CLNSIG'] IN ('Pathogenic', 'Likely_pathogenic')\n",
      "ORDER BY \n",
      "    v.contigname, \n",
      "    v.start\n",
      "Error executing Athena query: An error occurred (InvalidRequestException) when calling the StartQueryExecution operation: Queries of this type are not supported\n",
      "Let me try a different approach to get the pathogenic variants:\n",
      "Tool #3: execute_dynamic_genomics_query\n",
      "Executing query on database '<YOUR_AWS_PROFILE>': SELECT \n",
      "    v.contigname,\n",
      "    v.start,\n",
      "    v.end,\n",
      "    v.referenceallele,\n",
      "    v.alternatealleles[1] AS alternateallele,\n",
      "    v.sampleid,\n",
      "    a.attributes['CLNSIG'] AS clinical_significance,\n",
      "    CASE WHEN cardinality(v.annotations.vep) > 0 THEN v.annotations.vep[1].symbol END AS gene_symbol,\n",
      "    a.attributes['CLNDN'] AS disease_name,\n",
      "    a.attributes['CLNREVSTAT'] AS review_status\n",
      "FROM \n",
      "    genomicsvariantstore v\n",
      "INNER JOIN \n",
      "    genomicsannotationstore a\n",
      "ON \n",
      "    REPLACE(v.contigname, 'chr', '') = a.contigname\n",
      "    AND v.start = a.start\n",
      "    AND v.referenceallele = a.referenceallele\n",
      "    AND v.alternatealleles[1] = a.alternatealleles[1]\n",
      "WHERE \n",
      "    v.sampleid IN ('NA21135', 'NA21144')\n",
      "    AND v.qual > 30 \n",
      "    AND contains(v.filters, 'PASS')\n",
      "    AND a.attributes['CLNSIG'] IN ('Pathogenic', 'Likely_pathogenic')\n",
      "ORDER BY \n",
      "    v.contigname,\n",
      "    v.start;\n",
      "====================================================================================\n",
      "Executing query on database '<YOUR_AWS_PROFILE>': \n",
      "        SELECT \n",
      "    v.contigname,\n",
      "    v.start,\n",
      "    v.end,\n",
      "    v.referenceallele,\n",
      "    v.alternatealleles[1] AS alternateallele,\n",
      "    v.sampleid,\n",
      "    a.attributes['CLNSIG'] AS clinical_significance,\n",
      "    CASE WHEN cardinality(v.annotations.vep) > 0 THEN v.annotations.vep[1].symbol END AS gene_symbol,\n",
      "    a.attributes['CLNDN'] AS disease_name,\n",
      "    a.attributes['CLNREVSTAT'] AS review_status\n",
      "FROM \n",
      "    genomicsvariantstore v\n",
      "INNER JOIN \n",
      "    genomicsannotationstore a\n",
      "ON \n",
      "    REPLACE(v.contigname, 'chr', '') = a.contigname\n",
      "    AND v.start = a.start\n",
      "    AND v.referenceallele = a.referenceallele\n",
      "    AND v.alternatealleles[1] = a.alternatealleles[1]\n",
      "WHERE \n",
      "    v.sampleid IN ('NA21135', 'NA21144')\n",
      "    AND v.qual > 30 \n",
      "    AND contains(v.filters, 'PASS')\n",
      "    AND a.attributes['CLNSIG'] IN ('Pathogenic', 'Likely_pathogenic')\n",
      "ORDER BY \n",
      "    v.contigname,\n",
      "    v.start;\n",
      "Error executing Athena query: An error occurred (InvalidRequestException) when calling the StartQueryExecution operation: Queries of this type are not supported\n",
      "Let me try a more direct approach to get the pathogenic variants for each sample:\n",
      "Tool #4: execute_dynamic_genomics_query\n",
      "Executing query on database '<YOUR_AWS_PROFILE>': SELECT \n",
      "    v.contigname, \n",
      "    v.start, \n",
      "    v.end, \n",
      "    v.referenceallele,\n",
      "    v.alternatealleles[1] as alt_allele,\n",
      "    CASE WHEN cardinality(v.annotations.vep) > 0 THEN v.annotations.vep[1].symbol END as gene,\n",
      "    CASE WHEN cardinality(v.annotations.vep) > 0 THEN v.annotations.vep[1].impact END as impact,\n",
      "    a.attributes['CLNSIG'] as clinical_significance,\n",
      "    a.attributes['CLNDN'] as disease_name,\n",
      "    a.attributes['GENEINFO'] as gene_info,\n",
      "    a.attributes['CLNREVSTAT'] as review_status\n",
      "FROM \n",
      "    genomicsvariantstore v\n",
      "INNER JOIN \n",
      "    genomicsannotationstore a\n",
      "ON \n",
      "    REPLACE(v.contigname, 'chr', '') = a.contigname\n",
      "    AND v.start = a.start\n",
      "    AND v.referenceallele = a.referenceallele\n",
      "    AND v.alternatealleles[1] = a.alternatealleles[1]\n",
      "WHERE \n",
      "    v.sampleid = 'NA21135'\n",
      "    AND a.attributes['CLNSIG'] IN ('Pathogenic', 'Likely_pathogenic')\n",
      "    AND contains(v.filters, 'PASS')\n",
      "    AND v.qual > 30\n",
      "ORDER BY \n",
      "    v.contigname, \n",
      "    v.start\n",
      "====================================================================================\n",
      "Executing query on database '<YOUR_AWS_PROFILE>': \n",
      "        SELECT \n",
      "    v.contigname, \n",
      "    v.start, \n",
      "    v.end, \n",
      "    v.referenceallele,\n",
      "    v.alternatealleles[1] as alt_allele,\n",
      "    CASE WHEN cardinality(v.annotations.vep) > 0 THEN v.annotations.vep[1].symbol END as gene,\n",
      "    CASE WHEN cardinality(v.annotations.vep) > 0 THEN v.annotations.vep[1].impact END as impact,\n",
      "    a.attributes['CLNSIG'] as clinical_significance,\n",
      "    a.attributes['CLNDN'] as disease_name,\n",
      "    a.attributes['GENEINFO'] as gene_info,\n",
      "    a.attributes['CLNREVSTAT'] as review_status\n",
      "FROM \n",
      "    genomicsvariantstore v\n",
      "INNER JOIN \n",
      "    genomicsannotationstore a\n",
      "ON \n",
      "    REPLACE(v.contigname, 'chr', '') = a.contigname\n",
      "    AND v.start = a.start\n",
      "    AND v.referenceallele = a.referenceallele\n",
      "    AND v.alternatealleles[1] = a.alternatealleles[1]\n",
      "WHERE \n",
      "    v.sampleid = 'NA21135'\n",
      "    AND a.attributes['CLNSIG'] IN ('Pathogenic', 'Likely_pathogenic')\n",
      "    AND contains(v.filters, 'PASS')\n",
      "    AND v.qual > 30\n",
      "ORDER BY \n",
      "    v.contigname, \n",
      "    v.start\n",
      "Error executing Athena query: An error occurred (InvalidRequestException) when calling the StartQueryExecution operation: Queries of this type are not supported\n",
      "Let me try a different approach to get the pathogenic variants by querying specific genes that are commonly associated with pathogenic variants:\n",
      "Tool #5: query_variants_by_gene\n",
      "Executing query on database '<YOUR_AWS_PROFILE>': \n",
      "        WITH variant_annotations AS (\n",
      "            SELECT \n",
      "                v.sampleid,\n",
      "                v.contigname,\n",
      "                v.start,\n",
      "                v.referenceallele,\n",
      "                v.alternatealleles[1] as alternate_allele,\n",
      "                v.qual,\n",
      "                v.depth,\n",
      "                v.information['af'] as allele_frequency_1000g,\n",
      "                v.filters[1] as filter_status,\n",
      "                \n",
      "                CASE WHEN cardinality(v.annotations.vep) > 0 THEN v.annotations.vep[1].symbol END as vep_gene,\n",
      "                CASE WHEN cardinality(v.annotations.vep) > 0 THEN v.annotations.vep[1].impact END as vep_impact,\n",
      "                CASE WHEN cardinality(v.annotations.vep) > 0 AND cardinality(v.annotations.vep[1].consequence) > 0 \n",
      "                     THEN v.annotations.vep[1].consequence[1] END as vep_consequence,\n",
      "                \n",
      "                a.attributes['CLNSIG'] as clinvar_significance,\n",
      "                a.attributes['CLNDN'] as associated_disease,\n",
      "                split_part(a.attributes['GENEINFO'], ':', 1) as clinvar_gene\n",
      "                \n",
      "            FROM genomicsvariantstore v\n",
      "            LEFT JOIN genomicsannotationstore a ON (\n",
      "                REPLACE(v.contigname, 'chr', '') = REPLACE(a.contigname, 'chr', '')\n",
      "                AND v.start = a.start\n",
      "                AND v.referenceallele = a.referenceallele\n",
      "                AND v.alternatealleles[1] = a.alternatealleles[1]\n",
      "            )\n",
      "            WHERE v.qual > 30 \n",
      "                AND contains(v.filters, 'PASS')\n",
      "                AND (\n",
      "                    (cardinality(v.annotations.vep) > 0 AND UPPER(v.annotations.vep[1].symbol) IN ('BRCA1', 'BRCA2', 'TP53', 'CFTR', 'PTEN', 'MLH1', 'MSH2', 'APC', 'LDLR', 'APOB'))\n",
      "                    OR UPPER(split_part(a.attributes['GENEINFO'], ':', 1)) IN ('BRCA1', 'BRCA2', 'TP53', 'CFTR', 'PTEN', 'MLH1', 'MSH2', 'APC', 'LDLR', 'APOB')\n",
      "                )\n",
      "                AND v.sampleid IN ('NA21135', 'NA21144')\n",
      "        )\n",
      "        \n",
      "        SELECT \n",
      "            sampleid,\n",
      "            CONCAT(contigname, ':', CAST(start as VARCHAR), ':', referenceallele, '>', alternate_allele) as variant_id,\n",
      "            COALESCE(clinvar_gene, vep_gene) as gene_symbol,\n",
      "            vep_consequence as consequence,\n",
      "            vep_impact as impact,\n",
      "            clinvar_significance,\n",
      "            associated_disease,\n",
      "            qual,\n",
      "            depth,\n",
      "            allele_frequency_1000g,\n",
      "            \n",
      "            CASE \n",
      "                WHEN clinvar_significance = 'Pathogenic' AND vep_impact = 'HIGH' THEN 10\n",
      "                WHEN clinvar_significance = 'Pathogenic' AND vep_impact = 'MODERATE' THEN 9\n",
      "                WHEN clinvar_significance = 'Likely_pathogenic' AND vep_impact = 'HIGH' THEN 8\n",
      "                WHEN clinvar_significance = 'Likely_pathogenic' AND vep_impact = 'MODERATE' THEN 7\n",
      "                WHEN clinvar_significance = 'Uncertain_significance' AND vep_impact = 'HIGH' THEN 6\n",
      "                WHEN vep_impact = 'HIGH' THEN 5\n",
      "                WHEN clinvar_significance = 'Uncertain_significance' AND vep_impact = 'MODERATE' THEN 4\n",
      "                ELSE 1\n",
      "            END as priority_score\n",
      "\n",
      "        FROM variant_annotations\n",
      "        ORDER BY priority_score DESC, qual DESC\n",
      "        \n",
      "====================================================================================\n",
      "Executing query on database '<YOUR_AWS_PROFILE>': \n",
      "        \n",
      "        WITH variant_annotations AS (\n",
      "            SELECT \n",
      "                v.sampleid,\n",
      "                v.contigname,\n",
      "                v.start,\n",
      "                v.referenceallele,\n",
      "                v.alternatealleles[1] as alternate_allele,\n",
      "                v.qual,\n",
      "                v.depth,\n",
      "                v.information['af'] as allele_frequency_1000g,\n",
      "                v.filters[1] as filter_status,\n",
      "                \n",
      "                CASE WHEN cardinality(v.annotations.vep) > 0 THEN v.annotations.vep[1].symbol END as vep_gene,\n",
      "                CASE WHEN cardinality(v.annotations.vep) > 0 THEN v.annotations.vep[1].impact END as vep_impact,\n",
      "                CASE WHEN cardinality(v.annotations.vep) > 0 AND cardinality(v.annotations.vep[1].consequence) > 0 \n",
      "                     THEN v.annotations.vep[1].consequence[1] END as vep_consequence,\n",
      "                \n",
      "                a.attributes['CLNSIG'] as clinvar_significance,\n",
      "                a.attributes['CLNDN'] as associated_disease,\n",
      "                split_part(a.attributes['GENEINFO'], ':', 1) as clinvar_gene\n",
      "                \n",
      "            FROM genomicsvariantstore v\n",
      "            LEFT JOIN genomicsannotationstore a ON (\n",
      "                REPLACE(v.contigname, 'chr', '') = REPLACE(a.contigname, 'chr', '')\n",
      "                AND v.start = a.start\n",
      "                AND v.referenceallele = a.referenceallele\n",
      "                AND v.alternatealleles[1] = a.alternatealleles[1]\n",
      "            )\n",
      "            WHERE v.qual > 30 \n",
      "                AND contains(v.filters, 'PASS')\n",
      "                AND (\n",
      "                    (cardinality(v.annotations.vep) > 0 AND UPPER(v.annotations.vep[1].symbol) IN ('BRCA1', 'BRCA2', 'TP53', 'CFTR', 'PTEN', 'MLH1', 'MSH2', 'APC', 'LDLR', 'APOB'))\n",
      "                    OR UPPER(split_part(a.attributes['GENEINFO'], ':', 1)) IN ('BRCA1', 'BRCA2', 'TP53', 'CFTR', 'PTEN', 'MLH1', 'MSH2', 'APC', 'LDLR', 'APOB')\n",
      "                )\n",
      "                AND v.sampleid IN ('NA21135', 'NA21144')\n",
      "        )\n",
      "        \n",
      "        SELECT \n",
      "            sampleid,\n",
      "            CONCAT(contigname, ':', CAST(start as VARCHAR), ':', referenceallele, '>', alternate_allele) as variant_id,\n",
      "            COALESCE(clinvar_gene, vep_gene) as gene_symbol,\n",
      "            vep_consequence as consequence,\n",
      "            vep_impact as impact,\n",
      "            clinvar_significance,\n",
      "            associated_disease,\n",
      "            qual,\n",
      "            depth,\n",
      "            allele_frequency_1000g,\n",
      "            \n",
      "            CASE \n",
      "                WHEN clinvar_significance = 'Pathogenic' AND vep_impact = 'HIGH' THEN 10\n",
      "                WHEN clinvar_significance = 'Pathogenic' AND vep_impact = 'MODERATE' THEN 9\n",
      "                WHEN clinvar_significance = 'Likely_pathogenic' AND vep_impact = 'HIGH' THEN 8\n",
      "                WHEN clinvar_significance = 'Likely_pathogenic' AND vep_impact = 'MODERATE' THEN 7\n",
      "                WHEN clinvar_significance = 'Uncertain_significance' AND vep_impact = 'HIGH' THEN 6\n",
      "                WHEN vep_impact = 'HIGH' THEN 5\n",
      "                WHEN clinvar_significance = 'Uncertain_significance' AND vep_impact = 'MODERATE' THEN 4\n",
      "                ELSE 1\n",
      "            END as priority_score\n",
      "\n",
      "        FROM variant_annotations\n",
      "        ORDER BY priority_score DESC, qual DESC\n",
      "        \n",
      "Retrieved 2375 total rows from Athena query\n",
      "Let me try one more approach to get a comprehensive view of the pathogenic variants in these samples:\n",
      "Tool #6: execute_dynamic_genomics_query\n",
      "Executing query on database '<YOUR_AWS_PROFILE>': SELECT \n",
      "    v.contigname,\n",
      "    v.start,\n",
      "    v.end,\n",
      "    v.referenceallele,\n",
      "    v.alternatealleles[1] AS alt_allele,\n",
      "    CASE WHEN cardinality(v.annotations.vep) > 0 THEN v.annotations.vep[1].symbol END AS gene_symbol,\n",
      "    CASE WHEN cardinality(v.annotations.vep) > 0 THEN v.annotations.vep[1].impact END AS impact,\n",
      "    a.attributes['CLNSIG'] AS clinical_significance,\n",
      "    v.sampleid\n",
      "FROM \n",
      "    genomicsvariantstore v\n",
      "LEFT JOIN \n",
      "    genomicsannotationstore a\n",
      "ON \n",
      "    REPLACE(v.contigname, 'chr', '') = a.contigname\n",
      "    AND v.start = a.start\n",
      "    AND v.referenceallele = a.referenceallele\n",
      "    AND v.alternatealleles[1] = a.alternatealleles[1]\n",
      "WHERE \n",
      "    (v.sampleid = 'NA21135' OR v.sampleid = 'NA21144')\n",
      "    AND (\n",
      "        (CASE WHEN cardinality(v.annotations.vep) > 0 THEN v.annotations.vep[1].impact END = 'HIGH')\n",
      "        OR LOWER(a.attributes['CLNSIG']) LIKE '%pathogenic%'\n",
      "    )\n",
      "    AND v.qual > 30\n",
      "    AND contains(v.filters, 'PASS')\n",
      "====================================================================================\n",
      "Executing query on database '<YOUR_AWS_PROFILE>': \n",
      "        SELECT \n",
      "    v.contigname,\n",
      "    v.start,\n",
      "    v.end,\n",
      "    v.referenceallele,\n",
      "    v.alternatealleles[1] AS alt_allele,\n",
      "    CASE WHEN cardinality(v.annotations.vep) > 0 THEN v.annotations.vep[1].symbol END AS gene_symbol,\n",
      "    CASE WHEN cardinality(v.annotations.vep) > 0 THEN v.annotations.vep[1].impact END AS impact,\n",
      "    a.attributes['CLNSIG'] AS clinical_significance,\n",
      "    v.sampleid\n",
      "FROM \n",
      "    genomicsvariantstore v\n",
      "LEFT JOIN \n",
      "    genomicsannotationstore a\n",
      "ON \n",
      "    REPLACE(v.contigname, 'chr', '') = a.contigname\n",
      "    AND v.start = a.start\n",
      "    AND v.referenceallele = a.referenceallele\n",
      "    AND v.alternatealleles[1] = a.alternatealleles[1]\n",
      "WHERE \n",
      "    (v.sampleid = 'NA21135' OR v.sampleid = 'NA21144')\n",
      "    AND (\n",
      "        (CASE WHEN cardinality(v.annotations.vep) > 0 THEN v.annotations.vep[1].impact END = 'HIGH')\n",
      "        OR LOWER(a.attributes['CLNSIG']) LIKE '%pathogenic%'\n",
      "    )\n",
      "    AND v.qual > 30\n",
      "    AND contains(v.filters, 'PASS')\n",
      "Error executing Athena query: An error occurred (InvalidRequestException) when calling the StartQueryExecution operation: Queries of this type are not supported\n",
      "Based on the data I've gathered, let me provide a comprehensive comparison of the pathogenicity profiles of patients NA21135 and NA21144:\n",
      "\n",
      "# Pathogenicity Profile Comparison: NA21135 vs NA21144\n",
      "\n",
      "## Overall Variant Profile\n",
      "\n",
      "| Metric | NA21135 | NA21144 |\n",
      "|--------|---------|---------|\n",
      "| Total Variants | 4,978,141 | 5,013,114 |\n",
      "| Pathogenic Variants | 4 | 2 |\n",
      "| Likely Pathogenic Variants | 1 | 1 |\n",
      "| Variants of Uncertain Significance (VUS) | 267 | 282 |\n",
      "| Benign Variants | 42,258 | 42,323 |\n",
      "| High Impact Variants | 520 | 560 |\n",
      "| Moderate Impact Variants | 9,841 | 10,001 |\n",
      "| Low Impact Variants | 16,752 | 16,656 |\n",
      "| Unique Genes Affected | 31,214 | 31,085 |\n",
      "\n",
      "## Detailed Analysis\n",
      "\n",
      "### Pathogenic and Likely Pathogenic Variants\n",
      "Despite the sample comparison tool indicating the presence of pathogenic and likely pathogenic variants (4 pathogenic and 1 likely pathogenic in NA21135; 2 pathogenic and 1 likely pathogenic in NA21144), our detailed queries did not return specific information about these variants. This suggests these variants may be in genes other than the common cancer and disease-associated genes we specifically queried.\n",
      "\n",
      "### High Impact Variants\n",
      "NA21144 has slightly more high-impact variants (560) compared to NA21135 (520), which could potentially indicate a higher genetic risk burden for certain conditions.\n",
      "\n",
      "### Variants of Uncertain Significance (VUS)\n",
      "NA21144 has more VUS (282) compared to NA21135 (267). These variants require monitoring as their clinical significance may be reclassified as more evidence becomes available.\n",
      "\n",
      "### Gene-Specific Analysis\n",
      "In our query of common disease-associated genes (BRCA1, BRCA2, TP53, CFTR, PTEN, MLH1, MSH2, APC, LDLR, APOB), we found:\n",
      "- Most variants in these genes were classified as benign or of modifier impact\n",
      "- No pathogenic variants were identified in these specific genes\n",
      "- Both patients share common benign variants in several genes, including MSH2, BRCA2, and LDLR\n",
      "\n",
      "## Comparative Genetic Risk Assessment\n",
      "\n",
      "1. **Overall Pathogenic Burden**: NA21135 has a higher number of pathogenic variants (4 vs 2), suggesting potentially higher genetic risk for certain conditions.\n",
      "\n",
      "2. **High Impact Variants**: NA21144 has more high-impact variants (560 vs 520), which could affect protein function more significantly.\n",
      "\n",
      "3. **Variant Distribution**: Both patients have a similar distribution of variant types (SNVs, insertions, deletions), indicating no major structural variation differences.\n",
      "\n",
      "4. **Quality Metrics**: NA21135 has slightly higher average quality scores (86.94 vs 80.34) and depth of coverage (33.6 vs 28.46), suggesting more reliable variant calls.\n",
      "\n",
      "## Clinical Implications\n",
      "\n",
      "1. **Shared Genetic Background**: Both patients show similar overall genetic profiles, with the vast majority of variants being benign or of modifier impact.\n",
      "\n",
      "2. **Differential Risk**: NA21135 has more pathogenic variants, suggesting potentially higher risk for certain genetic conditions, though the specific conditions cannot be determined without knowing which genes contain these pathogenic variants.\n",
      "\n",
      "3. **Uncertain Findings**: Both patients have a substantial number of VUS that should be monitored for reclassification over time.\n",
      "\n",
      "4. **Follow-up Recommendations**:\n",
      "   - Further investigation of the specific pathogenic variants in both patients\n",
      "   - Periodic reassessment of VUS as knowledge evolves\n",
      "   - Family studies may be warranted to assess inheritance patterns\n",
      "\n",
      "In conclusion, while NA21135 has more pathogenic variants, and NA21144 has more high-impact variants, the overall genetic risk burden appears similar between the two patients. Without specific information about which genes contain the pathogenic variants, it's difficult to make precise clinical risk assessments. Further targeted analysis of the pathogenic variants would be necessary for more definitive clinical guidance.VCF Supervisor agent Response:\n",
      "Based on the data I've gathered, let me provide a comprehensive comparison of the pathogenicity profiles of patients NA21135 and NA21144:\n",
      "\n",
      "# Pathogenicity Profile Comparison: NA21135 vs NA21144\n",
      "\n",
      "## Overall Variant Profile\n",
      "\n",
      "| Metric | NA21135 | NA21144 |\n",
      "|--------|---------|---------|\n",
      "| Total Variants | 4,978,141 | 5,013,114 |\n",
      "| Pathogenic Variants | 4 | 2 |\n",
      "| Likely Pathogenic Variants | 1 | 1 |\n",
      "| Variants of Uncertain Significance (VUS) | 267 | 282 |\n",
      "| Benign Variants | 42,258 | 42,323 |\n",
      "| High Impact Variants | 520 | 560 |\n",
      "| Moderate Impact Variants | 9,841 | 10,001 |\n",
      "| Low Impact Variants | 16,752 | 16,656 |\n",
      "| Unique Genes Affected | 31,214 | 31,085 |\n",
      "\n",
      "## Detailed Analysis\n",
      "\n",
      "### Pathogenic and Likely Pathogenic Variants\n",
      "Despite the sample comparison tool indicating the presence of pathogenic and likely pathogenic variants (4 pathogenic and 1 likely pathogenic in NA21135; 2 pathogenic and 1 likely pathogenic in NA21144), our detailed queries did not return specific information about these variants. This suggests these variants may be in genes other than the common cancer and disease-associated genes we specifically queried.\n",
      "\n",
      "### High Impact Variants\n",
      "NA21144 has slightly more high-impact variants (560) compared to NA21135 (520), which could potentially indicate a higher genetic risk burden for certain conditions.\n",
      "\n",
      "### Variants of Uncertain Significance (VUS)\n",
      "NA21144 has more VUS (282) compared to NA21135 (267). These variants require monitoring as their clinical significance may be reclassified as more evidence becomes available.\n",
      "\n",
      "### Gene-Specific Analysis\n",
      "In our query of common disease-associated genes (BRCA1, BRCA2, TP53, CFTR, PTEN, MLH1, MSH2, APC, LDLR, APOB), we found:\n",
      "- Most variants in these genes were classified as benign or of modifier impact\n",
      "- No pathogenic variants were identified in these specific genes\n",
      "- Both patients share common benign variants in several genes, including MSH2, BRCA2, and LDLR\n",
      "\n",
      "## Comparative Genetic Risk Assessment\n",
      "\n",
      "1. **Overall Pathogenic Burden**: NA21135 has a higher number of pathogenic variants (4 vs 2), suggesting potentially higher genetic risk for certain conditions.\n",
      "\n",
      "2. **High Impact Variants**: NA21144 has more high-impact variants (560 vs 520), which could affect protein function more significantly.\n",
      "\n",
      "3. **Variant Distribution**: Both patients have a similar distribution of variant types (SNVs, insertions, deletions), indicating no major structural variation differences.\n",
      "\n",
      "4. **Quality Metrics**: NA21135 has slightly higher average quality scores (86.94 vs 80.34) and depth of coverage (33.6 vs 28.46), suggesting more reliable variant calls.\n",
      "\n",
      "## Clinical Implications\n",
      "\n",
      "1. **Shared Genetic Background**: Both patients show similar overall genetic profiles, with the vast majority of variants being benign or of modifier impact.\n",
      "\n",
      "2. **Differential Risk**: NA21135 has more pathogenic variants, suggesting potentially higher risk for certain genetic conditions, though the specific conditions cannot be determined without knowing which genes contain these pathogenic variants.\n",
      "\n",
      "3. **Uncertain Findings**: Both patients have a substantial number of VUS that should be monitored for reclassification over time.\n",
      "\n",
      "4. **Follow-up Recommendations**:\n",
      "   - Further investigation of the specific pathogenic variants in both patients\n",
      "   - Periodic reassessment of VUS as knowledge evolves\n",
      "   - Family studies may be warranted to assess inheritance patterns\n",
      "\n",
      "In conclusion, while NA21135 has more pathogenic variants, and NA21144 has more high-impact variants, the overall genetic risk burden appears similar between the two patients. Without specific information about which genes contain the pathogenic variants, it's difficult to make precise clinical risk assessments. Further targeted analysis of the pathogenic variants would be necessary for more definitive clinical guidance.\n",
      "\n"
     ]
    }
   ],
   "source": [
    "response = orchestrator(\"Can you compare the pathogenicity of patients in my cohort?\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "id": "<YOUR_JOB_ID>",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "I'll analyze the cohort for pathogenic and likely pathogenic variants across all samples. This will provide valuable clinical insights about disease-causing mutations in the patient population.\n",
      "\n",
      "To get a comprehensive view of clinically significant variants, I'll use the allele frequency analysis tool which will identify pathogenic and likely pathogenic variants across all samples in the cohort.\n",
      "Tool #1: analyze_allele_frequencies\n",
      "Executing query on database '<YOUR_AWS_PROFILE>': \n",
      "        WITH variant_data AS (\n",
      "            SELECT \n",
      "                v.sampleid,\n",
      "                v.contigname,\n",
      "                v.start,\n",
      "                v.referenceallele,\n",
      "                v.alternatealleles[1] as alternate_allele,\n",
      "                v.qual,\n",
      "                v.depth,\n",
      "                \n",
      "                CASE WHEN cardinality(v.annotations.vep) > 0 THEN v.annotations.vep[1].symbol END as vep_gene,\n",
      "                CASE WHEN cardinality(v.annotations.vep) > 0 THEN v.annotations.vep[1].impact END as vep_impact,\n",
      "                CASE WHEN cardinality(v.annotations.vep) > 0 AND cardinality(v.annotations.vep[1].consequence) > 0 \n",
      "                     THEN v.annotations.vep[1].consequence[1] END as vep_consequence,\n",
      "                \n",
      "                a.attributes['CLNSIG'] as clinical_significance,\n",
      "                split_part(a.attributes['GENEINFO'], ':', 1) as clinvar_gene,\n",
      "                \n",
      "                TRY_CAST(v.information['af'] as DOUBLE) as allele_frequency,\n",
      "                TRY_CAST(v.information['dp'] as INTEGER) as total_depth,\n",
      "                TRY_CAST(v.information['mq'] as DOUBLE) as mapping_quality\n",
      "                \n",
      "            FROM genomicsvariantstore v\n",
      "            LEFT JOIN genomicsannotationstore a ON (\n",
      "                REPLACE(v.contigname, 'chr', '') = REPLACE(a.contigname, 'chr', '')\n",
      "                AND v.start = a.start\n",
      "                AND v.referenceallele = a.referenceallele\n",
      "                AND v.alternatealleles[1] = a.alternatealleles[1]\n",
      "            )\n",
      "            WHERE v.information['af'] IS NOT NULL\n",
      "                AND v.qual > 30 \n",
      "                AND contains(v.filters, 'PASS')\n",
      "                \n",
      "        )\n",
      "\n",
      "        SELECT \n",
      "            sampleid,\n",
      "            COALESCE(clinvar_gene, vep_gene) as gene_symbol,\n",
      "            contigname,\n",
      "            start,\n",
      "            referenceallele,\n",
      "            alternate_allele,\n",
      "            qual,\n",
      "            depth,\n",
      "            allele_frequency,\n",
      "            total_depth,\n",
      "            mapping_quality,\n",
      "            clinical_significance,\n",
      "            vep_impact,\n",
      "            vep_consequence as consequence,\n",
      "            \n",
      "            CASE \n",
      "                WHEN qual > 100 AND depth > 20 THEN 'High Quality'\n",
      "                WHEN qual > 50 AND depth > 10 THEN 'Medium Quality'\n",
      "                ELSE 'Low Quality'\n",
      "            END as quality_tier,\n",
      "            \n",
      "            CASE \n",
      "                WHEN allele_frequency < 0.001 THEN 'Very Rare'\n",
      "                WHEN allele_frequency < 0.01 THEN 'Rare'\n",
      "                WHEN allele_frequency < 0.05 THEN 'Uncommon'\n",
      "                WHEN allele_frequency IS NOT NULL THEN 'Common'\n",
      "                ELSE 'Unknown'\n",
      "            END as rarity_category,\n",
      "            \n",
      "            CASE \n",
      "                WHEN allele_frequency IS NOT NULL AND allele_frequency > 0 \n",
      "                THEN ROUND(-LOG10(allele_frequency), 2)\n",
      "                ELSE NULL\n",
      "            END as rarity_score,\n",
      "            \n",
      "            CASE \n",
      "                WHEN allele_frequency IS NOT NULL AND allele_frequency > 0 AND allele_frequency < 1\n",
      "                THEN ROUND(2 * allele_frequency * (1 - allele_frequency), 4)\n",
      "                ELSE NULL\n",
      "            END as expected_het_frequency\n",
      "\n",
      "        FROM variant_data\n",
      "        WHERE allele_frequency IS NOT NULL\n",
      "        ORDER BY allele_frequency ASC, qual DESC\n",
      "        \n",
      "====================================================================================\n",
      "Executing query on database '<YOUR_AWS_PROFILE>': \n",
      "        \n",
      "        WITH variant_data AS (\n",
      "            SELECT \n",
      "                v.sampleid,\n",
      "                v.contigname,\n",
      "                v.start,\n",
      "                v.referenceallele,\n",
      "                v.alternatealleles[1] as alternate_allele,\n",
      "                v.qual,\n",
      "                v.depth,\n",
      "                \n",
      "                CASE WHEN cardinality(v.annotations.vep) > 0 THEN v.annotations.vep[1].symbol END as vep_gene,\n",
      "                CASE WHEN cardinality(v.annotations.vep) > 0 THEN v.annotations.vep[1].impact END as vep_impact,\n",
      "                CASE WHEN cardinality(v.annotations.vep) > 0 AND cardinality(v.annotations.vep[1].consequence) > 0 \n",
      "                     THEN v.annotations.vep[1].consequence[1] END as vep_consequence,\n",
      "                \n",
      "                a.attributes['CLNSIG'] as clinical_significance,\n",
      "                split_part(a.attributes['GENEINFO'], ':', 1) as clinvar_gene,\n",
      "                \n",
      "                TRY_CAST(v.information['af'] as DOUBLE) as allele_frequency,\n",
      "                TRY_CAST(v.information['dp'] as INTEGER) as total_depth,\n",
      "                TRY_CAST(v.information['mq'] as DOUBLE) as mapping_quality\n",
      "                \n",
      "            FROM genomicsvariantstore v\n",
      "            LEFT JOIN genomicsannotationstore a ON (\n",
      "                REPLACE(v.contigname, 'chr', '') = REPLACE(a.contigname, 'chr', '')\n",
      "                AND v.start = a.start\n",
      "                AND v.referenceallele = a.referenceallele\n",
      "                AND v.alternatealleles[1] = a.alternatealleles[1]\n",
      "            )\n",
      "            WHERE v.information['af'] IS NOT NULL\n",
      "                AND v.qual > 30 \n",
      "                AND contains(v.filters, 'PASS')\n",
      "                \n",
      "        )\n",
      "\n",
      "        SELECT \n",
      "            sampleid,\n",
      "            COALESCE(clinvar_gene, vep_gene) as gene_symbol,\n",
      "            contigname,\n",
      "            start,\n",
      "            referenceallele,\n",
      "            alternate_allele,\n",
      "            qual,\n",
      "            depth,\n",
      "            allele_frequency,\n",
      "            total_depth,\n",
      "            mapping_quality,\n",
      "            clinical_significance,\n",
      "            vep_impact,\n",
      "            vep_consequence as consequence,\n",
      "            \n",
      "            CASE \n",
      "                WHEN qual > 100 AND depth > 20 THEN 'High Quality'\n",
      "                WHEN qual > 50 AND depth > 10 THEN 'Medium Quality'\n",
      "                ELSE 'Low Quality'\n",
      "            END as quality_tier,\n",
      "            \n",
      "            CASE \n",
      "                WHEN allele_frequency < 0.001 THEN 'Very Rare'\n",
      "                WHEN allele_frequency < 0.01 THEN 'Rare'\n",
      "                WHEN allele_frequency < 0.05 THEN 'Uncommon'\n",
      "                WHEN allele_frequency IS NOT NULL THEN 'Common'\n",
      "                ELSE 'Unknown'\n",
      "            END as rarity_category,\n",
      "            \n",
      "            CASE \n",
      "                WHEN allele_frequency IS NOT NULL AND allele_frequency > 0 \n",
      "                THEN ROUND(-LOG10(allele_frequency), 2)\n",
      "                ELSE NULL\n",
      "            END as rarity_score,\n",
      "            \n",
      "            CASE \n",
      "                WHEN allele_frequency IS NOT NULL AND allele_frequency > 0 AND allele_frequency < 1\n",
      "                THEN ROUND(2 * allele_frequency * (1 - allele_frequency), 4)\n",
      "                ELSE NULL\n",
      "            END as expected_het_frequency\n",
      "\n",
      "        FROM variant_data\n",
      "        WHERE allele_frequency IS NOT NULL\n",
      "        ORDER BY allele_frequency ASC, qual DESC\n",
      "        \n",
      "Retrieved 0 total rows from Athena query\n",
      "I'll now query for pathogenic and likely pathogenic variants across key disease-associated genes. Let me start with a set of clinically important genes that are commonly associated with pathogenic variants:\n",
      "Tool #2: query_variants_by_gene\n",
      "Executing query on database '<YOUR_AWS_PROFILE>': \n",
      "        WITH variant_annotations AS (\n",
      "            SELECT \n",
      "                v.sampleid,\n",
      "                v.contigname,\n",
      "                v.start,\n",
      "                v.referenceallele,\n",
      "                v.alternatealleles[1] as alternate_allele,\n",
      "                v.qual,\n",
      "                v.depth,\n",
      "                v.information['af'] as allele_frequency_1000g,\n",
      "                v.filters[1] as filter_status,\n",
      "                \n",
      "                CASE WHEN cardinality(v.annotations.vep) > 0 THEN v.annotations.vep[1].symbol END as vep_gene,\n",
      "                CASE WHEN cardinality(v.annotations.vep) > 0 THEN v.annotations.vep[1].impact END as vep_impact,\n",
      "                CASE WHEN cardinality(v.annotations.vep) > 0 AND cardinality(v.annotations.vep[1].consequence) > 0 \n",
      "                     THEN v.annotations.vep[1].consequence[1] END as vep_consequence,\n",
      "                \n",
      "                a.attributes['CLNSIG'] as clinvar_significance,\n",
      "                a.attributes['CLNDN'] as associated_disease,\n",
      "                split_part(a.attributes['GENEINFO'], ':', 1) as clinvar_gene\n",
      "                \n",
      "            FROM genomicsvariantstore v\n",
      "            LEFT JOIN genomicsannotationstore a ON (\n",
      "                REPLACE(v.contigname, 'chr', '') = REPLACE(a.contigname, 'chr', '')\n",
      "                AND v.start = a.start\n",
      "                AND v.referenceallele = a.referenceallele\n",
      "                AND v.alternatealleles[1] = a.alternatealleles[1]\n",
      "            )\n",
      "            WHERE v.qual > 30 \n",
      "                AND contains(v.filters, 'PASS')\n",
      "                AND (\n",
      "                    (cardinality(v.annotations.vep) > 0 AND UPPER(v.annotations.vep[1].symbol) IN ('BRCA1', 'BRCA2', 'TP53', 'PTEN', 'MLH1', 'MSH2', 'MSH6', 'PMS2', 'APC', 'ATM', 'PALB2', 'CHEK2', 'BARD1', 'BRIP1', 'CDH1', 'NF1', 'RAD51C', 'RAD51D', 'STK11'))\n",
      "                    OR UPPER(split_part(a.attributes['GENEINFO'], ':', 1)) IN ('BRCA1', 'BRCA2', 'TP53', 'PTEN', 'MLH1', 'MSH2', 'MSH6', 'PMS2', 'APC', 'ATM', 'PALB2', 'CHEK2', 'BARD1', 'BRIP1', 'CDH1', 'NF1', 'RAD51C', 'RAD51D', 'STK11')\n",
      "                )\n",
      "                \n",
      "        )\n",
      "        \n",
      "        SELECT \n",
      "            sampleid,\n",
      "            CONCAT(contigname, ':', CAST(start as VARCHAR), ':', referenceallele, '>', alternate_allele) as variant_id,\n",
      "            COALESCE(clinvar_gene, vep_gene) as gene_symbol,\n",
      "            vep_consequence as consequence,\n",
      "            vep_impact as impact,\n",
      "            clinvar_significance,\n",
      "            associated_disease,\n",
      "            qual,\n",
      "            depth,\n",
      "            allele_frequency_1000g,\n",
      "            \n",
      "            CASE \n",
      "                WHEN clinvar_significance = 'Pathogenic' AND vep_impact = 'HIGH' THEN 10\n",
      "                WHEN clinvar_significance = 'Pathogenic' AND vep_impact = 'MODERATE' THEN 9\n",
      "                WHEN clinvar_significance = 'Likely_pathogenic' AND vep_impact = 'HIGH' THEN 8\n",
      "                WHEN clinvar_significance = 'Likely_pathogenic' AND vep_impact = 'MODERATE' THEN 7\n",
      "                WHEN clinvar_significance = 'Uncertain_significance' AND vep_impact = 'HIGH' THEN 6\n",
      "                WHEN vep_impact = 'HIGH' THEN 5\n",
      "                WHEN clinvar_significance = 'Uncertain_significance' AND vep_impact = 'MODERATE' THEN 4\n",
      "                ELSE 1\n",
      "            END as priority_score\n",
      "\n",
      "        FROM variant_annotations\n",
      "        ORDER BY priority_score DESC, qual DESC\n",
      "        \n",
      "====================================================================================\n",
      "Executing query on database '<YOUR_AWS_PROFILE>': \n",
      "        \n",
      "        WITH variant_annotations AS (\n",
      "            SELECT \n",
      "                v.sampleid,\n",
      "                v.contigname,\n",
      "                v.start,\n",
      "                v.referenceallele,\n",
      "                v.alternatealleles[1] as alternate_allele,\n",
      "                v.qual,\n",
      "                v.depth,\n",
      "                v.information['af'] as allele_frequency_1000g,\n",
      "                v.filters[1] as filter_status,\n",
      "                \n",
      "                CASE WHEN cardinality(v.annotations.vep) > 0 THEN v.annotations.vep[1].symbol END as vep_gene,\n",
      "                CASE WHEN cardinality(v.annotations.vep) > 0 THEN v.annotations.vep[1].impact END as vep_impact,\n",
      "                CASE WHEN cardinality(v.annotations.vep) > 0 AND cardinality(v.annotations.vep[1].consequence) > 0 \n",
      "                     THEN v.annotations.vep[1].consequence[1] END as vep_consequence,\n",
      "                \n",
      "                a.attributes['CLNSIG'] as clinvar_significance,\n",
      "                a.attributes['CLNDN'] as associated_disease,\n",
      "                split_part(a.attributes['GENEINFO'], ':', 1) as clinvar_gene\n",
      "                \n",
      "            FROM genomicsvariantstore v\n",
      "            LEFT JOIN genomicsannotationstore a ON (\n",
      "                REPLACE(v.contigname, 'chr', '') = REPLACE(a.contigname, 'chr', '')\n",
      "                AND v.start = a.start\n",
      "                AND v.referenceallele = a.referenceallele\n",
      "                AND v.alternatealleles[1] = a.alternatealleles[1]\n",
      "            )\n",
      "            WHERE v.qual > 30 \n",
      "                AND contains(v.filters, 'PASS')\n",
      "                AND (\n",
      "                    (cardinality(v.annotations.vep) > 0 AND UPPER(v.annotations.vep[1].symbol) IN ('BRCA1', 'BRCA2', 'TP53', 'PTEN', 'MLH1', 'MSH2', 'MSH6', 'PMS2', 'APC', 'ATM', 'PALB2', 'CHEK2', 'BARD1', 'BRIP1', 'CDH1', 'NF1', 'RAD51C', 'RAD51D', 'STK11'))\n",
      "                    OR UPPER(split_part(a.attributes['GENEINFO'], ':', 1)) IN ('BRCA1', 'BRCA2', 'TP53', 'PTEN', 'MLH1', 'MSH2', 'MSH6', 'PMS2', 'APC', 'ATM', 'PALB2', 'CHEK2', 'BARD1', 'BRIP1', 'CDH1', 'NF1', 'RAD51C', 'RAD51D', 'STK11')\n",
      "                )\n",
      "                \n",
      "        )\n",
      "        \n",
      "        SELECT \n",
      "            sampleid,\n",
      "            CONCAT(contigname, ':', CAST(start as VARCHAR), ':', referenceallele, '>', alternate_allele) as variant_id,\n",
      "            COALESCE(clinvar_gene, vep_gene) as gene_symbol,\n",
      "            vep_consequence as consequence,\n",
      "            vep_impact as impact,\n",
      "            clinvar_significance,\n",
      "            associated_disease,\n",
      "            qual,\n",
      "            depth,\n",
      "            allele_frequency_1000g,\n",
      "            \n",
      "            CASE \n",
      "                WHEN clinvar_significance = 'Pathogenic' AND vep_impact = 'HIGH' THEN 10\n",
      "                WHEN clinvar_significance = 'Pathogenic' AND vep_impact = 'MODERATE' THEN 9\n",
      "                WHEN clinvar_significance = 'Likely_pathogenic' AND vep_impact = 'HIGH' THEN 8\n",
      "                WHEN clinvar_significance = 'Likely_pathogenic' AND vep_impact = 'MODERATE' THEN 7\n",
      "                WHEN clinvar_significance = 'Uncertain_significance' AND vep_impact = 'HIGH' THEN 6\n",
      "                WHEN vep_impact = 'HIGH' THEN 5\n",
      "                WHEN clinvar_significance = 'Uncertain_significance' AND vep_impact = 'MODERATE' THEN 4\n",
      "                ELSE 1\n",
      "            END as priority_score\n",
      "\n",
      "        FROM variant_annotations\n",
      "        ORDER BY priority_score DESC, qual DESC\n",
      "        \n",
      "Retrieved 5162 total rows from Athena query\n",
      "Let me now use the dynamic query function to specifically search for pathogenic and likely pathogenic variants across all samples:\n",
      "Tool #3: execute_dynamic_genomics_query\n",
      "Executing query on database '<YOUR_AWS_PROFILE>': WITH PathogenicVariants AS (\n",
      "  SELECT\n",
      "    REPLACE(v.contigname, 'chr', '') AS chromosome,\n",
      "    v.start AS position,\n",
      "    v.referenceallele AS ref,\n",
      "    v.alternatealleles[1] AS alt,\n",
      "    CASE WHEN cardinality(v.annotations.vep) > 0 THEN v.annotations.vep[1].symbol END AS gene_symbol,\n",
      "    CASE WHEN cardinality(v.annotations.vep) > 0 THEN v.annotations.vep[1].impact END AS impact,\n",
      "    CASE WHEN cardinality(v.annotations.vep) > 0 AND cardinality(v.annotations.vep[1].consequence) > 0 THEN v.annotations.vep[1].consequence[1] END AS consequence,\n",
      "    a.attributes['CLNSIG'] AS clinical_significance,\n",
      "    a.attributes['CLNDN'] AS disease_name,\n",
      "    a.attributes['GENEINFO'] AS gene_info,\n",
      "    a.attributes['CLNREVSTAT'] AS review_status,\n",
      "    a.attributes['RS'] AS dbsnp_id,\n",
      "    v.sampleid\n",
      "  FROM\n",
      "    genomicsvariantstore v\n",
      "  INNER JOIN\n",
      "    genomicsannotationstore a\n",
      "  ON\n",
      "    REPLACE(v.contigname, 'chr', '') = a.contigname\n",
      "    AND v.start = a.start\n",
      "    AND v.referenceallele = a.referenceallele\n",
      "    AND v.alternatealleles[1] = a.alternatealleles[1]\n",
      "  WHERE\n",
      "    a.attributes['CLNSIG'] IN ('Pathogenic', 'Likely_pathogenic')\n",
      "    AND v.qual > 30\n",
      "    AND contains(v.filters, 'PASS')\n",
      ")\n",
      "SELECT * FROM PathogenicVariants\n",
      "ORDER BY chromosome, position, ref, alt, sampleid;\n",
      "====================================================================================\n",
      "Executing query on database '<YOUR_AWS_PROFILE>': \n",
      "        WITH PathogenicVariants AS (\n",
      "  SELECT\n",
      "    REPLACE(v.contigname, 'chr', '') AS chromosome,\n",
      "    v.start AS position,\n",
      "    v.referenceallele AS ref,\n",
      "    v.alternatealleles[1] AS alt,\n",
      "    CASE WHEN cardinality(v.annotations.vep) > 0 THEN v.annotations.vep[1].symbol END AS gene_symbol,\n",
      "    CASE WHEN cardinality(v.annotations.vep) > 0 THEN v.annotations.vep[1].impact END AS impact,\n",
      "    CASE WHEN cardinality(v.annotations.vep) > 0 AND cardinality(v.annotations.vep[1].consequence) > 0 THEN v.annotations.vep[1].consequence[1] END AS consequence,\n",
      "    a.attributes['CLNSIG'] AS clinical_significance,\n",
      "    a.attributes['CLNDN'] AS disease_name,\n",
      "    a.attributes['GENEINFO'] AS gene_info,\n",
      "    a.attributes['CLNREVSTAT'] AS review_status,\n",
      "    a.attributes['RS'] AS dbsnp_id,\n",
      "    v.sampleid\n",
      "  FROM\n",
      "    genomicsvariantstore v\n",
      "  INNER JOIN\n",
      "    genomicsannotationstore a\n",
      "  ON\n",
      "    REPLACE(v.contigname, 'chr', '') = a.contigname\n",
      "    AND v.start = a.start\n",
      "    AND v.referenceallele = a.referenceallele\n",
      "    AND v.alternatealleles[1] = a.alternatealleles[1]\n",
      "  WHERE\n",
      "    a.attributes['CLNSIG'] IN ('Pathogenic', 'Likely_pathogenic')\n",
      "    AND v.qual > 30\n",
      "    AND contains(v.filters, 'PASS')\n",
      ")\n",
      "SELECT * FROM PathogenicVariants\n",
      "ORDER BY chromosome, position, ref, alt, sampleid;\n",
      "Retrieved 8 total rows from Athena query\n",
      "Let me also check for any additional pathogenic variants in other important genes:\n",
      "Tool #4: query_variants_by_gene\n",
      "Executing query on database '<YOUR_AWS_PROFILE>': \n",
      "        WITH variant_annotations AS (\n",
      "            SELECT \n",
      "                v.sampleid,\n",
      "                v.contigname,\n",
      "                v.start,\n",
      "                v.referenceallele,\n",
      "                v.alternatealleles[1] as alternate_allele,\n",
      "                v.qual,\n",
      "                v.depth,\n",
      "                v.information['af'] as allele_frequency_1000g,\n",
      "                v.filters[1] as filter_status,\n",
      "                \n",
      "                CASE WHEN cardinality(v.annotations.vep) > 0 THEN v.annotations.vep[1].symbol END as vep_gene,\n",
      "                CASE WHEN cardinality(v.annotations.vep) > 0 THEN v.annotations.vep[1].impact END as vep_impact,\n",
      "                CASE WHEN cardinality(v.annotations.vep) > 0 AND cardinality(v.annotations.vep[1].consequence) > 0 \n",
      "                     THEN v.annotations.vep[1].consequence[1] END as vep_consequence,\n",
      "                \n",
      "                a.attributes['CLNSIG'] as clinvar_significance,\n",
      "                a.attributes['CLNDN'] as associated_disease,\n",
      "                split_part(a.attributes['GENEINFO'], ':', 1) as clinvar_gene\n",
      "                \n",
      "            FROM genomicsvariantstore v\n",
      "            LEFT JOIN genomicsannotationstore a ON (\n",
      "                REPLACE(v.contigname, 'chr', '') = REPLACE(a.contigname, 'chr', '')\n",
      "                AND v.start = a.start\n",
      "                AND v.referenceallele = a.referenceallele\n",
      "                AND v.alternatealleles[1] = a.alternatealleles[1]\n",
      "            )\n",
      "            WHERE v.qual > 30 \n",
      "                AND contains(v.filters, 'PASS')\n",
      "                AND (\n",
      "                    (cardinality(v.annotations.vep) > 0 AND UPPER(v.annotations.vep[1].symbol) IN ('GBP1', 'ADRA2A', 'PRB3', 'CLASP1', 'ZNF717', 'XG'))\n",
      "                    OR UPPER(split_part(a.attributes['GENEINFO'], ':', 1)) IN ('GBP1', 'ADRA2A', 'PRB3', 'CLASP1', 'ZNF717', 'XG')\n",
      "                )\n",
      "                \n",
      "        )\n",
      "        \n",
      "        SELECT \n",
      "            sampleid,\n",
      "            CONCAT(contigname, ':', CAST(start as VARCHAR), ':', referenceallele, '>', alternate_allele) as variant_id,\n",
      "            COALESCE(clinvar_gene, vep_gene) as gene_symbol,\n",
      "            vep_consequence as consequence,\n",
      "            vep_impact as impact,\n",
      "            clinvar_significance,\n",
      "            associated_disease,\n",
      "            qual,\n",
      "            depth,\n",
      "            allele_frequency_1000g,\n",
      "            \n",
      "            CASE \n",
      "                WHEN clinvar_significance = 'Pathogenic' AND vep_impact = 'HIGH' THEN 10\n",
      "                WHEN clinvar_significance = 'Pathogenic' AND vep_impact = 'MODERATE' THEN 9\n",
      "                WHEN clinvar_significance = 'Likely_pathogenic' AND vep_impact = 'HIGH' THEN 8\n",
      "                WHEN clinvar_significance = 'Likely_pathogenic' AND vep_impact = 'MODERATE' THEN 7\n",
      "                WHEN clinvar_significance = 'Uncertain_significance' AND vep_impact = 'HIGH' THEN 6\n",
      "                WHEN vep_impact = 'HIGH' THEN 5\n",
      "                WHEN clinvar_significance = 'Uncertain_significance' AND vep_impact = 'MODERATE' THEN 4\n",
      "                ELSE 1\n",
      "            END as priority_score\n",
      "\n",
      "        FROM variant_annotations\n",
      "        ORDER BY priority_score DESC, qual DESC\n",
      "        \n",
      "====================================================================================\n",
      "Executing query on database '<YOUR_AWS_PROFILE>': \n",
      "        \n",
      "        WITH variant_annotations AS (\n",
      "            SELECT \n",
      "                v.sampleid,\n",
      "                v.contigname,\n",
      "                v.start,\n",
      "                v.referenceallele,\n",
      "                v.alternatealleles[1] as alternate_allele,\n",
      "                v.qual,\n",
      "                v.depth,\n",
      "                v.information['af'] as allele_frequency_1000g,\n",
      "                v.filters[1] as filter_status,\n",
      "                \n",
      "                CASE WHEN cardinality(v.annotations.vep) > 0 THEN v.annotations.vep[1].symbol END as vep_gene,\n",
      "                CASE WHEN cardinality(v.annotations.vep) > 0 THEN v.annotations.vep[1].impact END as vep_impact,\n",
      "                CASE WHEN cardinality(v.annotations.vep) > 0 AND cardinality(v.annotations.vep[1].consequence) > 0 \n",
      "                     THEN v.annotations.vep[1].consequence[1] END as vep_consequence,\n",
      "                \n",
      "                a.attributes['CLNSIG'] as clinvar_significance,\n",
      "                a.attributes['CLNDN'] as associated_disease,\n",
      "                split_part(a.attributes['GENEINFO'], ':', 1) as clinvar_gene\n",
      "                \n",
      "            FROM genomicsvariantstore v\n",
      "            LEFT JOIN genomicsannotationstore a ON (\n",
      "                REPLACE(v.contigname, 'chr', '') = REPLACE(a.contigname, 'chr', '')\n",
      "                AND v.start = a.start\n",
      "                AND v.referenceallele = a.referenceallele\n",
      "                AND v.alternatealleles[1] = a.alternatealleles[1]\n",
      "            )\n",
      "            WHERE v.qual > 30 \n",
      "                AND contains(v.filters, 'PASS')\n",
      "                AND (\n",
      "                    (cardinality(v.annotations.vep) > 0 AND UPPER(v.annotations.vep[1].symbol) IN ('GBP1', 'ADRA2A', 'PRB3', 'CLASP1', 'ZNF717', 'XG'))\n",
      "                    OR UPPER(split_part(a.attributes['GENEINFO'], ':', 1)) IN ('GBP1', 'ADRA2A', 'PRB3', 'CLASP1', 'ZNF717', 'XG')\n",
      "                )\n",
      "                \n",
      "        )\n",
      "        \n",
      "        SELECT \n",
      "            sampleid,\n",
      "            CONCAT(contigname, ':', CAST(start as VARCHAR), ':', referenceallele, '>', alternate_allele) as variant_id,\n",
      "            COALESCE(clinvar_gene, vep_gene) as gene_symbol,\n",
      "            vep_consequence as consequence,\n",
      "            vep_impact as impact,\n",
      "            clinvar_significance,\n",
      "            associated_disease,\n",
      "            qual,\n",
      "            depth,\n",
      "            allele_frequency_1000g,\n",
      "            \n",
      "            CASE \n",
      "                WHEN clinvar_significance = 'Pathogenic' AND vep_impact = 'HIGH' THEN 10\n",
      "                WHEN clinvar_significance = 'Pathogenic' AND vep_impact = 'MODERATE' THEN 9\n",
      "                WHEN clinvar_significance = 'Likely_pathogenic' AND vep_impact = 'HIGH' THEN 8\n",
      "                WHEN clinvar_significance = 'Likely_pathogenic' AND vep_impact = 'MODERATE' THEN 7\n",
      "                WHEN clinvar_significance = 'Uncertain_significance' AND vep_impact = 'HIGH' THEN 6\n",
      "                WHEN vep_impact = 'HIGH' THEN 5\n",
      "                WHEN clinvar_significance = 'Uncertain_significance' AND vep_impact = 'MODERATE' THEN 4\n",
      "                ELSE 1\n",
      "            END as priority_score\n",
      "\n",
      "        FROM variant_annotations\n",
      "        ORDER BY priority_score DESC, qual DESC\n",
      "        \n",
      "Retrieved 2881 total rows from Athena query\n",
      "Let me now compare the samples to get a better understanding of the variant distribution across patients:\n",
      "Tool #5: compare_sample_variants\n",
      "Executing query on database '<YOUR_AWS_PROFILE>': \n",
      "        WITH sample_variants AS (\n",
      "            SELECT \n",
      "                v.sampleid,\n",
      "                v.qual,\n",
      "                v.depth,\n",
      "                v.referenceallele,\n",
      "                v.alternatealleles[1] as alternate_allele,\n",
      "                v.filters[1] as filter_status,\n",
      "                \n",
      "                CASE WHEN cardinality(v.annotations.vep) > 0 THEN v.annotations.vep[1].symbol END as vep_gene,\n",
      "                CASE WHEN cardinality(v.annotations.vep) > 0 THEN v.annotations.vep[1].impact END as vep_impact,\n",
      "                \n",
      "                a.attributes['CLNSIG'] as clinical_significance,\n",
      "                split_part(a.attributes['GENEINFO'], ':', 1) as clinvar_gene\n",
      "                \n",
      "            FROM genomicsvariantstore v\n",
      "            LEFT JOIN genomicsannotationstore a ON (\n",
      "                REPLACE(v.contigname, 'chr', '') = REPLACE(a.contigname, 'chr', '')\n",
      "                AND v.start = a.start\n",
      "                AND v.referenceallele = a.referenceallele\n",
      "                AND v.alternatealleles[1] = a.alternatealleles[1]\n",
      "            )\n",
      "            WHERE v.filters[1] = 'PASS'\n",
      "                AND v.sampleid IN ('NA21135', 'NA21144')\n",
      "        )\n",
      "\n",
      "        SELECT \n",
      "            sampleid,\n",
      "            COUNT(*) as total_variants,\n",
      "            \n",
      "            COUNT(CASE WHEN clinical_significance = 'Pathogenic' THEN 1 END) as pathogenic_count,\n",
      "            COUNT(CASE WHEN clinical_significance = 'Likely_pathogenic' THEN 1 END) as likely_pathogenic_count,\n",
      "            COUNT(CASE WHEN clinical_significance = 'Uncertain_significance' THEN 1 END) as vus_count,\n",
      "            COUNT(CASE WHEN clinical_significance IN ('Benign', 'Likely_benign') THEN 1 END) as benign_count,\n",
      "            \n",
      "            COUNT(CASE WHEN vep_impact = 'HIGH' THEN 1 END) as high_impact_count,\n",
      "            COUNT(CASE WHEN vep_impact = 'MODERATE' THEN 1 END) as moderate_impact_count,\n",
      "            COUNT(CASE WHEN vep_impact = 'LOW' THEN 1 END) as low_impact_count,\n",
      "            COUNT(CASE WHEN vep_impact = 'MODIFIER' THEN 1 END) as modifier_impact_count,\n",
      "            \n",
      "            ROUND(AVG(CAST(qual as DOUBLE)), 2) as avg_quality,\n",
      "            ROUND(AVG(CAST(depth as DOUBLE)), 2) as avg_depth,\n",
      "            MIN(qual) as min_quality,\n",
      "            MAX(qual) as max_quality,\n",
      "            \n",
      "            COUNT(DISTINCT COALESCE(clinvar_gene, vep_gene)) as unique_genes_affected,\n",
      "            \n",
      "            COUNT(CASE \n",
      "                WHEN LENGTH(referenceallele) = 1 AND LENGTH(alternate_allele) = 1 \n",
      "                THEN 1 \n",
      "            END) as snv_count,\n",
      "            \n",
      "            COUNT(CASE \n",
      "                WHEN LENGTH(referenceallele) > LENGTH(alternate_allele) \n",
      "                THEN 1 \n",
      "            END) as deletion_count,\n",
      "            \n",
      "            COUNT(CASE \n",
      "                WHEN LENGTH(referenceallele) < LENGTH(alternate_allele) \n",
      "                THEN 1 \n",
      "            END) as insertion_count,\n",
      "            \n",
      "            ROUND(\n",
      "                COUNT(CASE WHEN clinical_significance IN ('Pathogenic', 'Likely_pathogenic') THEN 1 END) * 100.0 / COUNT(*), \n",
      "                2\n",
      "            ) as pathogenic_percentage\n",
      "\n",
      "        FROM sample_variants\n",
      "        GROUP BY sampleid\n",
      "        ORDER BY sampleid\n",
      "        \n",
      "====================================================================================\n",
      "Executing query on database '<YOUR_AWS_PROFILE>': \n",
      "        \n",
      "        WITH sample_variants AS (\n",
      "            SELECT \n",
      "                v.sampleid,\n",
      "                v.qual,\n",
      "                v.depth,\n",
      "                v.referenceallele,\n",
      "                v.alternatealleles[1] as alternate_allele,\n",
      "                v.filters[1] as filter_status,\n",
      "                \n",
      "                CASE WHEN cardinality(v.annotations.vep) > 0 THEN v.annotations.vep[1].symbol END as vep_gene,\n",
      "                CASE WHEN cardinality(v.annotations.vep) > 0 THEN v.annotations.vep[1].impact END as vep_impact,\n",
      "                \n",
      "                a.attributes['CLNSIG'] as clinical_significance,\n",
      "                split_part(a.attributes['GENEINFO'], ':', 1) as clinvar_gene\n",
      "                \n",
      "            FROM genomicsvariantstore v\n",
      "            LEFT JOIN genomicsannotationstore a ON (\n",
      "                REPLACE(v.contigname, 'chr', '') = REPLACE(a.contigname, 'chr', '')\n",
      "                AND v.start = a.start\n",
      "                AND v.referenceallele = a.referenceallele\n",
      "                AND v.alternatealleles[1] = a.alternatealleles[1]\n",
      "            )\n",
      "            WHERE v.filters[1] = 'PASS'\n",
      "                AND v.sampleid IN ('NA21135', 'NA21144')\n",
      "        )\n",
      "\n",
      "        SELECT \n",
      "            sampleid,\n",
      "            COUNT(*) as total_variants,\n",
      "            \n",
      "            COUNT(CASE WHEN clinical_significance = 'Pathogenic' THEN 1 END) as pathogenic_count,\n",
      "            COUNT(CASE WHEN clinical_significance = 'Likely_pathogenic' THEN 1 END) as likely_pathogenic_count,\n",
      "            COUNT(CASE WHEN clinical_significance = 'Uncertain_significance' THEN 1 END) as vus_count,\n",
      "            COUNT(CASE WHEN clinical_significance IN ('Benign', 'Likely_benign') THEN 1 END) as benign_count,\n",
      "            \n",
      "            COUNT(CASE WHEN vep_impact = 'HIGH' THEN 1 END) as high_impact_count,\n",
      "            COUNT(CASE WHEN vep_impact = 'MODERATE' THEN 1 END) as moderate_impact_count,\n",
      "            COUNT(CASE WHEN vep_impact = 'LOW' THEN 1 END) as low_impact_count,\n",
      "            COUNT(CASE WHEN vep_impact = 'MODIFIER' THEN 1 END) as modifier_impact_count,\n",
      "            \n",
      "            ROUND(AVG(CAST(qual as DOUBLE)), 2) as avg_quality,\n",
      "            ROUND(AVG(CAST(depth as DOUBLE)), 2) as avg_depth,\n",
      "            MIN(qual) as min_quality,\n",
      "            MAX(qual) as max_quality,\n",
      "            \n",
      "            COUNT(DISTINCT COALESCE(clinvar_gene, vep_gene)) as unique_genes_affected,\n",
      "            \n",
      "            COUNT(CASE \n",
      "                WHEN LENGTH(referenceallele) = 1 AND LENGTH(alternate_allele) = 1 \n",
      "                THEN 1 \n",
      "            END) as snv_count,\n",
      "            \n",
      "            COUNT(CASE \n",
      "                WHEN LENGTH(referenceallele) > LENGTH(alternate_allele) \n",
      "                THEN 1 \n",
      "            END) as deletion_count,\n",
      "            \n",
      "            COUNT(CASE \n",
      "                WHEN LENGTH(referenceallele) < LENGTH(alternate_allele) \n",
      "                THEN 1 \n",
      "            END) as insertion_count,\n",
      "            \n",
      "            ROUND(\n",
      "                COUNT(CASE WHEN clinical_significance IN ('Pathogenic', 'Likely_pathogenic') THEN 1 END) * 100.0 / COUNT(*), \n",
      "                2\n",
      "            ) as pathogenic_percentage\n",
      "\n",
      "        FROM sample_variants\n",
      "        GROUP BY sampleid\n",
      "        ORDER BY sampleid\n",
      "        \n",
      "Retrieved 2 total rows from Athena query\n",
      "# Comprehensive Summary of Pathogenic and Likely Pathogenic Variants Across the Cohort\n",
      "\n",
      "Based on the genomic analysis of the cohort, I've identified a total of 8 pathogenic and likely pathogenic variants across the two patients (NA21135 and NA21144). Here's a detailed clinical summary:\n",
      "\n",
      "## Pathogenic Variants\n",
      "\n",
      "1. **ADRA2A (chr10:111079820:A>G)** - *Patient: NA21135*\n",
      "   - **Clinical Significance:** Pathogenic\n",
      "   - **Disease Association:** Lipodystrophy, familial partial, type 8\n",
      "   - **Impact:** MODIFIER (3' UTR variant)\n",
      "   - **Quality:** 185.38, Depth: 46\n",
      "   - **Population Frequency:** Present in 1000 Genomes\n",
      "   - **Clinical Implications:** Associated with familial partial lipodystrophy, which involves abnormal fat distribution and metabolic complications including insulin resistance and diabetes.\n",
      "\n",
      "2. **PRB3 (chr12:11267399:A>AG)** - *Patient: NA21144*\n",
      "   - **Clinical Significance:** Pathogenic\n",
      "   - **Disease Association:** PRB3M(NULL)\n",
      "   - **Impact:** HIGH (frameshift variant)\n",
      "   - **Quality:** 48.85, Depth: 17\n",
      "   - **Population Frequency:** 41.2% in 1000 Genomes\n",
      "   - **Clinical Implications:** This frameshift variant in the PRB3 gene affects salivary proline-rich proteins and may impact oral health.\n",
      "\n",
      "3. **CLASP1 (chr2:121530933:G>A)** - *Patient: NA21135*\n",
      "   - **Clinical Significance:** Pathogenic\n",
      "   - **Disease Association:** Multiple conditions including Osteodysplastic primordial dwarfism type 1, Lowry-Wood syndrome, and Roifman syndrome\n",
      "   - **Impact:** MODIFIER (intron variant)\n",
      "   - **Review Status:** Criteria provided, multiple submitters, no conflicts\n",
      "   - **Clinical Implications:** Associated with developmental disorders and growth abnormalities.\n",
      "\n",
      "4. **ZNF717 (chr3:75741670:A>G)** - *Patients: NA21135, NA21144*\n",
      "   - **Clinical Significance:** Pathogenic\n",
      "   - **Disease Association:** Susceptibility to severe coronavirus disease (COVID-19)\n",
      "   - **Impact:** LOW (synonymous variant)\n",
      "   - **Clinical Implications:** May increase susceptibility to severe COVID-19 outcomes, relevant for pandemic risk assessment.\n",
      "\n",
      "5. **XG (chrX:2748342:G>C)** - *Patient: NA21135*\n",
      "   - **Clinical Significance:** Pathogenic\n",
      "   - **Disease Association:** XG blood group system, Xg(a-) phenotype\n",
      "   - **Impact:** MODIFIER (upstream gene variant)\n",
      "   - **Clinical Implications:** Affects blood group antigen expression, potentially relevant for transfusion medicine.\n",
      "\n",
      "## Likely Pathogenic Variants\n",
      "\n",
      "6. **GBP1 (chr1:89054645:GAAAAAC>G)** - *Patients: NA21135, NA21144*\n",
      "   - **Clinical Significance:** Likely Pathogenic\n",
      "   - **Disease Association:** Neutrophil inclusion bodies\n",
      "   - **Impact:** MODIFIER (intron variant)\n",
      "   - **Clinical Implications:** Associated with neutrophil abnormalities that may affect immune function.\n",
      "\n",
      "## Patient-Specific Summary\n",
      "\n",
      "### Patient NA21135\n",
      "- **Total Variants:** 4,978,141\n",
      "- **Pathogenic Variants:** 4\n",
      "- **Likely Pathogenic Variants:** 1\n",
      "- **Genes Affected:** ADRA2A, CLASP1, ZNF717, XG, GBP1\n",
      "- **Key Clinical Concerns:** \n",
      "  - Lipodystrophy risk (ADRA2A)\n",
      "  - Developmental disorders (CLASP1)\n",
      "  - COVID-19 susceptibility (ZNF717)\n",
      "  - Blood group implications (XG)\n",
      "  - Neutrophil abnormalities (GBP1)\n",
      "\n",
      "### Patient NA21144\n",
      "- **Total Variants:** 5,013,114\n",
      "- **Pathogenic Variants:** 2\n",
      "- **Likely Pathogenic Variants:** 1\n",
      "- **Genes Affected:** PRB3, ZNF717, GBP1\n",
      "- **Key Clinical Concerns:**\n",
      "  - Salivary protein abnormalities (PRB3)\n",
      "  - COVID-19 susceptibility (ZNF717)\n",
      "  - Neutrophil abnormalities (GBP1)\n",
      "\n",
      "## Clinical Recommendations\n",
      "\n",
      "1. **Patient NA21135:**\n",
      "   - Metabolic evaluation for lipodystrophy features (glucose tolerance, lipid profile)\n",
      "   - Growth and development assessment\n",
      "   - Immunological workup for neutrophil function\n",
      "   - Blood typing confirmation for transfusion safety\n",
      "\n",
      "2. **Patient NA21144:**\n",
      "   - Dental/oral health evaluation\n",
      "   - COVID-19 risk counseling\n",
      "   - Immunological workup for neutrophil function\n",
      "\n",
      "3. **For Both Patients:**\n",
      "   - Genetic counseling to discuss implications of identified variants\n",
      "   - Family testing for relevant pathogenic variants\n",
      "   - Consideration of additional targeted testing for related conditions\n",
      "\n",
      "## Population Context\n",
      "\n",
      "Most of the identified pathogenic variants have representation in the 1000 Genomes Project, suggesting they are not extremely rare in the general population. However, their clinical significance remains important for individual patient care and family screening.\n",
      "\n",
      "This comprehensive analysis provides clinically actionable information that can guide patient management, genetic counseling, and preventive care strategies for both patients in the cohort.VCF Supervisor agent Response:\n",
      "# Comprehensive Summary of Pathogenic and Likely Pathogenic Variants Across the Cohort\n",
      "\n",
      "Based on the genomic analysis of the cohort, I've identified a total of 8 pathogenic and likely pathogenic variants across the two patients (NA21135 and NA21144). Here's a detailed clinical summary:\n",
      "\n",
      "## Pathogenic Variants\n",
      "\n",
      "1. **ADRA2A (chr10:111079820:A>G)** - *Patient: NA21135*\n",
      "   - **Clinical Significance:** Pathogenic\n",
      "   - **Disease Association:** Lipodystrophy, familial partial, type 8\n",
      "   - **Impact:** MODIFIER (3' UTR variant)\n",
      "   - **Quality:** 185.38, Depth: 46\n",
      "   - **Population Frequency:** Present in 1000 Genomes\n",
      "   - **Clinical Implications:** Associated with familial partial lipodystrophy, which involves abnormal fat distribution and metabolic complications including insulin resistance and diabetes.\n",
      "\n",
      "2. **PRB3 (chr12:11267399:A>AG)** - *Patient: NA21144*\n",
      "   - **Clinical Significance:** Pathogenic\n",
      "   - **Disease Association:** PRB3M(NULL)\n",
      "   - **Impact:** HIGH (frameshift variant)\n",
      "   - **Quality:** 48.85, Depth: 17\n",
      "   - **Population Frequency:** 41.2% in 1000 Genomes\n",
      "   - **Clinical Implications:** This frameshift variant in the PRB3 gene affects salivary proline-rich proteins and may impact oral health.\n",
      "\n",
      "3. **CLASP1 (chr2:121530933:G>A)** - *Patient: NA21135*\n",
      "   - **Clinical Significance:** Pathogenic\n",
      "   - **Disease Association:** Multiple conditions including Osteodysplastic primordial dwarfism type 1, Lowry-Wood syndrome, and Roifman syndrome\n",
      "   - **Impact:** MODIFIER (intron variant)\n",
      "   - **Review Status:** Criteria provided, multiple submitters, no conflicts\n",
      "   - **Clinical Implications:** Associated with developmental disorders and growth abnormalities.\n",
      "\n",
      "4. **ZNF717 (chr3:75741670:A>G)** - *Patients: NA21135, NA21144*\n",
      "   - **Clinical Significance:** Pathogenic\n",
      "   - **Disease Association:** Susceptibility to severe coronavirus disease (COVID-19)\n",
      "   - **Impact:** LOW (synonymous variant)\n",
      "   - **Clinical Implications:** May increase susceptibility to severe COVID-19 outcomes, relevant for pandemic risk assessment.\n",
      "\n",
      "5. **XG (chrX:2748342:G>C)** - *Patient: NA21135*\n",
      "   - **Clinical Significance:** Pathogenic\n",
      "   - **Disease Association:** XG blood group system, Xg(a-) phenotype\n",
      "   - **Impact:** MODIFIER (upstream gene variant)\n",
      "   - **Clinical Implications:** Affects blood group antigen expression, potentially relevant for transfusion medicine.\n",
      "\n",
      "## Likely Pathogenic Variants\n",
      "\n",
      "6. **GBP1 (chr1:89054645:GAAAAAC>G)** - *Patients: NA21135, NA21144*\n",
      "   - **Clinical Significance:** Likely Pathogenic\n",
      "   - **Disease Association:** Neutrophil inclusion bodies\n",
      "   - **Impact:** MODIFIER (intron variant)\n",
      "   - **Clinical Implications:** Associated with neutrophil abnormalities that may affect immune function.\n",
      "\n",
      "## Patient-Specific Summary\n",
      "\n",
      "### Patient NA21135\n",
      "- **Total Variants:** 4,978,141\n",
      "- **Pathogenic Variants:** 4\n",
      "- **Likely Pathogenic Variants:** 1\n",
      "- **Genes Affected:** ADRA2A, CLASP1, ZNF717, XG, GBP1\n",
      "- **Key Clinical Concerns:** \n",
      "  - Lipodystrophy risk (ADRA2A)\n",
      "  - Developmental disorders (CLASP1)\n",
      "  - COVID-19 susceptibility (ZNF717)\n",
      "  - Blood group implications (XG)\n",
      "  - Neutrophil abnormalities (GBP1)\n",
      "\n",
      "### Patient NA21144\n",
      "- **Total Variants:** 5,013,114\n",
      "- **Pathogenic Variants:** 2\n",
      "- **Likely Pathogenic Variants:** 1\n",
      "- **Genes Affected:** PRB3, ZNF717, GBP1\n",
      "- **Key Clinical Concerns:**\n",
      "  - Salivary protein abnormalities (PRB3)\n",
      "  - COVID-19 susceptibility (ZNF717)\n",
      "  - Neutrophil abnormalities (GBP1)\n",
      "\n",
      "## Clinical Recommendations\n",
      "\n",
      "1. **Patient NA21135:**\n",
      "   - Metabolic evaluation for lipodystrophy features (glucose tolerance, lipid profile)\n",
      "   - Growth and development assessment\n",
      "   - Immunological workup for neutrophil function\n",
      "   - Blood typing confirmation for transfusion safety\n",
      "\n",
      "2. **Patient NA21144:**\n",
      "   - Dental/oral health evaluation\n",
      "   - COVID-19 risk counseling\n",
      "   - Immunological workup for neutrophil function\n",
      "\n",
      "3. **For Both Patients:**\n",
      "   - Genetic counseling to discuss implications of identified variants\n",
      "   - Family testing for relevant pathogenic variants\n",
      "   - Consideration of additional targeted testing for related conditions\n",
      "\n",
      "## Population Context\n",
      "\n",
      "Most of the identified pathogenic variants have representation in the 1000 Genomes Project, suggesting they are not extremely rare in the general population. However, their clinical significance remains important for individual patient care and family screening.\n",
      "\n",
      "This comprehensive analysis provides clinically actionable information that can guide patient management, genetic counseling, and preventive care strategies for both patients in the cohort.\n",
      "\n"
     ]
    }
   ],
   "source": [
    "response = orchestrator(\"Analyze the patients cohort and provide a comprehensive clinical summary including: individual risk stratification, population-level insights, shared pathogenic variants, personalized medicine recommendations, and clinical prioritization for genetic counseling. And let me know how do you assess the risk and prioritization?\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "id": "<YOUR_JOB_ID>",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "I'll analyze pathogenic BRCA1 variants in the 1000 Genomes Project and check if patients NA21135 and NA21144 have any of these variants. Let me break this down into steps:\n",
      "\n",
      "1. First, I'll query BRCA1 variants with clinical annotations and frequency data\n",
      "2. Then I'll specifically check if samples NA21135 and NA21144 have any pathogenic BRCA1 variants\n",
      "3. Finally, I'll provide allele frequencies and clinical significance details\n",
      "\n",
      "Let's start with the BRCA1 variant analysis:\n",
      "Tool #1: query_variants_by_gene\n",
      "Executing query on database '<YOUR_AWS_PROFILE>': \n",
      "        WITH variant_annotations AS (\n",
      "            SELECT \n",
      "                v.sampleid,\n",
      "                v.contigname,\n",
      "                v.start,\n",
      "                v.referenceallele,\n",
      "                v.alternatealleles[1] as alternate_allele,\n",
      "                v.qual,\n",
      "                v.depth,\n",
      "                v.information['af'] as allele_frequency_1000g,\n",
      "                v.filters[1] as filter_status,\n",
      "                \n",
      "                CASE WHEN cardinality(v.annotations.vep) > 0 THEN v.annotations.vep[1].symbol END as vep_gene,\n",
      "                CASE WHEN cardinality(v.annotations.vep) > 0 THEN v.annotations.vep[1].impact END as vep_impact,\n",
      "                CASE WHEN cardinality(v.annotations.vep) > 0 AND cardinality(v.annotations.vep[1].consequence) > 0 \n",
      "                     THEN v.annotations.vep[1].consequence[1] END as vep_consequence,\n",
      "                \n",
      "                a.attributes['CLNSIG'] as clinvar_significance,\n",
      "                a.attributes['CLNDN'] as associated_disease,\n",
      "                split_part(a.attributes['GENEINFO'], ':', 1) as clinvar_gene\n",
      "                \n",
      "            FROM genomicsvariantstore v\n",
      "            LEFT JOIN genomicsannotationstore a ON (\n",
      "                REPLACE(v.contigname, 'chr', '') = REPLACE(a.contigname, 'chr', '')\n",
      "                AND v.start = a.start\n",
      "                AND v.referenceallele = a.referenceallele\n",
      "                AND v.alternatealleles[1] = a.alternatealleles[1]\n",
      "            )\n",
      "            WHERE v.qual > 30 \n",
      "                AND contains(v.filters, 'PASS')\n",
      "                AND (\n",
      "                    (cardinality(v.annotations.vep) > 0 AND UPPER(v.annotations.vep[1].symbol) IN ('BRCA1'))\n",
      "                    OR UPPER(split_part(a.attributes['GENEINFO'], ':', 1)) IN ('BRCA1')\n",
      "                )\n",
      "                \n",
      "        )\n",
      "        \n",
      "        SELECT \n",
      "            sampleid,\n",
      "            CONCAT(contigname, ':', CAST(start as VARCHAR), ':', referenceallele, '>', alternate_allele) as variant_id,\n",
      "            COALESCE(clinvar_gene, vep_gene) as gene_symbol,\n",
      "            vep_consequence as consequence,\n",
      "            vep_impact as impact,\n",
      "            clinvar_significance,\n",
      "            associated_disease,\n",
      "            qual,\n",
      "            depth,\n",
      "            allele_frequency_1000g,\n",
      "            \n",
      "            CASE \n",
      "                WHEN clinvar_significance = 'Pathogenic' AND vep_impact = 'HIGH' THEN 10\n",
      "                WHEN clinvar_significance = 'Pathogenic' AND vep_impact = 'MODERATE' THEN 9\n",
      "                WHEN clinvar_significance = 'Likely_pathogenic' AND vep_impact = 'HIGH' THEN 8\n",
      "                WHEN clinvar_significance = 'Likely_pathogenic' AND vep_impact = 'MODERATE' THEN 7\n",
      "                WHEN clinvar_significance = 'Uncertain_significance' AND vep_impact = 'HIGH' THEN 6\n",
      "                WHEN vep_impact = 'HIGH' THEN 5\n",
      "                WHEN clinvar_significance = 'Uncertain_significance' AND vep_impact = 'MODERATE' THEN 4\n",
      "                ELSE 1\n",
      "            END as priority_score\n",
      "\n",
      "        FROM variant_annotations\n",
      "        ORDER BY priority_score DESC, qual DESC\n",
      "        \n",
      "====================================================================================\n",
      "Executing query on database '<YOUR_AWS_PROFILE>': \n",
      "        \n",
      "        WITH variant_annotations AS (\n",
      "            SELECT \n",
      "                v.sampleid,\n",
      "                v.contigname,\n",
      "                v.start,\n",
      "                v.referenceallele,\n",
      "                v.alternatealleles[1] as alternate_allele,\n",
      "                v.qual,\n",
      "                v.depth,\n",
      "                v.information['af'] as allele_frequency_1000g,\n",
      "                v.filters[1] as filter_status,\n",
      "                \n",
      "                CASE WHEN cardinality(v.annotations.vep) > 0 THEN v.annotations.vep[1].symbol END as vep_gene,\n",
      "                CASE WHEN cardinality(v.annotations.vep) > 0 THEN v.annotations.vep[1].impact END as vep_impact,\n",
      "                CASE WHEN cardinality(v.annotations.vep) > 0 AND cardinality(v.annotations.vep[1].consequence) > 0 \n",
      "                     THEN v.annotations.vep[1].consequence[1] END as vep_consequence,\n",
      "                \n",
      "                a.attributes['CLNSIG'] as clinvar_significance,\n",
      "                a.attributes['CLNDN'] as associated_disease,\n",
      "                split_part(a.attributes['GENEINFO'], ':', 1) as clinvar_gene\n",
      "                \n",
      "            FROM genomicsvariantstore v\n",
      "            LEFT JOIN genomicsannotationstore a ON (\n",
      "                REPLACE(v.contigname, 'chr', '') = REPLACE(a.contigname, 'chr', '')\n",
      "                AND v.start = a.start\n",
      "                AND v.referenceallele = a.referenceallele\n",
      "                AND v.alternatealleles[1] = a.alternatealleles[1]\n",
      "            )\n",
      "            WHERE v.qual > 30 \n",
      "                AND contains(v.filters, 'PASS')\n",
      "                AND (\n",
      "                    (cardinality(v.annotations.vep) > 0 AND UPPER(v.annotations.vep[1].symbol) IN ('BRCA1'))\n",
      "                    OR UPPER(split_part(a.attributes['GENEINFO'], ':', 1)) IN ('BRCA1')\n",
      "                )\n",
      "                \n",
      "        )\n",
      "        \n",
      "        SELECT \n",
      "            sampleid,\n",
      "            CONCAT(contigname, ':', CAST(start as VARCHAR), ':', referenceallele, '>', alternate_allele) as variant_id,\n",
      "            COALESCE(clinvar_gene, vep_gene) as gene_symbol,\n",
      "            vep_consequence as consequence,\n",
      "            vep_impact as impact,\n",
      "            clinvar_significance,\n",
      "            associated_disease,\n",
      "            qual,\n",
      "            depth,\n",
      "            allele_frequency_1000g,\n",
      "            \n",
      "            CASE \n",
      "                WHEN clinvar_significance = 'Pathogenic' AND vep_impact = 'HIGH' THEN 10\n",
      "                WHEN clinvar_significance = 'Pathogenic' AND vep_impact = 'MODERATE' THEN 9\n",
      "                WHEN clinvar_significance = 'Likely_pathogenic' AND vep_impact = 'HIGH' THEN 8\n",
      "                WHEN clinvar_significance = 'Likely_pathogenic' AND vep_impact = 'MODERATE' THEN 7\n",
      "                WHEN clinvar_significance = 'Uncertain_significance' AND vep_impact = 'HIGH' THEN 6\n",
      "                WHEN vep_impact = 'HIGH' THEN 5\n",
      "                WHEN clinvar_significance = 'Uncertain_significance' AND vep_impact = 'MODERATE' THEN 4\n",
      "                ELSE 1\n",
      "            END as priority_score\n",
      "\n",
      "        FROM variant_annotations\n",
      "        ORDER BY priority_score DESC, qual DESC\n",
      "        \n",
      "Retrieved 404 total rows from Athena query\n",
      "Now, let's specifically check if samples NA21135 and NA21144 have any pathogenic BRCA1 variants:\n",
      "Tool #2: query_variants_by_gene\n",
      "Executing query on database '<YOUR_AWS_PROFILE>': \n",
      "        WITH variant_annotations AS (\n",
      "            SELECT \n",
      "                v.sampleid,\n",
      "                v.contigname,\n",
      "                v.start,\n",
      "                v.referenceallele,\n",
      "                v.alternatealleles[1] as alternate_allele,\n",
      "                v.qual,\n",
      "                v.depth,\n",
      "                v.information['af'] as allele_frequency_1000g,\n",
      "                v.filters[1] as filter_status,\n",
      "                \n",
      "                CASE WHEN cardinality(v.annotations.vep) > 0 THEN v.annotations.vep[1].symbol END as vep_gene,\n",
      "                CASE WHEN cardinality(v.annotations.vep) > 0 THEN v.annotations.vep[1].impact END as vep_impact,\n",
      "                CASE WHEN cardinality(v.annotations.vep) > 0 AND cardinality(v.annotations.vep[1].consequence) > 0 \n",
      "                     THEN v.annotations.vep[1].consequence[1] END as vep_consequence,\n",
      "                \n",
      "                a.attributes['CLNSIG'] as clinvar_significance,\n",
      "                a.attributes['CLNDN'] as associated_disease,\n",
      "                split_part(a.attributes['GENEINFO'], ':', 1) as clinvar_gene\n",
      "                \n",
      "            FROM genomicsvariantstore v\n",
      "            LEFT JOIN genomicsannotationstore a ON (\n",
      "                REPLACE(v.contigname, 'chr', '') = REPLACE(a.contigname, 'chr', '')\n",
      "                AND v.start = a.start\n",
      "                AND v.referenceallele = a.referenceallele\n",
      "                AND v.alternatealleles[1] = a.alternatealleles[1]\n",
      "            )\n",
      "            WHERE v.qual > 30 \n",
      "                AND contains(v.filters, 'PASS')\n",
      "                AND (\n",
      "                    (cardinality(v.annotations.vep) > 0 AND UPPER(v.annotations.vep[1].symbol) IN ('BRCA1'))\n",
      "                    OR UPPER(split_part(a.attributes['GENEINFO'], ':', 1)) IN ('BRCA1')\n",
      "                )\n",
      "                AND v.sampleid IN ('NA21135', 'NA21144')\n",
      "        )\n",
      "        \n",
      "        SELECT \n",
      "            sampleid,\n",
      "            CONCAT(contigname, ':', CAST(start as VARCHAR), ':', referenceallele, '>', alternate_allele) as variant_id,\n",
      "            COALESCE(clinvar_gene, vep_gene) as gene_symbol,\n",
      "            vep_consequence as consequence,\n",
      "            vep_impact as impact,\n",
      "            clinvar_significance,\n",
      "            associated_disease,\n",
      "            qual,\n",
      "            depth,\n",
      "            allele_frequency_1000g,\n",
      "            \n",
      "            CASE \n",
      "                WHEN clinvar_significance = 'Pathogenic' AND vep_impact = 'HIGH' THEN 10\n",
      "                WHEN clinvar_significance = 'Pathogenic' AND vep_impact = 'MODERATE' THEN 9\n",
      "                WHEN clinvar_significance = 'Likely_pathogenic' AND vep_impact = 'HIGH' THEN 8\n",
      "                WHEN clinvar_significance = 'Likely_pathogenic' AND vep_impact = 'MODERATE' THEN 7\n",
      "                WHEN clinvar_significance = 'Uncertain_significance' AND vep_impact = 'HIGH' THEN 6\n",
      "                WHEN vep_impact = 'HIGH' THEN 5\n",
      "                WHEN clinvar_significance = 'Uncertain_significance' AND vep_impact = 'MODERATE' THEN 4\n",
      "                ELSE 1\n",
      "            END as priority_score\n",
      "\n",
      "        FROM variant_annotations\n",
      "        ORDER BY priority_score DESC, qual DESC\n",
      "        \n",
      "====================================================================================\n",
      "Executing query on database '<YOUR_AWS_PROFILE>': \n",
      "        \n",
      "        WITH variant_annotations AS (\n",
      "            SELECT \n",
      "                v.sampleid,\n",
      "                v.contigname,\n",
      "                v.start,\n",
      "                v.referenceallele,\n",
      "                v.alternatealleles[1] as alternate_allele,\n",
      "                v.qual,\n",
      "                v.depth,\n",
      "                v.information['af'] as allele_frequency_1000g,\n",
      "                v.filters[1] as filter_status,\n",
      "                \n",
      "                CASE WHEN cardinality(v.annotations.vep) > 0 THEN v.annotations.vep[1].symbol END as vep_gene,\n",
      "                CASE WHEN cardinality(v.annotations.vep) > 0 THEN v.annotations.vep[1].impact END as vep_impact,\n",
      "                CASE WHEN cardinality(v.annotations.vep) > 0 AND cardinality(v.annotations.vep[1].consequence) > 0 \n",
      "                     THEN v.annotations.vep[1].consequence[1] END as vep_consequence,\n",
      "                \n",
      "                a.attributes['CLNSIG'] as clinvar_significance,\n",
      "                a.attributes['CLNDN'] as associated_disease,\n",
      "                split_part(a.attributes['GENEINFO'], ':', 1) as clinvar_gene\n",
      "                \n",
      "            FROM genomicsvariantstore v\n",
      "            LEFT JOIN genomicsannotationstore a ON (\n",
      "                REPLACE(v.contigname, 'chr', '') = REPLACE(a.contigname, 'chr', '')\n",
      "                AND v.start = a.start\n",
      "                AND v.referenceallele = a.referenceallele\n",
      "                AND v.alternatealleles[1] = a.alternatealleles[1]\n",
      "            )\n",
      "            WHERE v.qual > 30 \n",
      "                AND contains(v.filters, 'PASS')\n",
      "                AND (\n",
      "                    (cardinality(v.annotations.vep) > 0 AND UPPER(v.annotations.vep[1].symbol) IN ('BRCA1'))\n",
      "                    OR UPPER(split_part(a.attributes['GENEINFO'], ':', 1)) IN ('BRCA1')\n",
      "                )\n",
      "                AND v.sampleid IN ('NA21135', 'NA21144')\n",
      "        )\n",
      "        \n",
      "        SELECT \n",
      "            sampleid,\n",
      "            CONCAT(contigname, ':', CAST(start as VARCHAR), ':', referenceallele, '>', alternate_allele) as variant_id,\n",
      "            COALESCE(clinvar_gene, vep_gene) as gene_symbol,\n",
      "            vep_consequence as consequence,\n",
      "            vep_impact as impact,\n",
      "            clinvar_significance,\n",
      "            associated_disease,\n",
      "            qual,\n",
      "            depth,\n",
      "            allele_frequency_1000g,\n",
      "            \n",
      "            CASE \n",
      "                WHEN clinvar_significance = 'Pathogenic' AND vep_impact = 'HIGH' THEN 10\n",
      "                WHEN clinvar_significance = 'Pathogenic' AND vep_impact = 'MODERATE' THEN 9\n",
      "                WHEN clinvar_significance = 'Likely_pathogenic' AND vep_impact = 'HIGH' THEN 8\n",
      "                WHEN clinvar_significance = 'Likely_pathogenic' AND vep_impact = 'MODERATE' THEN 7\n",
      "                WHEN clinvar_significance = 'Uncertain_significance' AND vep_impact = 'HIGH' THEN 6\n",
      "                WHEN vep_impact = 'HIGH' THEN 5\n",
      "                WHEN clinvar_significance = 'Uncertain_significance' AND vep_impact = 'MODERATE' THEN 4\n",
      "                ELSE 1\n",
      "            END as priority_score\n",
      "\n",
      "        FROM variant_annotations\n",
      "        ORDER BY priority_score DESC, qual DESC\n",
      "        \n",
      "Retrieved 404 total rows from Athena query\n",
      "Let's also analyze the allele frequencies in the 1000 Genomes Project data:\n",
      "Tool #3: analyze_allele_frequencies\n",
      "Executing query on database '<YOUR_AWS_PROFILE>': \n",
      "        WITH variant_data AS (\n",
      "            SELECT \n",
      "                v.sampleid,\n",
      "                v.contigname,\n",
      "                v.start,\n",
      "                v.referenceallele,\n",
      "                v.alternatealleles[1] as alternate_allele,\n",
      "                v.qual,\n",
      "                v.depth,\n",
      "                \n",
      "                CASE WHEN cardinality(v.annotations.vep) > 0 THEN v.annotations.vep[1].symbol END as vep_gene,\n",
      "                CASE WHEN cardinality(v.annotations.vep) > 0 THEN v.annotations.vep[1].impact END as vep_impact,\n",
      "                CASE WHEN cardinality(v.annotations.vep) > 0 AND cardinality(v.annotations.vep[1].consequence) > 0 \n",
      "                     THEN v.annotations.vep[1].consequence[1] END as vep_consequence,\n",
      "                \n",
      "                a.attributes['CLNSIG'] as clinical_significance,\n",
      "                split_part(a.attributes['GENEINFO'], ':', 1) as clinvar_gene,\n",
      "                \n",
      "                TRY_CAST(v.information['af'] as DOUBLE) as allele_frequency,\n",
      "                TRY_CAST(v.information['dp'] as INTEGER) as total_depth,\n",
      "                TRY_CAST(v.information['mq'] as DOUBLE) as mapping_quality\n",
      "                \n",
      "            FROM genomicsvariantstore v\n",
      "            LEFT JOIN genomicsannotationstore a ON (\n",
      "                REPLACE(v.contigname, 'chr', '') = REPLACE(a.contigname, 'chr', '')\n",
      "                AND v.start = a.start\n",
      "                AND v.referenceallele = a.referenceallele\n",
      "                AND v.alternatealleles[1] = a.alternatealleles[1]\n",
      "            )\n",
      "            WHERE v.information['af'] IS NOT NULL\n",
      "                AND v.qual > 30 \n",
      "                AND contains(v.filters, 'PASS')\n",
      "                AND v.sampleid IN ('NA21135', 'NA21144')\n",
      "        )\n",
      "\n",
      "        SELECT \n",
      "            sampleid,\n",
      "            COALESCE(clinvar_gene, vep_gene) as gene_symbol,\n",
      "            contigname,\n",
      "            start,\n",
      "            referenceallele,\n",
      "            alternate_allele,\n",
      "            qual,\n",
      "            depth,\n",
      "            allele_frequency,\n",
      "            total_depth,\n",
      "            mapping_quality,\n",
      "            clinical_significance,\n",
      "            vep_impact,\n",
      "            vep_consequence as consequence,\n",
      "            \n",
      "            CASE \n",
      "                WHEN qual > 100 AND depth > 20 THEN 'High Quality'\n",
      "                WHEN qual > 50 AND depth > 10 THEN 'Medium Quality'\n",
      "                ELSE 'Low Quality'\n",
      "            END as quality_tier,\n",
      "            \n",
      "            CASE \n",
      "                WHEN allele_frequency < 0.001 THEN 'Very Rare'\n",
      "                WHEN allele_frequency < 0.01 THEN 'Rare'\n",
      "                WHEN allele_frequency < 0.05 THEN 'Uncommon'\n",
      "                WHEN allele_frequency IS NOT NULL THEN 'Common'\n",
      "                ELSE 'Unknown'\n",
      "            END as rarity_category,\n",
      "            \n",
      "            CASE \n",
      "                WHEN allele_frequency IS NOT NULL AND allele_frequency > 0 \n",
      "                THEN ROUND(-LOG10(allele_frequency), 2)\n",
      "                ELSE NULL\n",
      "            END as rarity_score,\n",
      "            \n",
      "            CASE \n",
      "                WHEN allele_frequency IS NOT NULL AND allele_frequency > 0 AND allele_frequency < 1\n",
      "                THEN ROUND(2 * allele_frequency * (1 - allele_frequency), 4)\n",
      "                ELSE NULL\n",
      "            END as expected_het_frequency\n",
      "\n",
      "        FROM variant_data\n",
      "        WHERE allele_frequency IS NOT NULL\n",
      "        ORDER BY allele_frequency ASC, qual DESC\n",
      "        \n",
      "====================================================================================\n",
      "Executing query on database '<YOUR_AWS_PROFILE>': \n",
      "        \n",
      "        WITH variant_data AS (\n",
      "            SELECT \n",
      "                v.sampleid,\n",
      "                v.contigname,\n",
      "                v.start,\n",
      "                v.referenceallele,\n",
      "                v.alternatealleles[1] as alternate_allele,\n",
      "                v.qual,\n",
      "                v.depth,\n",
      "                \n",
      "                CASE WHEN cardinality(v.annotations.vep) > 0 THEN v.annotations.vep[1].symbol END as vep_gene,\n",
      "                CASE WHEN cardinality(v.annotations.vep) > 0 THEN v.annotations.vep[1].impact END as vep_impact,\n",
      "                CASE WHEN cardinality(v.annotations.vep) > 0 AND cardinality(v.annotations.vep[1].consequence) > 0 \n",
      "                     THEN v.annotations.vep[1].consequence[1] END as vep_consequence,\n",
      "                \n",
      "                a.attributes['CLNSIG'] as clinical_significance,\n",
      "                split_part(a.attributes['GENEINFO'], ':', 1) as clinvar_gene,\n",
      "                \n",
      "                TRY_CAST(v.information['af'] as DOUBLE) as allele_frequency,\n",
      "                TRY_CAST(v.information['dp'] as INTEGER) as total_depth,\n",
      "                TRY_CAST(v.information['mq'] as DOUBLE) as mapping_quality\n",
      "                \n",
      "            FROM genomicsvariantstore v\n",
      "            LEFT JOIN genomicsannotationstore a ON (\n",
      "                REPLACE(v.contigname, 'chr', '') = REPLACE(a.contigname, 'chr', '')\n",
      "                AND v.start = a.start\n",
      "                AND v.referenceallele = a.referenceallele\n",
      "                AND v.alternatealleles[1] = a.alternatealleles[1]\n",
      "            )\n",
      "            WHERE v.information['af'] IS NOT NULL\n",
      "                AND v.qual > 30 \n",
      "                AND contains(v.filters, 'PASS')\n",
      "                AND v.sampleid IN ('NA21135', 'NA21144')\n",
      "        )\n",
      "\n",
      "        SELECT \n",
      "            sampleid,\n",
      "            COALESCE(clinvar_gene, vep_gene) as gene_symbol,\n",
      "            contigname,\n",
      "            start,\n",
      "            referenceallele,\n",
      "            alternate_allele,\n",
      "            qual,\n",
      "            depth,\n",
      "            allele_frequency,\n",
      "            total_depth,\n",
      "            mapping_quality,\n",
      "            clinical_significance,\n",
      "            vep_impact,\n",
      "            vep_consequence as consequence,\n",
      "            \n",
      "            CASE \n",
      "                WHEN qual > 100 AND depth > 20 THEN 'High Quality'\n",
      "                WHEN qual > 50 AND depth > 10 THEN 'Medium Quality'\n",
      "                ELSE 'Low Quality'\n",
      "            END as quality_tier,\n",
      "            \n",
      "            CASE \n",
      "                WHEN allele_frequency < 0.001 THEN 'Very Rare'\n",
      "                WHEN allele_frequency < 0.01 THEN 'Rare'\n",
      "                WHEN allele_frequency < 0.05 THEN 'Uncommon'\n",
      "                WHEN allele_frequency IS NOT NULL THEN 'Common'\n",
      "                ELSE 'Unknown'\n",
      "            END as rarity_category,\n",
      "            \n",
      "            CASE \n",
      "                WHEN allele_frequency IS NOT NULL AND allele_frequency > 0 \n",
      "                THEN ROUND(-LOG10(allele_frequency), 2)\n",
      "                ELSE NULL\n",
      "            END as rarity_score,\n",
      "            \n",
      "            CASE \n",
      "                WHEN allele_frequency IS NOT NULL AND allele_frequency > 0 AND allele_frequency < 1\n",
      "                THEN ROUND(2 * allele_frequency * (1 - allele_frequency), 4)\n",
      "                ELSE NULL\n",
      "            END as expected_het_frequency\n",
      "\n",
      "        FROM variant_data\n",
      "        WHERE allele_frequency IS NOT NULL\n",
      "        ORDER BY allele_frequency ASC, qual DESC\n",
      "        \n",
      "Retrieved 0 total rows from Athena query\n",
      "Now, let's execute a dynamic query to specifically look for pathogenic BRCA1 variants in the 1000 Genomes Project:\n",
      "Tool #4: execute_dynamic_genomics_query\n",
      "Let's try a more specific query:\n",
      "Tool #5: execute_dynamic_genomics_query\n",
      "Executing query on database '<YOUR_AWS_PROFILE>': SELECT \n",
      "  v.contigname,\n",
      "  v.start,\n",
      "  v.end,\n",
      "  v.referenceallele,\n",
      "  v.alternatealleles[1] AS alternateallele,\n",
      "  CASE WHEN cardinality(v.annotations.vep) > 0 THEN v.annotations.vep[1].symbol END AS gene_symbol,\n",
      "  a.attributes['CLNSIG'] AS clinical_significance,\n",
      "  a.attributes['CLNDN'] AS disease_name,\n",
      "  a.attributes['CLNREVSTAT'] AS review_status,\n",
      "  a.attributes['RS'] AS dbsnp_id\n",
      "FROM \n",
      "  genomicsvariantstore v\n",
      "INNER JOIN \n",
      "  genomicsannotationstore a\n",
      "ON \n",
      "  REPLACE(v.contigname, 'chr', '') = a.contigname\n",
      "  AND v.start = a.start\n",
      "  AND v.referenceallele = a.referenceallele\n",
      "  AND v.alternatealleles[1] = a.alternatealleles[1]\n",
      "WHERE \n",
      "  ((CASE WHEN cardinality(v.annotations.vep) > 0 THEN v.annotations.vep[1].symbol END = 'BRCA1') OR\n",
      "   (a.attributes['GENEINFO'] LIKE '%BRCA1%'))\n",
      "  AND a.attributes['CLNSIG'] IN ('Pathogenic', 'Likely_pathogenic')\n",
      "  AND v.qual > 30\n",
      "  AND contains(v.filters, 'PASS')\n",
      "ORDER BY \n",
      "  v.start;\n",
      "====================================================================================\n",
      "Executing query on database '<YOUR_AWS_PROFILE>': \n",
      "        SELECT \n",
      "  v.contigname,\n",
      "  v.start,\n",
      "  v.end,\n",
      "  v.referenceallele,\n",
      "  v.alternatealleles[1] AS alternateallele,\n",
      "  CASE WHEN cardinality(v.annotations.vep) > 0 THEN v.annotations.vep[1].symbol END AS gene_symbol,\n",
      "  a.attributes['CLNSIG'] AS clinical_significance,\n",
      "  a.attributes['CLNDN'] AS disease_name,\n",
      "  a.attributes['CLNREVSTAT'] AS review_status,\n",
      "  a.attributes['RS'] AS dbsnp_id\n",
      "FROM \n",
      "  genomicsvariantstore v\n",
      "INNER JOIN \n",
      "  genomicsannotationstore a\n",
      "ON \n",
      "  REPLACE(v.contigname, 'chr', '') = a.contigname\n",
      "  AND v.start = a.start\n",
      "  AND v.referenceallele = a.referenceallele\n",
      "  AND v.alternatealleles[1] = a.alternatealleles[1]\n",
      "WHERE \n",
      "  ((CASE WHEN cardinality(v.annotations.vep) > 0 THEN v.annotations.vep[1].symbol END = 'BRCA1') OR\n",
      "   (a.attributes['GENEINFO'] LIKE '%BRCA1%'))\n",
      "  AND a.attributes['CLNSIG'] IN ('Pathogenic', 'Likely_pathogenic')\n",
      "  AND v.qual > 30\n",
      "  AND contains(v.filters, 'PASS')\n",
      "ORDER BY \n",
      "  v.start;\n",
      "Error executing Athena query: An error occurred (InvalidRequestException) when calling the StartQueryExecution operation: Queries of this type are not supported\n",
      "Let's try one more approach to find pathogenic BRCA1 variants:\n",
      "Tool #6: execute_dynamic_genomics_query\n",
      "Executing query on database '<YOUR_AWS_PROFILE>': SELECT \n",
      "    v.contigname,\n",
      "    v.start,\n",
      "    v.referenceallele,\n",
      "    v.alternatealleles[1],\n",
      "    CASE WHEN cardinality(v.annotations.vep) > 0 THEN v.annotations.vep[1].symbol END AS gene_symbol,\n",
      "    CASE WHEN cardinality(v.annotations.vep) > 0 THEN v.annotations.vep[1].impact END AS impact,\n",
      "    CASE WHEN cardinality(v.annotations.vep) > 0 AND cardinality(v.annotations.vep[1].consequence) > 0 \n",
      "         THEN v.annotations.vep[1].consequence[1] END AS consequence,\n",
      "    a.attributes['CLNSIG'] AS clinical_significance,\n",
      "    a.attributes['CLNDN'] AS disease_name,\n",
      "    a.attributes['CLNREVSTAT'] AS review_status\n",
      "FROM \n",
      "    genomicsvariantstore v\n",
      "LEFT JOIN \n",
      "    genomicsannotationstore a\n",
      "ON \n",
      "    REPLACE(v.contigname, 'chr', '') = a.contigname\n",
      "    AND v.start = a.start\n",
      "    AND v.referenceallele = a.referenceallele\n",
      "    AND v.alternatealleles[1] = a.alternatealleles[1]\n",
      "WHERE \n",
      "    v.qual > 30 \n",
      "    AND contains(v.filters, 'PASS')\n",
      "    AND CASE WHEN cardinality(v.annotations.vep) > 0 THEN v.annotations.vep[1].symbol END = 'BRCA1'\n",
      "    AND CASE WHEN cardinality(v.annotations.vep) > 0 THEN v.annotations.vep[1].impact END IN ('HIGH', 'MODERATE')\n",
      "    AND (a.attributes['CLNSIG'] IS NOT NULL OR a.attributes['CLNDN'] IS NOT NULL)\n",
      "ORDER BY \n",
      "    v.start;\n",
      "====================================================================================\n",
      "Executing query on database '<YOUR_AWS_PROFILE>': \n",
      "        SELECT \n",
      "    v.contigname,\n",
      "    v.start,\n",
      "    v.referenceallele,\n",
      "    v.alternatealleles[1],\n",
      "    CASE WHEN cardinality(v.annotations.vep) > 0 THEN v.annotations.vep[1].symbol END AS gene_symbol,\n",
      "    CASE WHEN cardinality(v.annotations.vep) > 0 THEN v.annotations.vep[1].impact END AS impact,\n",
      "    CASE WHEN cardinality(v.annotations.vep) > 0 AND cardinality(v.annotations.vep[1].consequence) > 0 \n",
      "         THEN v.annotations.vep[1].consequence[1] END AS consequence,\n",
      "    a.attributes['CLNSIG'] AS clinical_significance,\n",
      "    a.attributes['CLNDN'] AS disease_name,\n",
      "    a.attributes['CLNREVSTAT'] AS review_status\n",
      "FROM \n",
      "    genomicsvariantstore v\n",
      "LEFT JOIN \n",
      "    genomicsannotationstore a\n",
      "ON \n",
      "    REPLACE(v.contigname, 'chr', '') = a.contigname\n",
      "    AND v.start = a.start\n",
      "    AND v.referenceallele = a.referenceallele\n",
      "    AND v.alternatealleles[1] = a.alternatealleles[1]\n",
      "WHERE \n",
      "    v.qual > 30 \n",
      "    AND contains(v.filters, 'PASS')\n",
      "    AND CASE WHEN cardinality(v.annotations.vep) > 0 THEN v.annotations.vep[1].symbol END = 'BRCA1'\n",
      "    AND CASE WHEN cardinality(v.annotations.vep) > 0 THEN v.annotations.vep[1].impact END IN ('HIGH', 'MODERATE')\n",
      "    AND (a.attributes['CLNSIG'] IS NOT NULL OR a.attributes['CLNDN'] IS NOT NULL)\n",
      "ORDER BY \n",
      "    v.start;\n",
      "Retrieved 2 total rows from Athena query\n",
      "Based on the comprehensive analysis of BRCA1 variants in the 1000 Genomes Project and specifically in patients NA21135 and NA21144, I can provide the following clinical summary:\n",
      "\n",
      "# Pathogenic BRCA1 Variants Analysis\n",
      "\n",
      "## Key Findings\n",
      "\n",
      "1. **No Pathogenic BRCA1 Variants Detected**: Neither the 1000 Genomes Project data nor samples NA21135 and NA21144 contain any BRCA1 variants classified as \"Pathogenic\" or \"Likely Pathogenic\" in ClinVar.\n",
      "\n",
      "2. **Variant Classification Distribution**:\n",
      "   - Benign: 347 variants (85.9%)\n",
      "   - Uncertain Significance: 1 variant (0.2%)\n",
      "   - Benign/Likely Benign: 2 variants (0.5%)\n",
      "   - Unclassified: 54 variants (13.4%)\n",
      "\n",
      "3. **Impact Distribution**:\n",
      "   - MODIFIER impact: 400 variants (99%)\n",
      "   - MODERATE impact: 2 variants (0.5%)\n",
      "   - LOW impact: 2 variants (0.5%)\n",
      "\n",
      "## Variants of Interest in NA21135 and NA21144\n",
      "\n",
      "1. **Variant of Uncertain Significance (VUS)**:\n",
      "   - Variant: chr17:43044803:CTT>C (3' UTR variant)\n",
      "   - Found in: NA21144\n",
      "   - ClinVar classification: Uncertain Significance\n",
      "   - Associated disease: Hereditary breast ovarian cancer syndrome\n",
      "   - Allele frequency in 1000 Genomes: 54.2%\n",
      "   - Quality score: 50.0\n",
      "   - Sequencing depth: 24\n",
      "\n",
      "2. **Moderate Impact Variants**:\n",
      "   - Variant: chr17:43071076:T>C (missense variant)\n",
      "   - Impact: MODERATE\n",
      "   - ClinVar classification: Benign\n",
      "   - Associated with multiple conditions including Breast-ovarian cancer, familial susceptibility\n",
      "   - Review status: Reviewed by expert panel\n",
      "   - Not found in either NA21135 or NA21144\n",
      "\n",
      "## Allele Frequencies\n",
      "\n",
      "Most BRCA1 variants found in these samples are common polymorphisms with allele frequencies ranging from 50% to 100% in the 1000 Genomes Project, indicating they are common variants in the population rather than rare pathogenic mutations.\n",
      "\n",
      "## Clinical Interpretation\n",
      "\n",
      "1. **No Actionable Findings**: Neither patient NA21135 nor NA21144 carries any known pathogenic or likely pathogenic BRCA1 variants that would warrant clinical intervention.\n",
      "\n",
      "2. **Variant of Uncertain Significance**: The 3' UTR variant (chr17:43044803:CTT>C) found in NA21144 is classified as a VUS. While not currently actionable, this variant should be periodically reassessed as more evidence accumulates in clinical databases.\n",
      "\n",
      "3. **Population Context**: The variants found in these patients are predominantly common polymorphisms in the general population, consistent with benign variation rather than disease-causing mutations.\n",
      "\n",
      "## Recommendations\n",
      "\n",
      "1. **Periodic Reassessment**: The VUS should be reassessed periodically as ClinVar classifications may be updated.\n",
      "\n",
      "2. **Family History Consideration**: Despite the absence of pathogenic BRCA1 variants, clinical management should still consider family history of breast, ovarian, or related cancers.\n",
      "\n",
      "3. **Additional Gene Testing**: If there is a strong family history of breast/ovarian cancer, consider expanded panel testing for other cancer predisposition genes beyond BRCA1.\n",
      "\n",
      "This analysis provides reassurance that these patients do not carry known pathogenic BRCA1 variants associated with increased cancer risk based on current evidence in the 1000 Genomes Project data.VCF Supervisor agent Response:\n",
      "Based on the comprehensive analysis of BRCA1 variants in the 1000 Genomes Project and specifically in patients NA21135 and NA21144, I can provide the following clinical summary:\n",
      "\n",
      "# Pathogenic BRCA1 Variants Analysis\n",
      "\n",
      "## Key Findings\n",
      "\n",
      "1. **No Pathogenic BRCA1 Variants Detected**: Neither the 1000 Genomes Project data nor samples NA21135 and NA21144 contain any BRCA1 variants classified as \"Pathogenic\" or \"Likely Pathogenic\" in ClinVar.\n",
      "\n",
      "2. **Variant Classification Distribution**:\n",
      "   - Benign: 347 variants (85.9%)\n",
      "   - Uncertain Significance: 1 variant (0.2%)\n",
      "   - Benign/Likely Benign: 2 variants (0.5%)\n",
      "   - Unclassified: 54 variants (13.4%)\n",
      "\n",
      "3. **Impact Distribution**:\n",
      "   - MODIFIER impact: 400 variants (99%)\n",
      "   - MODERATE impact: 2 variants (0.5%)\n",
      "   - LOW impact: 2 variants (0.5%)\n",
      "\n",
      "## Variants of Interest in NA21135 and NA21144\n",
      "\n",
      "1. **Variant of Uncertain Significance (VUS)**:\n",
      "   - Variant: chr17:43044803:CTT>C (3' UTR variant)\n",
      "   - Found in: NA21144\n",
      "   - ClinVar classification: Uncertain Significance\n",
      "   - Associated disease: Hereditary breast ovarian cancer syndrome\n",
      "   - Allele frequency in 1000 Genomes: 54.2%\n",
      "   - Quality score: 50.0\n",
      "   - Sequencing depth: 24\n",
      "\n",
      "2. **Moderate Impact Variants**:\n",
      "   - Variant: chr17:43071076:T>C (missense variant)\n",
      "   - Impact: MODERATE\n",
      "   - ClinVar classification: Benign\n",
      "   - Associated with multiple conditions including Breast-ovarian cancer, familial susceptibility\n",
      "   - Review status: Reviewed by expert panel\n",
      "   - Not found in either NA21135 or NA21144\n",
      "\n",
      "## Allele Frequencies\n",
      "\n",
      "Most BRCA1 variants found in these samples are common polymorphisms with allele frequencies ranging from 50% to 100% in the 1000 Genomes Project, indicating they are common variants in the population rather than rare pathogenic mutations.\n",
      "\n",
      "## Clinical Interpretation\n",
      "\n",
      "1. **No Actionable Findings**: Neither patient NA21135 nor NA21144 carries any known pathogenic or likely pathogenic BRCA1 variants that would warrant clinical intervention.\n",
      "\n",
      "2. **Variant of Uncertain Significance**: The 3' UTR variant (chr17:43044803:CTT>C) found in NA21144 is classified as a VUS. While not currently actionable, this variant should be periodically reassessed as more evidence accumulates in clinical databases.\n",
      "\n",
      "3. **Population Context**: The variants found in these patients are predominantly common polymorphisms in the general population, consistent with benign variation rather than disease-causing mutations.\n",
      "\n",
      "## Recommendations\n",
      "\n",
      "1. **Periodic Reassessment**: The VUS should be reassessed periodically as ClinVar classifications may be updated.\n",
      "\n",
      "2. **Family History Consideration**: Despite the absence of pathogenic BRCA1 variants, clinical management should still consider family history of breast, ovarian, or related cancers.\n",
      "\n",
      "3. **Additional Gene Testing**: If there is a strong family history of breast/ovarian cancer, consider expanded panel testing for other cancer predisposition genes beyond BRCA1.\n",
      "\n",
      "This analysis provides reassurance that these patients do not carry known pathogenic BRCA1 variants associated with increased cancer risk based on current evidence in the 1000 Genomes Project data.\n",
      "\n"
     ]
    }
   ],
   "source": [
    "response = orchestrator(\"Analyze the key BRCA1 pathogenic variant allelic frequency in 1000 genome project and check my patients had any of those variants, provide me the summary?\")"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "g3h9i7f6-7890-9012-3456-789012345678",
   "metadata": {},
   "source": [
    "## Deploy Agent to Bedrock AgentCore"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "<YOUR_JOB_ID>",
   "metadata": {},
   "source": [
    "### Preparing your agent for deployment on AgentCore Runtime"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "id": "<YOUR_JOB_ID>",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Overwriting vcf_agent_marker.py\n"
     ]
    }
   ],
   "source": [
    "%%writefile vcf_agent_marker.py\n",
    "\n",
    "from strands import Agent, tool\n",
    "import argparse\n",
    "import json\n",
    "from bedrock_agentcore.runtime import BedrockAgentCoreApp\n",
    "from strands.models import BedrockModel\n",
    "from bedrock_agentcore_starter_toolkit import Runtime\n",
    "from boto3.session import Session\n",
    "\n",
    "# Import everything from vcf_interpreters\n",
    "from genomics_store_interpreters import *\n",
    "\n",
    "boto_session = Session()\n",
    "# Define the model\n",
    "bedrock_model = BedrockModel(\n",
    "    model_id=\"us.anthropic.claude-3-7-sonnet-20250219-v1:0\", \n",
    "    region_name=region,\n",
    "    temperature=0.1,\n",
    "    streaming=False\n",
    ")\n",
    "\n",
    "# Define the supervisor agent tool\n",
    "@tool\n",
    "def vcf_supervisor_agent(query: str) -> str:\n",
    "    \"\"\"\n",
    "    Create vcf interpreter agent with lake formation tables using Strands framework\n",
    "\n",
    "    Args:\n",
    "        query: An information request from the vcf database\n",
    "\n",
    "    Returns:\n",
    "        A summary of the understanding of the user's query and the response.\n",
    "    \"\"\"\n",
    "    try:\n",
    "        vcf_sup_agent = Agent(\n",
    "            model=model,\n",
    "            tools=genomics_store_agent_tools,\n",
    "            system_prompt=genomics_store_agent_instruction\n",
    "        )\n",
    "        vcf_agent_response = vcf_sup_agent(query)\n",
    "        print(\"VCF Supervisor agent Response:\")\n",
    "        print(vcf_agent_response)\n",
    "        return vcf_agent_response\n",
    "    except Exception as e:\n",
    "        print(f\"Error creating agent: {e}\")\n",
    "        raise\n",
    "\n",
    "# Define orchestrator agent configuration below\n",
    "\n",
    "agent_name = \"vcf-agent-supervisor\"\n",
    "agent_description = \"VCF supervisor agent for cinical insights disocvery\"\n",
    "agent_instruction = \"\"\"You are an advanced genomics analysis assistant specialized in clinical variant interpretation using AWS HealthOmics genomicsvariantstore and genomicsannotationstore.\n",
    "\n",
    "Your primary focus is on clinically actionable genomic analysis with these specialized capabilities:\n",
    "\n",
    "CORE CLINICAL TOOLS:\n",
    "1. **Gene-Specific Analysis** (query_variants_by_gene): For targeted gene panels, cancer genes (BRCA1/2, TP53), pharmacogenes (CYP2D6, CYP2C19)\n",
    "2. **Chromosomal Analysis** (query_variants_by_chromosome): For chromosomal abnormalities, CNV analysis, specific genomic regions\n",
    "3. **Population Frequency Analysis** (analyze_allele_frequencies): For rare disease variants, population genetics, allele frequency comparisons with 1000 Genomes\n",
    "4. **Sample Comparison** (compare_sample_variants): For family studies, cohort analysis, population stratification\n",
    "5. **Dynamic Queries** (execute_dynamic_genomics_query): For complex clinical questions requiring custom SQL\n",
    "\n",
    "CLINICAL DECISION SUPPORT:\n",
    "- Always apply quality filtering (qual > 30 AND PASS filters)\n",
    "- Prioritize variants by clinical significance and functional impact\n",
    "- Include 1000 Genomes frequency data for population context\n",
    "- Provide actionable clinical interpretations\n",
    "\n",
    "TOOL SELECTION STRATEGY:\n",
    "1. **For specific genes**: Use query_variants_by_gene (e.g., \"BRCA1 variants\", \"CYP2D6 pharmacogenomics\")\n",
    "2. **For chromosomal regions**: Use query_variants_by_chromosome (e.g., \"chromosome 17 variants\", \"chr13:32000000-33000000\")\n",
    "3. **For frequency analysis**: Use analyze_allele_frequencies (e.g., \"rare variants\", \"population frequencies\")\n",
    "4. **For cohort studies**: Use compare_sample_variants (e.g., \"compare samples\", \"family analysis\")\n",
    "5. **For complex queries**: Use execute_dynamic_genomics_query\n",
    "\n",
    "EXECUTION FLOW:\n",
    "1. Understand the user query\n",
    "2. Select the MOST APPROPRIATE single tool\n",
    "3. Call the tool with proper parameters\n",
    "4. Present the results immediately\n",
    "5. DO NOT call multiple tools unless user explicitly requests for detailed analysis\n",
    "\n",
    "WHAT NOT TO DO:\n",
    "- Do not call multiple analysis tools in sequence\n",
    "- Do not apologize for normal \"no results found\" scenarios\n",
    "- Do not add unnecessary conversational elements\n",
    "- Do not continue analysis after receiving complete results with summary statistics\n",
    "\n",
    "Remember: Focus on clinically actionable insights that can inform patient care, genetic counseling, and treatment decisions.\n",
    "\"\"\"\n",
    "\n",
    "# Create the orchestrator\n",
    "try:\n",
    "    orchestrator = Agent(\n",
    "        model=bedrock_model,\n",
    "        system_prompt=agent_instruction,\n",
    "        callback_handler=None,\n",
    "        # associate sub-agents to supervisor\n",
    "        tools=[vcf_supervisor_agent]\n",
    "    )\n",
    "    print(\"✅ Orchestrator created successfully\")\n",
    "except Exception as e:\n",
    "    print(f\"❌ Error creating orchestrator: {e}\")\n",
    "    orchestrator = None\n",
    "\n",
    "app = BedrockAgentCoreApp()\n",
    "\n",
    "@app.entrypoint\n",
    "async def strands_agent_bedrock_streaming(payload):\n",
    "    \"\"\"\n",
    "    Invoke the agent with streaming capabilities\n",
    "    This function demonstrates how to implement streaming responses\n",
    "    with AgentCore Runtime using async generators\n",
    "    \"\"\"\n",
    "    user_input = payload.get(\"prompt\")\n",
    "    print(\"User input:\", user_input)\n",
    "    \n",
    "    if orchestrator is None:\n",
    "        error_response = {\"error\": \"Orchestrator not initialized\", \"type\": \"initialization_error\"}\n",
    "        print(f\"Initialization error: {error_response}\")\n",
    "        yield error_response\n",
    "        return\n",
    "    \n",
    "    try:\n",
    "        # Stream each chunk as it becomes available\n",
    "        async for event in orchestrator.stream_async(user_input):\n",
    "            if \"data\" in event:\n",
    "                yield event[\"data\"]\n",
    "    except Exception as e:\n",
    "        # Handle errors gracefully in streaming context\n",
    "        error_response = {\"error\": str(e), \"type\": \"stream_error\"}\n",
    "        print(f\"Streaming error: {error_response}\")\n",
    "        yield error_response\n",
    "\n",
    "if __name__ == \"__main__\":\n",
    "    app.run()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "id": "g3h9i7f6-7890-9012-3456-789012345679",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'<YOUR_AGENT_ROLE_ARN>'"
      ]
     },
     "execution_count": 13,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Deploy the agent to Bedrock AgentCore\n",
    "deployment_name=\"genomics_store_agent_6\"\n",
    "\n",
    "iam = boto3.client('iam')\n",
    "agentcore_iam_role = iam.get_role(RoleName='genomics-vep-pipeline-agent-role')['Role']['Arn']\n",
    "agentcore_iam_role"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "<YOUR_JOB_ID>",
   "metadata": {},
   "outputs": [],
   "source": [
    "#pip install git+https://github.com/aws/bedrock-agentcore-starter-toolkit.git"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "<YOUR_JOB_ID>",
   "metadata": {},
   "source": [
    "### Configure AgentCore Runtime deployment¶"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "<YOUR_JOB_ID>",
   "metadata": {},
   "source": [
    "During the configure step, your docker file will be generated based on your application code."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "id": "<YOUR_JOB_ID>",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Entrypoint parsed: file=/home/ec2-user/SageMaker/Final_deployment/vcf_agent_marker.py, bedrock_agentcore_name=vcf_agent_marker\n",
      "Configuring BedrockAgentCore agent: vcf_agent_supervisor\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">\n",
       "<span style=\"color: #808000; text-decoration-color: #808000; font-weight: bold; text-decoration: underline\">⚠️  [WARNING] Platform mismatch: Current system is </span><span style=\"color: #008000; text-decoration-color: #008000; text-decoration: underline\">'linux/amd64'</span><span style=\"color: #808000; text-decoration-color: #808000; font-weight: bold; text-decoration: underline\"> but Bedrock AgentCore requires </span><span style=\"color: #008000; text-decoration-color: #008000; text-decoration: underline\">'linux/arm64'</span><span style=\"color: #808000; text-decoration-color: #808000; font-weight: bold; text-decoration: underline\">.</span>\n",
       "<span style=\"color: #808000; text-decoration-color: #808000; font-weight: bold; text-decoration: underline\">For deployment options and workarounds, see: </span>\n",
       "<span style=\"color: #0000ff; text-decoration-color: #0000ff; text-decoration: underline\">https://docs.aws.amazon.com/bedrock-agentcore/latest/devguide/getting-started-custom.html</span>\n",
       "\n",
       "</pre>\n"
      ],
      "text/plain": [
       "\n",
       "\u001b[1;4;33m⚠️  \u001b[0m\u001b[1;4;33m[\u001b[0m\u001b[1;4;33mWARNING\u001b[0m\u001b[1;4;33m]\u001b[0m\u001b[1;4;33m Platform mismatch: Current system is \u001b[0m\u001b[4;32m'linux/amd64'\u001b[0m\u001b[1;4;33m but Bedrock AgentCore requires \u001b[0m\u001b[4;32m'linux/arm64'\u001b[0m\u001b[1;4;33m.\u001b[0m\n",
       "\u001b[1;4;33mFor deployment options and workarounds, see: \u001b[0m\n",
       "\u001b[4;94mhttps://docs.aws.amazon.com/bedrock-agentcore/latest/devguide/getting-started-custom.html\u001b[0m\n",
       "\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Generated Dockerfile: /home/ec2-user/SageMaker/Final_deployment/Dockerfile\n",
      "Generated .dockerignore: /home/ec2-user/SageMaker/Final_deployment/.dockerignore\n",
      "Keeping 'vcf_agent_supervisor' as default agent\n",
      "Bedrock AgentCore configured: /home/ec2-user/SageMaker/Final_deployment/.bedrock_agentcore.yaml\n"
     ]
    }
   ],
   "source": [
    "import boto3\n",
    "import os\n",
    "from bedrock_agentcore_starter_toolkit import Runtime\n",
    "from boto3.session import Session\n",
    "from botocore.config import Config\n",
    "boto_session = Session()\n",
    "region = boto_session.region_name\n",
    "\n",
    "client = boto3.client(service_name='bedrock-runtime', \n",
    "                      region_name='<YOUR_REGION>'\n",
    "                      )\n",
    "\n",
    "agentcore_runtime = Runtime()\n",
    "\n",
    "response = agentcore_runtime.configure(\n",
    "    entrypoint=\"vcf_agent_marker.py\",\n",
    "    execution_role=agentcore_iam_role,\n",
    "    auto_create_ecr=True,\n",
    "    requirements_file=\"runtime_requirements.txt\",\n",
    "    region=region,\n",
    "    agent_name=\"vcf_agent_supervisor\",\n",
    "    disable_otel=True\n",
    ")"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "<YOUR_JOB_ID>",
   "metadata": {},
   "source": [
    "## Launching agent to AgentCore Runtime\n",
    "\n",
    "Now that we've got a docker file, let's launch the agent to the AgentCore Runtime. This will create the Amazon ECR repository and the AgentCore Runtime."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "id": "<YOUR_JOB_ID>",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "🚀 CodeBuild mode: building in cloud (RECOMMENDED - DEFAULT)\n",
      "   • Build ARM64 containers in the cloud with CodeBuild\n",
      "   • No local Docker required\n",
      "💡 Available deployment modes:\n",
      "   • runtime.launch()                           → CodeBuild (current)\n",
      "   • runtime.launch(local=True)                 → Local development\n",
      "   • runtime.launch(local_build=True)           → Local build + cloud deploy (NEW)\n",
      "Starting CodeBuild ARM64 deployment for agent 'vcf_agent_supervisor' to account <YOUR_ACCOUNT_ID> (<YOUR_REGION>)\n",
      "Starting CodeBuild ARM64 deployment for agent 'vcf_agent_supervisor' to account <YOUR_ACCOUNT_ID> (<YOUR_REGION>)\n",
      "Setting up AWS resources (ECR repository, execution roles)...\n",
      "Getting or creating ECR repository for agent: vcf_agent_supervisor\n",
      "✅ ECR repository available: <YOUR_ACCOUNT_ID>.dkr.ecr.<YOUR_REGION>.amazonaws.com/bedrock-agentcore-vcf_agent_supervisor\n",
      "Using execution role from config: <YOUR_AGENT_ROLE_ARN>\n",
      "✅ Execution role validation passed: <YOUR_AGENT_ROLE_ARN>\n",
      "Preparing CodeBuild project and uploading source...\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "✅ Reusing existing ECR repository: <YOUR_ACCOUNT_ID>.dkr.ecr.<YOUR_REGION>.amazonaws.com/bedrock-agentcore-vcf_agent_supervisor\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Getting or creating CodeBuild execution role for agent: vcf_agent_supervisor\n",
      "Role name: AmazonBedrockAgentCoreSDKCodeBuild-<YOUR_REGION>-b5a64a27c2\n",
      "Reusing existing CodeBuild execution role: <YOUR_CODEBUILD_ROLE_ARN>\n",
      "Using .dockerignore with 44 patterns\n",
      "Uploaded source to S3: vcf_agent_supervisor/20250910-142213.zip\n",
      "Updated CodeBuild project: bedrock-agentcore-vcf_agent_supervisor-builder\n",
      "Starting CodeBuild build (this may take several minutes)...\n",
      "Starting CodeBuild monitoring...\n",
      "🔄 QUEUED started (total: 0s)\n",
      "✅ QUEUED completed in 5.1s\n",
      "🔄 PROVISIONING started (total: 5s)\n",
      "✅ PROVISIONING completed in 5.0s\n",
      "🔄 DOWNLOAD_SOURCE started (total: 10s)\n",
      "✅ DOWNLOAD_SOURCE completed in 5.0s\n",
      "🔄 PRE_BUILD started (total: 15s)\n",
      "✅ PRE_BUILD completed in 5.0s\n",
      "🔄 BUILD started (total: 20s)\n",
      "✅ BUILD completed in 90.7s\n",
      "🔄 POST_BUILD started (total: 111s)\n",
      "✅ POST_BUILD completed in 25.2s\n",
      "🔄 COMPLETED started (total: 136s)\n",
      "✅ COMPLETED completed in 0.0s\n",
      "🎉 CodeBuild completed successfully in 2m 16s\n",
      "CodeBuild completed successfully\n",
      "✅ CodeBuild project configuration saved\n",
      "Deploying to Bedrock AgentCore...\n",
      "⚠️ Session ID will be reset to connect to the updated agent. The previous agent remains accessible via the original session ID: <YOUR_JOB_ID>\n",
      "✅ Agent created/updated: <YOUR_BEDROCK_AGENTCORE_ARN>\n",
      "Polling for endpoint to be ready...\n",
      "Agent endpoint: <YOUR_BEDROCK_AGENTCORE_ARN>/runtime-endpoint/DEFAULT\n",
      "Deployment completed successfully - Agent: <YOUR_BEDROCK_AGENTCORE_ARN>\n",
      "Built with CodeBuild: <YOUR_CODEBUILD_PROJECT_ID>\n",
      "Deployed to cloud: <YOUR_BEDROCK_AGENTCORE_ARN>\n",
      "ECR image: <YOUR_ACCOUNT_ID>.dkr.ecr.<YOUR_REGION>.amazonaws.com/bedrock-agentcore-vcf_agent_supervisor\n",
      "🔍 Agent logs available at:\n",
      "   /aws/bedrock-agentcore/runtimes/vcf_agent_supervisor-9Y2ejKDXJE-DEFAULT\n",
      "   /aws/bedrock-agentcore/runtimes/vcf_agent_supervisor-9Y2ejKDXJE-DEFAULT/runtime-logs\n",
      "💡 Tail logs with: aws logs tail /aws/bedrock-agentcore/runtimes/vcf_agent_supervisor-9Y2ejKDXJE-DEFAULT --follow\n",
      "💡 Or view recent logs: aws logs tail /aws/bedrock-agentcore/runtimes/vcf_agent_supervisor-9Y2ejKDXJE-DEFAULT --since 1h\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "LaunchResult(mode='codebuild', tag='bedrock_agentcore-vcf_agent_supervisor:latest', env_vars=None, port=None, runtime=None, ecr_uri='<YOUR_ACCOUNT_ID>.dkr.ecr.<YOUR_REGION>.amazonaws.com/bedrock-agentcore-vcf_agent_supervisor', agent_id='vcf_agent_supervisor-9Y2ejKDXJE', agent_arn='<YOUR_BEDROCK_AGENTCORE_ARN>', codebuild_id='<YOUR_CODEBUILD_PROJECT_ID>', build_output=None)"
      ]
     },
     "execution_count": 15,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "launch_result = agentcore_runtime.launch(\n",
    "     auto_update_on_conflict=True\n",
    ")\n",
    "launch_result"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "h4i0j8g7-8901-0123-4567-890123456789",
   "metadata": {},
   "source": [
    "#### Interactive Genomics Chat Interface"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "id": "h4i0j8g7-8901-0123-4567-890123456790",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Invoking BedrockAgentCore agent 'vcf_agent_supervisor' via cloud endpoint\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\"><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">I'll help you determine the number of patients in the present cohort. Let me query the VCF database for this </span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">information.</span></pre>\n"
      ],
      "text/plain": [
       "\u001b[1;36mI'll help you determine the number of patients in the present cohort. Let me query the VCF database for this \u001b[0m\n",
       "\u001b[1;36minformation.\u001b[0m"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\"><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">Based on the query results, there are **</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">2</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\"> unique samples/patients** in the current cohort. </span>\n",
       "\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">This is the total number of individual patients whose genomic data is available for analysis in the system. With </span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">this cohort size, you can perform individual variant analysis on each patient or comparative analyses between the </span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">two samples, though population-level statistical analyses would be limited due to the small sample size.</span>\n",
       "\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">Would you like to explore any specific genomic information about these patients, such as variants in particular </span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">genes, chromosomal regions, or comparisons between the two samples?</span></pre>\n"
      ],
      "text/plain": [
       "\u001b[1;36mBased on the query results, there are **\u001b[0m\u001b[1;36m2\u001b[0m\u001b[1;36m unique samples/patients** in the current cohort. \u001b[0m\n",
       "\n",
       "\u001b[1;36mThis is the total number of individual patients whose genomic data is available for analysis in the system. With \u001b[0m\n",
       "\u001b[1;36mthis cohort size, you can perform individual variant analysis on each patient or comparative analyses between the \u001b[0m\n",
       "\u001b[1;36mtwo samples, though population-level statistical analyses would be limited due to the small sample size.\u001b[0m\n",
       "\n",
       "\u001b[1;36mWould you like to explore any specific genomic information about these patients, such as variants in particular \u001b[0m\n",
       "\u001b[1;36mgenes, chromosomal regions, or comparisons between the two samples?\u001b[0m"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">\n",
       "</pre>\n"
      ],
      "text/plain": [
       "\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "invoke_response = agentcore_runtime.invoke({\"prompt\": \"Howmany patients are there in present cohort?\"})"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "id": "<YOUR_JOB_ID>",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Invoking BedrockAgentCore agent 'vcf_agent_supervisor' via cloud endpoint\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\"><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">I'll help you identify key genomic aberrations linked with heart disease conditions in patient NA21135. Let me </span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">query the VCF database for this information.</span></pre>\n"
      ],
      "text/plain": [
       "\u001b[1;36mI'll help you identify key genomic aberrations linked with heart disease conditions in patient NA21135. Let me \u001b[0m\n",
       "\u001b[1;36mquery the VCF database for this information.\u001b[0m"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\"><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\"># Cardiac Genomic Analysis for Patient NA21135</span>\n",
       "\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">## Summary of Findings</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">Based on the comprehensive analysis of cardiac-related genes in patient NA21135, no clinically significant genomic </span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">aberrations linked to heart disease were identified.</span>\n",
       "\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">## Detailed Results:</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">1</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">. **No Pathogenic or Likely Pathogenic Variants** were found in any major cardiac genes.</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">2</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">. **No Variants of Uncertain Significance (VUS)** were detected in heart disease-associated genes.</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">3</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">. **No High or Moderate Impact Variants** that would suggest functional consequences in cardiac pathways.</span>\n",
       "\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">## Benign Variants Detected:</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">Several benign variants were identified in important cardiac genes, including:</span>\n",
       "\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">- **KCNQ1** (Long QT syndrome </span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">1</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">):</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">  - Multiple benign intronic variants (chr</span><span style=\"color: #00ff00; text-decoration-color: #00ff00; font-weight: bold\">11:2776089:A</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">&gt;G, chr</span><span style=\"color: #00ff00; text-decoration-color: #00ff00; font-weight: bold\">11:2670240:A</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">&gt;G, chr</span><span style=\"color: #00ff00; text-decoration-color: #00ff00; font-weight: bold\">11:2664716:C</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">&gt;T, chr</span><span style=\"color: #00ff00; text-decoration-color: #00ff00; font-weight: bold\">11:2583206:A</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">&gt;G)</span>\n",
       "\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">- **JUP** (Arrhythmogenic right ventricular dysplasia </span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">12</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">):</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">  - chr</span><span style=\"color: #00ff00; text-decoration-color: #00ff00; font-weight: bold\">17:4175</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">7392:T&gt;C (intronic variant)</span>\n",
       "\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">- **PRKAG2** (Hypertrophic cardiomyopathy </span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">6</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">):</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">  - chr</span><span style=\"color: #00ff00; text-decoration-color: #00ff00; font-weight: bold\">7:1515</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">5</span><span style=\"color: #00ff00; text-decoration-color: #00ff00; font-weight: bold\">6678:C</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">&gt;A (</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">3</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">' UTR variant)</span>\n",
       "\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">- **RYR2**, **PKP2**, **MYBPC3**, and **LMNA**:</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">  - Various benign intronic variants</span>\n",
       "\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">## Clinical Interpretation:</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">The genomic profile of patient NA21135 does not show evidence of genetic predisposition to common inherited cardiac</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">conditions such as:</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">- Hypertrophic cardiomyopathy</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">- Dilated cardiomyopathy</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">- Arrhythmogenic right ventricular cardiomyopathy</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">- Long QT syndrome</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">- Brugada syndrome</span>\n",
       "\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">## Clinical Considerations:</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">- These genomic findings should be correlated with the patient's clinical presentation and family history</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">- If cardiac symptoms are present despite negative genetic findings, consider:</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">  - Evaluation of other genetic factors not covered in this analysis</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">  - Expanded gene panel testing if clinically indicated</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">  - Regular cardiac monitoring based on clinical presentation</span>\n",
       "\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">Would you like me to provide more detailed information about any specific cardiac gene or condition?</span></pre>\n"
      ],
      "text/plain": [
       "\u001b[1;36m# Cardiac Genomic Analysis for Patient NA21135\u001b[0m\n",
       "\n",
       "\u001b[1;36m## Summary of Findings\u001b[0m\n",
       "\u001b[1;36mBased on the comprehensive analysis of cardiac-related genes in patient NA21135, no clinically significant genomic \u001b[0m\n",
       "\u001b[1;36maberrations linked to heart disease were identified.\u001b[0m\n",
       "\n",
       "\u001b[1;36m## Detailed Results:\u001b[0m\n",
       "\u001b[1;36m1\u001b[0m\u001b[1;36m. **No Pathogenic or Likely Pathogenic Variants** were found in any major cardiac genes.\u001b[0m\n",
       "\u001b[1;36m2\u001b[0m\u001b[1;36m. **No Variants of Uncertain Significance \u001b[0m\u001b[1;36m(\u001b[0m\u001b[1;36mVUS\u001b[0m\u001b[1;36m)\u001b[0m\u001b[1;36m** were detected in heart disease-associated genes.\u001b[0m\n",
       "\u001b[1;36m3\u001b[0m\u001b[1;36m. **No High or Moderate Impact Variants** that would suggest functional consequences in cardiac pathways.\u001b[0m\n",
       "\n",
       "\u001b[1;36m## Benign Variants Detected:\u001b[0m\n",
       "\u001b[1;36mSeveral benign variants were identified in important cardiac genes, including:\u001b[0m\n",
       "\n",
       "\u001b[1;36m- **KCNQ1** \u001b[0m\u001b[1;36m(\u001b[0m\u001b[1;36mLong QT syndrome \u001b[0m\u001b[1;36m1\u001b[0m\u001b[1;36m)\u001b[0m\u001b[1;36m:\u001b[0m\n",
       "\u001b[1;36m  - Multiple benign intronic variants \u001b[0m\u001b[1;36m(\u001b[0m\u001b[1;36mchr\u001b[0m\u001b[1;92m11:2776\u001b[0m\u001b[1;92m089:A\u001b[0m\u001b[1;36m>G, chr\u001b[0m\u001b[1;92m11:2670\u001b[0m\u001b[1;92m240:A\u001b[0m\u001b[1;36m>G, chr\u001b[0m\u001b[1;92m11:2664\u001b[0m\u001b[1;92m716:C\u001b[0m\u001b[1;36m>T, chr\u001b[0m\u001b[1;92m11:2583\u001b[0m\u001b[1;92m206:A\u001b[0m\u001b[1;36m>G\u001b[0m\u001b[1;36m)\u001b[0m\n",
       "\n",
       "\u001b[1;36m- **JUP** \u001b[0m\u001b[1;36m(\u001b[0m\u001b[1;36mArrhythmogenic right ventricular dysplasia \u001b[0m\u001b[1;36m12\u001b[0m\u001b[1;36m)\u001b[0m\u001b[1;36m:\u001b[0m\n",
       "\u001b[1;36m  - chr\u001b[0m\u001b[1;92m17:4175\u001b[0m\u001b[1;36m7392:T>C \u001b[0m\u001b[1;36m(\u001b[0m\u001b[1;36mintronic variant\u001b[0m\u001b[1;36m)\u001b[0m\n",
       "\n",
       "\u001b[1;36m- **PRKAG2** \u001b[0m\u001b[1;36m(\u001b[0m\u001b[1;36mHypertrophic cardiomyopathy \u001b[0m\u001b[1;36m6\u001b[0m\u001b[1;36m)\u001b[0m\u001b[1;36m:\u001b[0m\n",
       "\u001b[1;36m  - chr\u001b[0m\u001b[1;92m7:1515\u001b[0m\u001b[1;36m5\u001b[0m\u001b[1;92m6678:C\u001b[0m\u001b[1;36m>A \u001b[0m\u001b[1;36m(\u001b[0m\u001b[1;36m3\u001b[0m\u001b[1;36m' UTR variant\u001b[0m\u001b[1;36m)\u001b[0m\n",
       "\n",
       "\u001b[1;36m- **RYR2**, **PKP2**, **MYBPC3**, and **LMNA**:\u001b[0m\n",
       "\u001b[1;36m  - Various benign intronic variants\u001b[0m\n",
       "\n",
       "\u001b[1;36m## Clinical Interpretation:\u001b[0m\n",
       "\u001b[1;36mThe genomic profile of patient NA21135 does not show evidence of genetic predisposition to common inherited cardiac\u001b[0m\n",
       "\u001b[1;36mconditions such as:\u001b[0m\n",
       "\u001b[1;36m- Hypertrophic cardiomyopathy\u001b[0m\n",
       "\u001b[1;36m- Dilated cardiomyopathy\u001b[0m\n",
       "\u001b[1;36m- Arrhythmogenic right ventricular cardiomyopathy\u001b[0m\n",
       "\u001b[1;36m- Long QT syndrome\u001b[0m\n",
       "\u001b[1;36m- Brugada syndrome\u001b[0m\n",
       "\n",
       "\u001b[1;36m## Clinical Considerations:\u001b[0m\n",
       "\u001b[1;36m- These genomic findings should be correlated with the patient's clinical presentation and family history\u001b[0m\n",
       "\u001b[1;36m- If cardiac symptoms are present despite negative genetic findings, consider:\u001b[0m\n",
       "\u001b[1;36m  - Evaluation of other genetic factors not covered in this analysis\u001b[0m\n",
       "\u001b[1;36m  - Expanded gene panel testing if clinically indicated\u001b[0m\n",
       "\u001b[1;36m  - Regular cardiac monitoring based on clinical presentation\u001b[0m\n",
       "\n",
       "\u001b[1;36mWould you like me to provide more detailed information about any specific cardiac gene or condition?\u001b[0m"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">\n",
       "</pre>\n"
      ],
      "text/plain": [
       "\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "invoke_response = agentcore_runtime.invoke({\"prompt\": \"What are the key genomics aberrations linked with heart disease conditions in patient NA21135?\"})"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "id": "<YOUR_JOB_ID>",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Invoking BedrockAgentCore agent 'vcf_agent_supervisor' via cloud endpoint\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\"><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">I'll help you determine how many benign variants are present in patient NA21144. Let me query the VCF database for </span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">this information.</span></pre>\n"
      ],
      "text/plain": [
       "\u001b[1;36mI'll help you determine how many benign variants are present in patient NA21144. Let me query the VCF database for \u001b[0m\n",
       "\u001b[1;36mthis information.\u001b[0m"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\"><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">Based on the analysis of the genomic data for patient NA21144, there are **</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">41</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">,</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">999</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\"> benign variants** identified.</span>\n",
       "\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">These benign variants:</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">- Are classified specifically with </span><span style=\"color: #008000; text-decoration-color: #008000\">\"Benign\"</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\"> clinical significance in their annotations</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">- Pass quality filters (PASS filter status)</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">- Have quality scores greater than </span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">30</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">, ensuring reliable variant calls</span>\n",
       "\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">This represents the normal genetic variation in this patient that is not associated with disease or adverse health </span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">outcomes. These benign variants are typically common in the general population and do not disrupt gene function.</span>\n",
       "\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">Would you like me to provide more specific information about these benign variants, such as their distribution </span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">across chromosomes or within specific genes of interest?</span></pre>\n"
      ],
      "text/plain": [
       "\u001b[1;36mBased on the analysis of the genomic data for patient NA21144, there are **\u001b[0m\u001b[1;36m41\u001b[0m\u001b[1;36m,\u001b[0m\u001b[1;36m999\u001b[0m\u001b[1;36m benign variants** identified.\u001b[0m\n",
       "\n",
       "\u001b[1;36mThese benign variants:\u001b[0m\n",
       "\u001b[1;36m- Are classified specifically with \u001b[0m\u001b[32m\"Benign\"\u001b[0m\u001b[1;36m clinical significance in their annotations\u001b[0m\n",
       "\u001b[1;36m- Pass quality filters \u001b[0m\u001b[1;36m(\u001b[0m\u001b[1;36mPASS filter status\u001b[0m\u001b[1;36m)\u001b[0m\n",
       "\u001b[1;36m- Have quality scores greater than \u001b[0m\u001b[1;36m30\u001b[0m\u001b[1;36m, ensuring reliable variant calls\u001b[0m\n",
       "\n",
       "\u001b[1;36mThis represents the normal genetic variation in this patient that is not associated with disease or adverse health \u001b[0m\n",
       "\u001b[1;36moutcomes. These benign variants are typically common in the general population and do not disrupt gene function.\u001b[0m\n",
       "\n",
       "\u001b[1;36mWould you like me to provide more specific information about these benign variants, such as their distribution \u001b[0m\n",
       "\u001b[1;36macross chromosomes or within specific genes of interest?\u001b[0m"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">\n",
       "</pre>\n"
      ],
      "text/plain": [
       "\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    " invoke_response = agentcore_runtime.invoke({\"prompt\": \"Howmany benign variants are in NA21144?\"})"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "id": "<YOUR_JOB_ID>",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Invoking BedrockAgentCore agent 'vcf_agent_supervisor' via cloud endpoint\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\"><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">I'll help you analyze patient NA21135 and provide risk stratification. To do this effectively, I need to query the </span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">genomic variant data for this specific patient.</span></pre>\n"
      ],
      "text/plain": [
       "\u001b[1;36mI'll help you analyze patient NA21135 and provide risk stratification. To do this effectively, I need to query the \u001b[0m\n",
       "\u001b[1;36mgenomic variant data for this specific patient.\u001b[0m"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\"><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\"># Risk Stratification Report: Patient NA21135</span>\n",
       "\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">## Overall Risk Assessment</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">Based on comprehensive genomic analysis, patient NA21135 presents with **LOW GENETIC RISK** for hereditary </span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">conditions across all analyzed disease categories.</span>\n",
       "\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">## Key Findings</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">- **No pathogenic or likely pathogenic variants** identified in any analyzed genes</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">- **No variants of uncertain significance (VUS)** detected</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">- Multiple benign variants found in clinically relevant genes</span>\n",
       "\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">## Disease-Specific Risk Assessment</span>\n",
       "\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">### Hereditary Cancer Risk: LOW</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">- **Breast/Ovarian Cancer**: No pathogenic BRCA1/BRCA2 variants detected</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">- **Lynch Syndrome**: No pathogenic MSH2 variants detected</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">- **Li-Fraumeni Syndrome**: No pathogenic TP53 variants detected</span>\n",
       "\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">### Cardiovascular Risk: LOW</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">- **Familial Hypercholesterolemia**: No pathogenic LDLR variants detected</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">- **Pharmacogenomic Finding**: APOE variant (chr</span><span style=\"color: #00ff00; text-decoration-color: #00ff00; font-weight: bold\">19:4490</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">5578:T&gt;G) may affect warfarin response</span>\n",
       "\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">## Clinical Implications</span>\n",
       "\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">1</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">. **Cancer Screening**: Follow standard age-appropriate cancer screening guidelines; no indication for enhanced </span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">surveillance based on genomic findings</span>\n",
       "\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">2</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">. **Cardiovascular Management**: </span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">   - Standard lipid monitoring recommended</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">   - Consider APOE variant if warfarin therapy is needed (may require dosage adjustment)</span>\n",
       "\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">3</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">. **Family Testing**: Not indicated based on current findings</span>\n",
       "\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">## Recommendations</span>\n",
       "\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">1</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">. **Clinical Correlation**: Integrate these genomic findings with family history and other clinical risk factors</span>\n",
       "\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">2</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">. **Follow-up**: Standard preventive care; no specialized genetic follow-up required unless family history </span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">suggests otherwise</span>\n",
       "\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">3</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">. **Medication Considerations**: Document the APOE warfarin response variant in the patient's medical record for </span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">future reference</span>\n",
       "\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">This risk stratification is based on current genomic knowledge and available variant classifications. Risk </span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">assessment should be periodically reviewed as variant interpretations may evolve over time.</span></pre>\n"
      ],
      "text/plain": [
       "\u001b[1;36m# Risk Stratification Report: Patient NA21135\u001b[0m\n",
       "\n",
       "\u001b[1;36m## Overall Risk Assessment\u001b[0m\n",
       "\u001b[1;36mBased on comprehensive genomic analysis, patient NA21135 presents with **LOW GENETIC RISK** for hereditary \u001b[0m\n",
       "\u001b[1;36mconditions across all analyzed disease categories.\u001b[0m\n",
       "\n",
       "\u001b[1;36m## Key Findings\u001b[0m\n",
       "\u001b[1;36m- **No pathogenic or likely pathogenic variants** identified in any analyzed genes\u001b[0m\n",
       "\u001b[1;36m- **No variants of uncertain significance \u001b[0m\u001b[1;36m(\u001b[0m\u001b[1;36mVUS\u001b[0m\u001b[1;36m)\u001b[0m\u001b[1;36m** detected\u001b[0m\n",
       "\u001b[1;36m- Multiple benign variants found in clinically relevant genes\u001b[0m\n",
       "\n",
       "\u001b[1;36m## Disease-Specific Risk Assessment\u001b[0m\n",
       "\n",
       "\u001b[1;36m### Hereditary Cancer Risk: LOW\u001b[0m\n",
       "\u001b[1;36m- **Breast/Ovarian Cancer**: No pathogenic BRCA1/BRCA2 variants detected\u001b[0m\n",
       "\u001b[1;36m- **Lynch Syndrome**: No pathogenic MSH2 variants detected\u001b[0m\n",
       "\u001b[1;36m- **Li-Fraumeni Syndrome**: No pathogenic TP53 variants detected\u001b[0m\n",
       "\n",
       "\u001b[1;36m### Cardiovascular Risk: LOW\u001b[0m\n",
       "\u001b[1;36m- **Familial Hypercholesterolemia**: No pathogenic LDLR variants detected\u001b[0m\n",
       "\u001b[1;36m- **Pharmacogenomic Finding**: APOE variant \u001b[0m\u001b[1;36m(\u001b[0m\u001b[1;36mchr\u001b[0m\u001b[1;92m19:4490\u001b[0m\u001b[1;36m5578:T>G\u001b[0m\u001b[1;36m)\u001b[0m\u001b[1;36m may affect warfarin response\u001b[0m\n",
       "\n",
       "\u001b[1;36m## Clinical Implications\u001b[0m\n",
       "\n",
       "\u001b[1;36m1\u001b[0m\u001b[1;36m. **Cancer Screening**: Follow standard age-appropriate cancer screening guidelines; no indication for enhanced \u001b[0m\n",
       "\u001b[1;36msurveillance based on genomic findings\u001b[0m\n",
       "\n",
       "\u001b[1;36m2\u001b[0m\u001b[1;36m. **Cardiovascular Management**: \u001b[0m\n",
       "\u001b[1;36m   - Standard lipid monitoring recommended\u001b[0m\n",
       "\u001b[1;36m   - Consider APOE variant if warfarin therapy is needed \u001b[0m\u001b[1;36m(\u001b[0m\u001b[1;36mmay require dosage adjustment\u001b[0m\u001b[1;36m)\u001b[0m\n",
       "\n",
       "\u001b[1;36m3\u001b[0m\u001b[1;36m. **Family Testing**: Not indicated based on current findings\u001b[0m\n",
       "\n",
       "\u001b[1;36m## Recommendations\u001b[0m\n",
       "\n",
       "\u001b[1;36m1\u001b[0m\u001b[1;36m. **Clinical Correlation**: Integrate these genomic findings with family history and other clinical risk factors\u001b[0m\n",
       "\n",
       "\u001b[1;36m2\u001b[0m\u001b[1;36m. **Follow-up**: Standard preventive care; no specialized genetic follow-up required unless family history \u001b[0m\n",
       "\u001b[1;36msuggests otherwise\u001b[0m\n",
       "\n",
       "\u001b[1;36m3\u001b[0m\u001b[1;36m. **Medication Considerations**: Document the APOE warfarin response variant in the patient's medical record for \u001b[0m\n",
       "\u001b[1;36mfuture reference\u001b[0m\n",
       "\n",
       "\u001b[1;36mThis risk stratification is based on current genomic knowledge and available variant classifications. Risk \u001b[0m\n",
       "\u001b[1;36massessment should be periodically reviewed as variant interpretations may evolve over time.\u001b[0m"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">\n",
       "</pre>\n"
      ],
      "text/plain": [
       "\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "invoke_response = agentcore_runtime.invoke({\"prompt\": \"Analyze patient NA21135 and provide individual risk stratification\"})"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "id": "<YOUR_JOB_ID>",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Invoking BedrockAgentCore agent 'vcf_agent_supervisor' via cloud endpoint\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\"><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">I'll analyze the drug-related variants in this patient and compare their allele frequencies with the </span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">1000</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\"> Genomes </span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">Project data.</span></pre>\n"
      ],
      "text/plain": [
       "\u001b[1;36mI'll analyze the drug-related variants in this patient and compare their allele frequencies with the \u001b[0m\u001b[1;36m1000\u001b[0m\u001b[1;36m Genomes \u001b[0m\n",
       "\u001b[1;36mProject data.\u001b[0m"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\"><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\"># Pharmacogenomic Pathway Analysis: Patient NA21135</span>\n",
       "\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">## Major Drug-Related Impactful Variant Pathways</span>\n",
       "\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">Based on the analysis of patient NA21135, the following pharmacogenomic pathways show significant variants:</span>\n",
       "\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">### </span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">1</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">. CYP2D6 Metabolic Pathway (Most Significant)</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">- **Key Variant**: chr</span><span style=\"color: #00ff00; text-decoration-color: #00ff00; font-weight: bold\">22:42128944:C</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">&gt;T (splice_acceptor_variant)</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">- **Allele Frequency**:</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">  - **Patient**: Present (heterozygous)</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">  - **1000G**: </span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">43.8</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">%</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">- **Affected Drugs**:</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">  - Antidepressants (fluoxetine, paroxetine)</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">  - Opioid analgesics (codeine, tramadol)</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">  - Antipsychotics (risperidone, aripiprazole)</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">  - Breast cancer therapy (tamoxifen)</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">  - Movement disorder treatment (deutetrabenazine)</span>\n",
       "\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">### </span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">2</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">. Drug Transport Pathway (ABCB1/P-glycoprotein)</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">- **Key Variant**: chr</span><span style=\"color: #00ff00; text-decoration-color: #00ff00; font-weight: bold\">7:8760</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">0184:T&gt;C (5_prime_UTR_variant)</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">- **Allele Frequency**:</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">  - **Patient**: Present</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">  - **1000G**: </span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">100</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">% (common variant)</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">- **Affected Drugs**:</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">  - Anticancer agents</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">  - Immunosuppressants</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">  - Analgesics (including tramadol)</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">  - Cardiovascular drugs</span>\n",
       "\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">### </span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">3</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">. Catecholamine Metabolism Pathway (COMT)</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">- **Key Variant**: chr</span><span style=\"color: #00ff00; text-decoration-color: #00ff00; font-weight: bold\">22:19962904:A</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">&gt;G (intron_variant)</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">- **Allele Frequency**:</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">  - **Patient**: Present</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">  - **1000G**: </span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">100</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">% (common variant)</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">- **Affected Drugs**:</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">  - Pain medications</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">  - Psychiatric medications</span>\n",
       "\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">## Allele Frequency Comparison Summary</span>\n",
       "\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">| Gene   | Variant Position    | Variant Type        | Patient AF | 1000G AF | Clinical Significance |</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">|--------|---------------------|---------------------|------------|----------|----------------------|</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">| CYP2D6 | chr</span><span style=\"color: #00ff00; text-decoration-color: #00ff00; font-weight: bold\">22:42128944:C</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">&gt;T  | Splice acceptor     | Present    | </span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">43.8</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">%    | Likely benign/drug response |</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">| ABCB1  | chr</span><span style=\"color: #00ff00; text-decoration-color: #00ff00; font-weight: bold\">7:8760</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">0184:T&gt;C   | </span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">5</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">' UTR variant      | Present    | </span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">100</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">%     | Drug response        |</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">| COMT   | chr</span><span style=\"color: #00ff00; text-decoration-color: #00ff00; font-weight: bold\">22:19962904:A</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">&gt;G  | Intronic variant    | Present    | </span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">100</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">%     | Benign               |</span>\n",
       "\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">## Clinical Interpretation</span>\n",
       "\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">The most clinically relevant pathway enrichment is in the **CYP2D6 metabolic pathway**, which affects approximately</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">25</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">% of commonly prescribed medications. The splice acceptor variant (chr</span><span style=\"color: #00ff00; text-decoration-color: #00ff00; font-weight: bold\">22:42128944:C</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">&gt;T) is present in the patient </span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">but is not rare in the general population (</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">43.8</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">% in 1000G).</span>\n",
       "\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">While the patient carries variants in other important pharmacogenes (CYP2C9, CYP2C19, CYP3A4/</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">5</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">, DPYD, SLCO1B1), </span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">these are common intronic variants without significant predicted impact on drug metabolism.</span>\n",
       "\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">The CYP2D6 pathway enrichment suggests potential for altered metabolism of CYP2D6 substrates, which may require </span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">clinical monitoring when prescribing affected medications, particularly those with narrow therapeutic indices.</span></pre>\n"
      ],
      "text/plain": [
       "\u001b[1;36m# Pharmacogenomic Pathway Analysis: Patient NA21135\u001b[0m\n",
       "\n",
       "\u001b[1;36m## Major Drug-Related Impactful Variant Pathways\u001b[0m\n",
       "\n",
       "\u001b[1;36mBased on the analysis of patient NA21135, the following pharmacogenomic pathways show significant variants:\u001b[0m\n",
       "\n",
       "\u001b[1;36m### \u001b[0m\u001b[1;36m1\u001b[0m\u001b[1;36m. CYP2D6 Metabolic Pathway \u001b[0m\u001b[1;36m(\u001b[0m\u001b[1;36mMost Significant\u001b[0m\u001b[1;36m)\u001b[0m\n",
       "\u001b[1;36m- **Key Variant**: chr\u001b[0m\u001b[1;92m22:4212\u001b[0m\u001b[1;92m8944:C\u001b[0m\u001b[1;36m>T \u001b[0m\u001b[1;36m(\u001b[0m\u001b[1;36msplice_acceptor_variant\u001b[0m\u001b[1;36m)\u001b[0m\n",
       "\u001b[1;36m- **Allele Frequency**:\u001b[0m\n",
       "\u001b[1;36m  - **Patient**: Present \u001b[0m\u001b[1;36m(\u001b[0m\u001b[1;36mheterozygous\u001b[0m\u001b[1;36m)\u001b[0m\n",
       "\u001b[1;36m  - **1000G**: \u001b[0m\u001b[1;36m43.8\u001b[0m\u001b[1;36m%\u001b[0m\n",
       "\u001b[1;36m- **Affected Drugs**:\u001b[0m\n",
       "\u001b[1;36m  - Antidepressants \u001b[0m\u001b[1;36m(\u001b[0m\u001b[1;36mfluoxetine, paroxetine\u001b[0m\u001b[1;36m)\u001b[0m\n",
       "\u001b[1;36m  - Opioid analgesics \u001b[0m\u001b[1;36m(\u001b[0m\u001b[1;36mcodeine, tramadol\u001b[0m\u001b[1;36m)\u001b[0m\n",
       "\u001b[1;36m  - Antipsychotics \u001b[0m\u001b[1;36m(\u001b[0m\u001b[1;36mrisperidone, aripiprazole\u001b[0m\u001b[1;36m)\u001b[0m\n",
       "\u001b[1;36m  - Breast cancer therapy \u001b[0m\u001b[1;36m(\u001b[0m\u001b[1;36mtamoxifen\u001b[0m\u001b[1;36m)\u001b[0m\n",
       "\u001b[1;36m  - Movement disorder treatment \u001b[0m\u001b[1;36m(\u001b[0m\u001b[1;36mdeutetrabenazine\u001b[0m\u001b[1;36m)\u001b[0m\n",
       "\n",
       "\u001b[1;36m### \u001b[0m\u001b[1;36m2\u001b[0m\u001b[1;36m. Drug Transport Pathway \u001b[0m\u001b[1;36m(\u001b[0m\u001b[1;36mABCB1/P-glycoprotein\u001b[0m\u001b[1;36m)\u001b[0m\n",
       "\u001b[1;36m- **Key Variant**: chr\u001b[0m\u001b[1;92m7:8760\u001b[0m\u001b[1;36m0184:T>C \u001b[0m\u001b[1;36m(\u001b[0m\u001b[1;36m5_prime_UTR_variant\u001b[0m\u001b[1;36m)\u001b[0m\n",
       "\u001b[1;36m- **Allele Frequency**:\u001b[0m\n",
       "\u001b[1;36m  - **Patient**: Present\u001b[0m\n",
       "\u001b[1;36m  - **1000G**: \u001b[0m\u001b[1;36m100\u001b[0m\u001b[1;36m% \u001b[0m\u001b[1;36m(\u001b[0m\u001b[1;36mcommon variant\u001b[0m\u001b[1;36m)\u001b[0m\n",
       "\u001b[1;36m- **Affected Drugs**:\u001b[0m\n",
       "\u001b[1;36m  - Anticancer agents\u001b[0m\n",
       "\u001b[1;36m  - Immunosuppressants\u001b[0m\n",
       "\u001b[1;36m  - Analgesics \u001b[0m\u001b[1;36m(\u001b[0m\u001b[1;36mincluding tramadol\u001b[0m\u001b[1;36m)\u001b[0m\n",
       "\u001b[1;36m  - Cardiovascular drugs\u001b[0m\n",
       "\n",
       "\u001b[1;36m### \u001b[0m\u001b[1;36m3\u001b[0m\u001b[1;36m. Catecholamine Metabolism Pathway \u001b[0m\u001b[1;36m(\u001b[0m\u001b[1;36mCOMT\u001b[0m\u001b[1;36m)\u001b[0m\n",
       "\u001b[1;36m- **Key Variant**: chr\u001b[0m\u001b[1;92m22:1996\u001b[0m\u001b[1;92m2904:A\u001b[0m\u001b[1;36m>G \u001b[0m\u001b[1;36m(\u001b[0m\u001b[1;36mintron_variant\u001b[0m\u001b[1;36m)\u001b[0m\n",
       "\u001b[1;36m- **Allele Frequency**:\u001b[0m\n",
       "\u001b[1;36m  - **Patient**: Present\u001b[0m\n",
       "\u001b[1;36m  - **1000G**: \u001b[0m\u001b[1;36m100\u001b[0m\u001b[1;36m% \u001b[0m\u001b[1;36m(\u001b[0m\u001b[1;36mcommon variant\u001b[0m\u001b[1;36m)\u001b[0m\n",
       "\u001b[1;36m- **Affected Drugs**:\u001b[0m\n",
       "\u001b[1;36m  - Pain medications\u001b[0m\n",
       "\u001b[1;36m  - Psychiatric medications\u001b[0m\n",
       "\n",
       "\u001b[1;36m## Allele Frequency Comparison Summary\u001b[0m\n",
       "\n",
       "\u001b[1;36m| Gene   | Variant Position    | Variant Type        | Patient AF | 1000G AF | Clinical Significance |\u001b[0m\n",
       "\u001b[1;36m|--------|---------------------|---------------------|------------|----------|----------------------|\u001b[0m\n",
       "\u001b[1;36m| CYP2D6 | chr\u001b[0m\u001b[1;92m22:4212\u001b[0m\u001b[1;92m8944:C\u001b[0m\u001b[1;36m>T  | Splice acceptor     | Present    | \u001b[0m\u001b[1;36m43.8\u001b[0m\u001b[1;36m%    | Likely benign/drug response |\u001b[0m\n",
       "\u001b[1;36m| ABCB1  | chr\u001b[0m\u001b[1;92m7:8760\u001b[0m\u001b[1;36m0184:T>C   | \u001b[0m\u001b[1;36m5\u001b[0m\u001b[1;36m' UTR variant      | Present    | \u001b[0m\u001b[1;36m100\u001b[0m\u001b[1;36m%     | Drug response        |\u001b[0m\n",
       "\u001b[1;36m| COMT   | chr\u001b[0m\u001b[1;92m22:1996\u001b[0m\u001b[1;92m2904:A\u001b[0m\u001b[1;36m>G  | Intronic variant    | Present    | \u001b[0m\u001b[1;36m100\u001b[0m\u001b[1;36m%     | Benign               |\u001b[0m\n",
       "\n",
       "\u001b[1;36m## Clinical Interpretation\u001b[0m\n",
       "\n",
       "\u001b[1;36mThe most clinically relevant pathway enrichment is in the **CYP2D6 metabolic pathway**, which affects approximately\u001b[0m\n",
       "\u001b[1;36m25\u001b[0m\u001b[1;36m% of commonly prescribed medications. The splice acceptor variant \u001b[0m\u001b[1;36m(\u001b[0m\u001b[1;36mchr\u001b[0m\u001b[1;92m22:4212\u001b[0m\u001b[1;92m8944:C\u001b[0m\u001b[1;36m>T\u001b[0m\u001b[1;36m)\u001b[0m\u001b[1;36m is present in the patient \u001b[0m\n",
       "\u001b[1;36mbut is not rare in the general population \u001b[0m\u001b[1;36m(\u001b[0m\u001b[1;36m43.8\u001b[0m\u001b[1;36m% in 1000G\u001b[0m\u001b[1;36m)\u001b[0m\u001b[1;36m.\u001b[0m\n",
       "\n",
       "\u001b[1;36mWhile the patient carries variants in other important pharmacogenes \u001b[0m\u001b[1;36m(\u001b[0m\u001b[1;36mCYP2C9, CYP2C19, CYP3A4/\u001b[0m\u001b[1;36m5\u001b[0m\u001b[1;36m, DPYD, SLCO1B1\u001b[0m\u001b[1;36m)\u001b[0m\u001b[1;36m, \u001b[0m\n",
       "\u001b[1;36mthese are common intronic variants without significant predicted impact on drug metabolism.\u001b[0m\n",
       "\n",
       "\u001b[1;36mThe CYP2D6 pathway enrichment suggests potential for altered metabolism of CYP2D6 substrates, which may require \u001b[0m\n",
       "\u001b[1;36mclinical monitoring when prescribing affected medications, particularly those with narrow therapeutic indices.\u001b[0m"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">\n",
       "</pre>\n"
      ],
      "text/plain": [
       "\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "invoke_response = agentcore_runtime.invoke({\"prompt\": \"which are the major drug related impactful variant pathway enriched in the patients in the cohort and tell me the allele frequecy reported here and 1000 genome(1000g)\"})"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "id": "<YOUR_JOB_ID>",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Invoking BedrockAgentCore agent 'vcf_agent_supervisor' via cloud endpoint\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\"><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">I'll check for BRCA family gene variants in patient NA21144 and their clinical significance.</span></pre>\n"
      ],
      "text/plain": [
       "\u001b[1;36mI'll check for BRCA family gene variants in patient NA21144 and their clinical significance.\u001b[0m"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\"><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\"># BRCA Gene Variant Analysis for Patient NA21144</span>\n",
       "\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">## Summary of BRCA Variants</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">Patient NA21144 has a total of **</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">255</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\"> BRCA family variants**:</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">- **</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">202</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\"> variants** in BRCA1</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">- **</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">53</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\"> variants** in BRCA2</span>\n",
       "\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">## Clinical Significance Breakdown</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">- **Pathogenic variants**: </span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold; font-style: italic\">None</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\"> detected</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">- **Likely pathogenic variants**: </span><span style=\"color: #800080; text-decoration-color: #800080; font-weight: bold; font-style: italic\">None</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\"> detected</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">- **Variants of uncertain significance (VUS)**: </span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">1</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\"> variant</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">- **Benign/Likely benign variants**: </span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">219</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\"> variants</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">- **Unclassified variants**: </span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">35</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\"> variants</span>\n",
       "\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">## Key Variants by Impact Level</span>\n",
       "\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">### MODERATE Impact Variants (Missense)</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">Two missense variants in BRCA2, both classified as benign:</span>\n",
       "\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">1</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">. **BRCA2 chr</span><span style=\"color: #00ff00; text-decoration-color: #00ff00; font-weight: bold\">13:32332591:A</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">&gt;C**</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">   - Clinical significance: Benign</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">   - Associated with: Hereditary breast ovarian cancer syndrome</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">   - Population frequency: Common (</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">1.0</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\"> in </span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">1000</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\"> Genomes)</span>\n",
       "\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">2</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">. **BRCA2 chr</span><span style=\"color: #00ff00; text-decoration-color: #00ff00; font-weight: bold\">13:3235</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">5249:T&gt;C**</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">   - Clinical significance: Benign</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">   - Associated with: Breast ductal adenocarcinoma, Hereditary breast ovarian cancer</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">   - Population frequency: Common (</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">1.0</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\"> in </span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">1000</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\"> Genomes)</span>\n",
       "\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">### LOW Impact Variants (Synonymous)</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">Two synonymous variants in BRCA2, both classified as benign:</span>\n",
       "\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">1</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">. **BRCA2 chr</span><span style=\"color: #00ff00; text-decoration-color: #00ff00; font-weight: bold\">13:3234</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">0867:G&gt;C**</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">   - Clinical significance: Benign</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">   - Associated with: Familial breast cancer</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">   - Population frequency: Common (</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">1.0</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\"> in </span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">1000</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\"> Genomes)</span>\n",
       "\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">2</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">. **BRCA2 chr</span><span style=\"color: #00ff00; text-decoration-color: #00ff00; font-weight: bold\">13:32338917:A</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">&gt;G**</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">   - Clinical significance: Benign</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">   - Associated with: Fanconi anemia, Hereditary breast ovarian cancer</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">   - Population frequency: Common (</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">1.0</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\"> in </span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">1000</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\"> Genomes)</span>\n",
       "\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">## Clinical Significance to Note</span>\n",
       "\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">The most important finding is the presence of **one variant of uncertain significance (VUS)**. While specific </span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">details of this VUS weren't highlighted in the top results, its presence has clinical implications:</span>\n",
       "\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">1</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">. **Not immediately actionable**: VUS findings alone don't warrant changes in medical management</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">2</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">. **Requires monitoring**: The classification may change as more evidence becomes available</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">3</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">. **Documentation needed**: Should be recorded in the patient's medical record</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">4</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">. **Genetic counseling recommended**: To explain implications and limitations of this finding</span>\n",
       "\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">## Recommendations</span>\n",
       "\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">1</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">. **Standard cancer screening**: Follow age-appropriate guidelines as there are no pathogenic BRCA variants</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">2</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">. **Genetic counseling referral**: To discuss the VUS and its implications</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">3</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">. **Periodic reassessment**: The VUS should be reevaluated every </span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">1</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">-</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">2</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\"> years as classifications may change</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">4</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">. **Family history evaluation**: Continue to monitor family cancer history for comprehensive risk assessment</span>\n",
       "\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">The absence of pathogenic BRCA variants is reassuring, though the presence of a VUS warrants appropriate follow-up </span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">and monitoring.</span></pre>\n"
      ],
      "text/plain": [
       "\u001b[1;36m# BRCA Gene Variant Analysis for Patient NA21144\u001b[0m\n",
       "\n",
       "\u001b[1;36m## Summary of BRCA Variants\u001b[0m\n",
       "\u001b[1;36mPatient NA21144 has a total of **\u001b[0m\u001b[1;36m255\u001b[0m\u001b[1;36m BRCA family variants**:\u001b[0m\n",
       "\u001b[1;36m- **\u001b[0m\u001b[1;36m202\u001b[0m\u001b[1;36m variants** in BRCA1\u001b[0m\n",
       "\u001b[1;36m- **\u001b[0m\u001b[1;36m53\u001b[0m\u001b[1;36m variants** in BRCA2\u001b[0m\n",
       "\n",
       "\u001b[1;36m## Clinical Significance Breakdown\u001b[0m\n",
       "\u001b[1;36m- **Pathogenic variants**: \u001b[0m\u001b[1;3;35mNone\u001b[0m\u001b[1;36m detected\u001b[0m\n",
       "\u001b[1;36m- **Likely pathogenic variants**: \u001b[0m\u001b[1;3;35mNone\u001b[0m\u001b[1;36m detected\u001b[0m\n",
       "\u001b[1;36m- **Variants of uncertain significance \u001b[0m\u001b[1;36m(\u001b[0m\u001b[1;36mVUS\u001b[0m\u001b[1;36m)\u001b[0m\u001b[1;36m**: \u001b[0m\u001b[1;36m1\u001b[0m\u001b[1;36m variant\u001b[0m\n",
       "\u001b[1;36m- **Benign/Likely benign variants**: \u001b[0m\u001b[1;36m219\u001b[0m\u001b[1;36m variants\u001b[0m\n",
       "\u001b[1;36m- **Unclassified variants**: \u001b[0m\u001b[1;36m35\u001b[0m\u001b[1;36m variants\u001b[0m\n",
       "\n",
       "\u001b[1;36m## Key Variants by Impact Level\u001b[0m\n",
       "\n",
       "\u001b[1;36m### MODERATE Impact Variants \u001b[0m\u001b[1;36m(\u001b[0m\u001b[1;36mMissense\u001b[0m\u001b[1;36m)\u001b[0m\n",
       "\u001b[1;36mTwo missense variants in BRCA2, both classified as benign:\u001b[0m\n",
       "\n",
       "\u001b[1;36m1\u001b[0m\u001b[1;36m. **BRCA2 chr\u001b[0m\u001b[1;92m13:3233\u001b[0m\u001b[1;92m2591:A\u001b[0m\u001b[1;36m>C**\u001b[0m\n",
       "\u001b[1;36m   - Clinical significance: Benign\u001b[0m\n",
       "\u001b[1;36m   - Associated with: Hereditary breast ovarian cancer syndrome\u001b[0m\n",
       "\u001b[1;36m   - Population frequency: Common \u001b[0m\u001b[1;36m(\u001b[0m\u001b[1;36m1.0\u001b[0m\u001b[1;36m in \u001b[0m\u001b[1;36m1000\u001b[0m\u001b[1;36m Genomes\u001b[0m\u001b[1;36m)\u001b[0m\n",
       "\n",
       "\u001b[1;36m2\u001b[0m\u001b[1;36m. **BRCA2 chr\u001b[0m\u001b[1;92m13:3235\u001b[0m\u001b[1;36m5249:T>C**\u001b[0m\n",
       "\u001b[1;36m   - Clinical significance: Benign\u001b[0m\n",
       "\u001b[1;36m   - Associated with: Breast ductal adenocarcinoma, Hereditary breast ovarian cancer\u001b[0m\n",
       "\u001b[1;36m   - Population frequency: Common \u001b[0m\u001b[1;36m(\u001b[0m\u001b[1;36m1.0\u001b[0m\u001b[1;36m in \u001b[0m\u001b[1;36m1000\u001b[0m\u001b[1;36m Genomes\u001b[0m\u001b[1;36m)\u001b[0m\n",
       "\n",
       "\u001b[1;36m### LOW Impact Variants \u001b[0m\u001b[1;36m(\u001b[0m\u001b[1;36mSynonymous\u001b[0m\u001b[1;36m)\u001b[0m\n",
       "\u001b[1;36mTwo synonymous variants in BRCA2, both classified as benign:\u001b[0m\n",
       "\n",
       "\u001b[1;36m1\u001b[0m\u001b[1;36m. **BRCA2 chr\u001b[0m\u001b[1;92m13:3234\u001b[0m\u001b[1;36m0867:G>C**\u001b[0m\n",
       "\u001b[1;36m   - Clinical significance: Benign\u001b[0m\n",
       "\u001b[1;36m   - Associated with: Familial breast cancer\u001b[0m\n",
       "\u001b[1;36m   - Population frequency: Common \u001b[0m\u001b[1;36m(\u001b[0m\u001b[1;36m1.0\u001b[0m\u001b[1;36m in \u001b[0m\u001b[1;36m1000\u001b[0m\u001b[1;36m Genomes\u001b[0m\u001b[1;36m)\u001b[0m\n",
       "\n",
       "\u001b[1;36m2\u001b[0m\u001b[1;36m. **BRCA2 chr\u001b[0m\u001b[1;92m13:3233\u001b[0m\u001b[1;92m8917:A\u001b[0m\u001b[1;36m>G**\u001b[0m\n",
       "\u001b[1;36m   - Clinical significance: Benign\u001b[0m\n",
       "\u001b[1;36m   - Associated with: Fanconi anemia, Hereditary breast ovarian cancer\u001b[0m\n",
       "\u001b[1;36m   - Population frequency: Common \u001b[0m\u001b[1;36m(\u001b[0m\u001b[1;36m1.0\u001b[0m\u001b[1;36m in \u001b[0m\u001b[1;36m1000\u001b[0m\u001b[1;36m Genomes\u001b[0m\u001b[1;36m)\u001b[0m\n",
       "\n",
       "\u001b[1;36m## Clinical Significance to Note\u001b[0m\n",
       "\n",
       "\u001b[1;36mThe most important finding is the presence of **one variant of uncertain significance \u001b[0m\u001b[1;36m(\u001b[0m\u001b[1;36mVUS\u001b[0m\u001b[1;36m)\u001b[0m\u001b[1;36m**. While specific \u001b[0m\n",
       "\u001b[1;36mdetails of this VUS weren't highlighted in the top results, its presence has clinical implications:\u001b[0m\n",
       "\n",
       "\u001b[1;36m1\u001b[0m\u001b[1;36m. **Not immediately actionable**: VUS findings alone don't warrant changes in medical management\u001b[0m\n",
       "\u001b[1;36m2\u001b[0m\u001b[1;36m. **Requires monitoring**: The classification may change as more evidence becomes available\u001b[0m\n",
       "\u001b[1;36m3\u001b[0m\u001b[1;36m. **Documentation needed**: Should be recorded in the patient's medical record\u001b[0m\n",
       "\u001b[1;36m4\u001b[0m\u001b[1;36m. **Genetic counseling recommended**: To explain implications and limitations of this finding\u001b[0m\n",
       "\n",
       "\u001b[1;36m## Recommendations\u001b[0m\n",
       "\n",
       "\u001b[1;36m1\u001b[0m\u001b[1;36m. **Standard cancer screening**: Follow age-appropriate guidelines as there are no pathogenic BRCA variants\u001b[0m\n",
       "\u001b[1;36m2\u001b[0m\u001b[1;36m. **Genetic counseling referral**: To discuss the VUS and its implications\u001b[0m\n",
       "\u001b[1;36m3\u001b[0m\u001b[1;36m. **Periodic reassessment**: The VUS should be reevaluated every \u001b[0m\u001b[1;36m1\u001b[0m\u001b[1;36m-\u001b[0m\u001b[1;36m2\u001b[0m\u001b[1;36m years as classifications may change\u001b[0m\n",
       "\u001b[1;36m4\u001b[0m\u001b[1;36m. **Family history evaluation**: Continue to monitor family cancer history for comprehensive risk assessment\u001b[0m\n",
       "\n",
       "\u001b[1;36mThe absence of pathogenic BRCA variants is reassuring, though the presence of a VUS warrants appropriate follow-up \u001b[0m\n",
       "\u001b[1;36mand monitoring.\u001b[0m"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">\n",
       "</pre>\n"
      ],
      "text/plain": [
       "\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "invoke_response = agentcore_runtime.invoke({\"prompt\": \"Can you check howmany variants are present for BRCA family of genes in patient 'NA21144' and any clinical significance need to be known?\"})"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "id": "<YOUR_JOB_ID>",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Invoking BedrockAgentCore agent 'vcf_agent_supervisor' via cloud endpoint\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\"><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">I'll check the frequency of the BRCA2 variant chr</span><span style=\"color: #00ff00; text-decoration-color: #00ff00; font-weight: bold\">13:32332591:A</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">&gt;C in this cohort and compare it with the </span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">1000</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\"> </span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">Genomes (1000G) cohort. Let me query the database for this specific information.</span></pre>\n"
      ],
      "text/plain": [
       "\u001b[1;36mI'll check the frequency of the BRCA2 variant chr\u001b[0m\u001b[1;92m13:3233\u001b[0m\u001b[1;92m2591:A\u001b[0m\u001b[1;36m>C in this cohort and compare it with the \u001b[0m\u001b[1;36m1000\u001b[0m\u001b[1;36m \u001b[0m\n",
       "\u001b[1;36mGenomes \u001b[0m\u001b[1;36m(\u001b[0m\u001b[1;36m1000G\u001b[0m\u001b[1;36m)\u001b[0m\u001b[1;36m cohort. Let me query the database for this specific information.\u001b[0m"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\"><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\"># Frequency Analysis of BRCA2 Variant chr</span><span style=\"color: #00ff00; text-decoration-color: #00ff00; font-weight: bold\">13:32332591:A</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">&gt;C</span>\n",
       "\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">## Cohort Frequency</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">- **Current Cohort**: Found in </span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">2</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\"> out of </span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">2</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\"> samples (</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">100</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">%)</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">  - Present in both NA21135 and NA21144</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">  - High quality variant calls with quality scores of </span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">164.32</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\"> and </span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">139.82</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">  - Good sequencing depth (39x and 31x coverage)</span>\n",
       "\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">## </span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">1000</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\"> Genomes (1000G) Frequency</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">- **1000G Allele Frequency**: </span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">1.0</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\"> (</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">100</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">%)</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">  - This indicates the variant is present in all individuals in the </span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">1000</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\"> Genomes population</span>\n",
       "\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">## Variant Details</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">- **Gene**: BRCA2</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">- **Genomic Position**: Chromosome </span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">13</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">, position </span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">32332591</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">- **Nucleotide Change**: A&gt;C</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">- **Consequence**: Missense variant</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">- **Impact**: MODERATE</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">- **Clinical Significance**: Benign (according to ClinVar)</span>\n",
       "\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">## Clinical Interpretation</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">This BRCA2 variant (chr</span><span style=\"color: #00ff00; text-decoration-color: #00ff00; font-weight: bold\">13:32332591:A</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">&gt;C) is a common polymorphism that appears to be present in </span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">100</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">% of both your </span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">cohort and the </span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">1000</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\"> Genomes reference population. Its universal presence in the 1000G database and classification </span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">as </span><span style=\"color: #008000; text-decoration-color: #008000\">\"Benign\"</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\"> in ClinVar confirms that this is a common, non-pathogenic variant.</span>\n",
       "\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">The variant has been evaluated in the context of multiple conditions including:</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">- Hereditary breast ovarian cancer syndrome</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">- Breast-ovarian cancer, familial, susceptibility to, </span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">2</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">- Fanconi anemia complementation group D1</span>\n",
       "\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">Despite being a missense variant with moderate predicted impact, its high frequency in the general population </span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">strongly supports its benign classification. This variant is not considered clinically actionable for cancer risk </span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">assessment.</span></pre>\n"
      ],
      "text/plain": [
       "\u001b[1;36m# Frequency Analysis of BRCA2 Variant chr\u001b[0m\u001b[1;92m13:3233\u001b[0m\u001b[1;92m2591:A\u001b[0m\u001b[1;36m>C\u001b[0m\n",
       "\n",
       "\u001b[1;36m## Cohort Frequency\u001b[0m\n",
       "\u001b[1;36m- **Current Cohort**: Found in \u001b[0m\u001b[1;36m2\u001b[0m\u001b[1;36m out of \u001b[0m\u001b[1;36m2\u001b[0m\u001b[1;36m samples \u001b[0m\u001b[1;36m(\u001b[0m\u001b[1;36m100\u001b[0m\u001b[1;36m%\u001b[0m\u001b[1;36m)\u001b[0m\n",
       "\u001b[1;36m  - Present in both NA21135 and NA21144\u001b[0m\n",
       "\u001b[1;36m  - High quality variant calls with quality scores of \u001b[0m\u001b[1;36m164.32\u001b[0m\u001b[1;36m and \u001b[0m\u001b[1;36m139.82\u001b[0m\n",
       "\u001b[1;36m  - Good sequencing depth \u001b[0m\u001b[1;36m(\u001b[0m\u001b[1;36m39x and 31x coverage\u001b[0m\u001b[1;36m)\u001b[0m\n",
       "\n",
       "\u001b[1;36m## \u001b[0m\u001b[1;36m1000\u001b[0m\u001b[1;36m Genomes \u001b[0m\u001b[1;36m(\u001b[0m\u001b[1;36m1000G\u001b[0m\u001b[1;36m)\u001b[0m\u001b[1;36m Frequency\u001b[0m\n",
       "\u001b[1;36m- **1000G Allele Frequency**: \u001b[0m\u001b[1;36m1.0\u001b[0m\u001b[1;36m \u001b[0m\u001b[1;36m(\u001b[0m\u001b[1;36m100\u001b[0m\u001b[1;36m%\u001b[0m\u001b[1;36m)\u001b[0m\n",
       "\u001b[1;36m  - This indicates the variant is present in all individuals in the \u001b[0m\u001b[1;36m1000\u001b[0m\u001b[1;36m Genomes population\u001b[0m\n",
       "\n",
       "\u001b[1;36m## Variant Details\u001b[0m\n",
       "\u001b[1;36m- **Gene**: BRCA2\u001b[0m\n",
       "\u001b[1;36m- **Genomic Position**: Chromosome \u001b[0m\u001b[1;36m13\u001b[0m\u001b[1;36m, position \u001b[0m\u001b[1;36m32332591\u001b[0m\n",
       "\u001b[1;36m- **Nucleotide Change**: A>C\u001b[0m\n",
       "\u001b[1;36m- **Consequence**: Missense variant\u001b[0m\n",
       "\u001b[1;36m- **Impact**: MODERATE\u001b[0m\n",
       "\u001b[1;36m- **Clinical Significance**: Benign \u001b[0m\u001b[1;36m(\u001b[0m\u001b[1;36maccording to ClinVar\u001b[0m\u001b[1;36m)\u001b[0m\n",
       "\n",
       "\u001b[1;36m## Clinical Interpretation\u001b[0m\n",
       "\u001b[1;36mThis BRCA2 variant \u001b[0m\u001b[1;36m(\u001b[0m\u001b[1;36mchr\u001b[0m\u001b[1;92m13:3233\u001b[0m\u001b[1;92m2591:A\u001b[0m\u001b[1;36m>C\u001b[0m\u001b[1;36m)\u001b[0m\u001b[1;36m is a common polymorphism that appears to be present in \u001b[0m\u001b[1;36m100\u001b[0m\u001b[1;36m% of both your \u001b[0m\n",
       "\u001b[1;36mcohort and the \u001b[0m\u001b[1;36m1000\u001b[0m\u001b[1;36m Genomes reference population. Its universal presence in the 1000G database and classification \u001b[0m\n",
       "\u001b[1;36mas \u001b[0m\u001b[32m\"Benign\"\u001b[0m\u001b[1;36m in ClinVar confirms that this is a common, non-pathogenic variant.\u001b[0m\n",
       "\n",
       "\u001b[1;36mThe variant has been evaluated in the context of multiple conditions including:\u001b[0m\n",
       "\u001b[1;36m- Hereditary breast ovarian cancer syndrome\u001b[0m\n",
       "\u001b[1;36m- Breast-ovarian cancer, familial, susceptibility to, \u001b[0m\u001b[1;36m2\u001b[0m\n",
       "\u001b[1;36m- Fanconi anemia complementation group D1\u001b[0m\n",
       "\n",
       "\u001b[1;36mDespite being a missense variant with moderate predicted impact, its high frequency in the general population \u001b[0m\n",
       "\u001b[1;36mstrongly supports its benign classification. This variant is not considered clinically actionable for cancer risk \u001b[0m\n",
       "\u001b[1;36massessment.\u001b[0m"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">\n",
       "</pre>\n"
      ],
      "text/plain": [
       "\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "invoke_response = agentcore_runtime.invoke({\"prompt\": \"Whats the frequency of chr13:32332591 in BRCA2 variant in this cohort and 1000 genome cohort(1000g)\"})"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "id": "<YOUR_JOB_ID>",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Invoking BedrockAgentCore agent 'vcf_agent_supervisor' via cloud endpoint\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\"><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">I'll analyze the chromosome </span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">17</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\"> variants in patient NA21144. Let me query the database for this information.</span></pre>\n"
      ],
      "text/plain": [
       "\u001b[1;36mI'll analyze the chromosome \u001b[0m\u001b[1;36m17\u001b[0m\u001b[1;36m variants in patient NA21144. Let me query the database for this information.\u001b[0m"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\"><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\"># Chromosome </span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">17</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\"> Variant Analysis for Patient NA21144</span>\n",
       "\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">## Overview</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">I've analyzed all variants on chromosome </span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">17</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\"> for patient NA21144. Chromosome </span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">17</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\"> is clinically significant as it </span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">contains several important genes including BRCA1 (breast cancer susceptibility gene) and TP53 (tumor suppressor </span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">gene).</span>\n",
       "\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">## Variant Summary</span>\n",
       "\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">### Total Variants: </span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">132</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">,</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">122</span>\n",
       "\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">### Impact Distribution:</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">- **MODIFIER**: </span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">130</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">,</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">835</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\"> (</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">99.03</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">%) - primarily non-coding variants</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">- **LOW**: </span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">788</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\"> (</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">0.60</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">%) - synonymous or splice region variants</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">- **MODERATE**: </span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">477</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\"> (</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">0.36</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">%) - missense variants</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">- **HIGH**: </span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">22</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\"> (</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">0.02</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">%) - variants with potentially severe impact (stop gained, frameshift, etc.)</span>\n",
       "\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">### Top Genes with Variants:</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">1</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">. ASIC2: </span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">1</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">,</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">896</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\"> variants</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">2</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">. CEP112: </span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">1</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">,</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">665</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\"> variants</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">3</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">. RBFOX3: </span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">1</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">,</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">539</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\"> variants</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">4</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">. UBBP4: </span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">1</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">,</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">163</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\"> variants</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">5</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">. SLC39A11: </span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">1</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">,</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">082</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\"> variants</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">6</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">. BCAS3: </span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">956</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\"> variants</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">7</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">. CA10: </span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">923</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\"> variants</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">8</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">. RPTOR: </span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">819</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\"> variants</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">9</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">. PRKCA: </span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">796</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\"> variants</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">10</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">. ABR: </span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">777</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\"> variants</span>\n",
       "\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">## Clinically Important Genes</span>\n",
       "\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">### BRCA1 Gene (</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">202</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\"> variants)</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">- **Clinical Classifications**:</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">  - Benign: </span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">185</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\"> variants</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">  - Benign/Likely benign: </span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">2</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\"> variants</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">  - Uncertain significance: </span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">2</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\"> variants</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">  - No classification: </span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">13</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\"> variants</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">- **Notable variant**: chr</span><span style=\"color: #00ff00; text-decoration-color: #00ff00; font-weight: bold\">17:43044803:C</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">TT&gt;C (</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">3</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">' UTR variant with uncertain significance)</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">- **No pathogenic or likely pathogenic BRCA1 variants** were identified</span>\n",
       "\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">### TP53 Gene (</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">35</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\"> variants)</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">- **Key variants**:</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">  - chr</span><span style=\"color: #00ff00; text-decoration-color: #00ff00; font-weight: bold\">17:7676</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">153:G&gt;C (missense variant, classified as Benign)</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">  - chr</span><span style=\"color: #00ff00; text-decoration-color: #00ff00; font-weight: bold\">17:7668</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">835:GA&gt;G (</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">3</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">' UTR variant, uncertain significance)</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">- Most variants are intronic or downstream gene variants</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">- **No pathogenic or likely pathogenic TP53 variants** were identified</span>\n",
       "\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">## Variants of Uncertain Significance (VUS)</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">Two VUS warrant monitoring:</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">1</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">. chr</span><span style=\"color: #00ff00; text-decoration-color: #00ff00; font-weight: bold\">17:7668</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">835:GA&gt;G in TP53 (</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">3</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">' UTR variant)</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">2</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">. chr</span><span style=\"color: #00ff00; text-decoration-color: #00ff00; font-weight: bold\">17:43044803:C</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">TT&gt;C in BRCA1 (</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">3</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">' UTR variant)</span>\n",
       "\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">## Quality Assessment</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">- The majority of variants have quality scores above </span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">30</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">, indicating good confidence in variant calls</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">- Sequencing depth ranges from 3x to 167x, with most variants having adequate coverage</span>\n",
       "\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">## Population Context</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">- Most variants have high allele frequencies in the </span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">1000</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\"> Genomes Project data, suggesting they are common </span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">polymorphisms</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">- No rare variants of clinical significance were identified in the key cancer-related genes</span>\n",
       "\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">## Clinical Interpretation</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">Patient NA21144 does not appear to have any clinically actionable variants in the major cancer predisposition genes</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">on chromosome </span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">17</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\"> (BRCA1 and TP53). All identified variants in these genes are either benign or of uncertain </span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">significance, with most being common polymorphisms in the general population.</span>\n",
       "\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">## Recommendations</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">1</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">. No immediate clinical action is required based on the chromosome </span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">17</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\"> variant profile</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">2</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">. Consider periodic reassessment of the VUS as knowledge of variant significance evolves</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">3</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">. Standard cancer screening protocols should be followed based on the patient's personal and family history</span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">4</span><span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">. If there is a strong family history of cancer, consider comprehensive genetic counseling and testing for other </span>\n",
       "<span style=\"color: #008080; text-decoration-color: #008080; font-weight: bold\">cancer predisposition genes</span></pre>\n"
      ],
      "text/plain": [
       "\u001b[1;36m# Chromosome \u001b[0m\u001b[1;36m17\u001b[0m\u001b[1;36m Variant Analysis for Patient NA21144\u001b[0m\n",
       "\n",
       "\u001b[1;36m## Overview\u001b[0m\n",
       "\u001b[1;36mI've analyzed all variants on chromosome \u001b[0m\u001b[1;36m17\u001b[0m\u001b[1;36m for patient NA21144. Chromosome \u001b[0m\u001b[1;36m17\u001b[0m\u001b[1;36m is clinically significant as it \u001b[0m\n",
       "\u001b[1;36mcontains several important genes including BRCA1 \u001b[0m\u001b[1;36m(\u001b[0m\u001b[1;36mbreast cancer susceptibility gene\u001b[0m\u001b[1;36m)\u001b[0m\u001b[1;36m and TP53 \u001b[0m\u001b[1;36m(\u001b[0m\u001b[1;36mtumor suppressor \u001b[0m\n",
       "\u001b[1;36mgene\u001b[0m\u001b[1;36m)\u001b[0m\u001b[1;36m.\u001b[0m\n",
       "\n",
       "\u001b[1;36m## Variant Summary\u001b[0m\n",
       "\n",
       "\u001b[1;36m### Total Variants: \u001b[0m\u001b[1;36m132\u001b[0m\u001b[1;36m,\u001b[0m\u001b[1;36m122\u001b[0m\n",
       "\n",
       "\u001b[1;36m### Impact Distribution:\u001b[0m\n",
       "\u001b[1;36m- **MODIFIER**: \u001b[0m\u001b[1;36m130\u001b[0m\u001b[1;36m,\u001b[0m\u001b[1;36m835\u001b[0m\u001b[1;36m \u001b[0m\u001b[1;36m(\u001b[0m\u001b[1;36m99.03\u001b[0m\u001b[1;36m%\u001b[0m\u001b[1;36m)\u001b[0m\u001b[1;36m - primarily non-coding variants\u001b[0m\n",
       "\u001b[1;36m- **LOW**: \u001b[0m\u001b[1;36m788\u001b[0m\u001b[1;36m \u001b[0m\u001b[1;36m(\u001b[0m\u001b[1;36m0.60\u001b[0m\u001b[1;36m%\u001b[0m\u001b[1;36m)\u001b[0m\u001b[1;36m - synonymous or splice region variants\u001b[0m\n",
       "\u001b[1;36m- **MODERATE**: \u001b[0m\u001b[1;36m477\u001b[0m\u001b[1;36m \u001b[0m\u001b[1;36m(\u001b[0m\u001b[1;36m0.36\u001b[0m\u001b[1;36m%\u001b[0m\u001b[1;36m)\u001b[0m\u001b[1;36m - missense variants\u001b[0m\n",
       "\u001b[1;36m- **HIGH**: \u001b[0m\u001b[1;36m22\u001b[0m\u001b[1;36m \u001b[0m\u001b[1;36m(\u001b[0m\u001b[1;36m0.02\u001b[0m\u001b[1;36m%\u001b[0m\u001b[1;36m)\u001b[0m\u001b[1;36m - variants with potentially severe impact \u001b[0m\u001b[1;36m(\u001b[0m\u001b[1;36mstop gained, frameshift, etc.\u001b[0m\u001b[1;36m)\u001b[0m\n",
       "\n",
       "\u001b[1;36m### Top Genes with Variants:\u001b[0m\n",
       "\u001b[1;36m1\u001b[0m\u001b[1;36m. ASIC2: \u001b[0m\u001b[1;36m1\u001b[0m\u001b[1;36m,\u001b[0m\u001b[1;36m896\u001b[0m\u001b[1;36m variants\u001b[0m\n",
       "\u001b[1;36m2\u001b[0m\u001b[1;36m. CEP112: \u001b[0m\u001b[1;36m1\u001b[0m\u001b[1;36m,\u001b[0m\u001b[1;36m665\u001b[0m\u001b[1;36m variants\u001b[0m\n",
       "\u001b[1;36m3\u001b[0m\u001b[1;36m. RBFOX3: \u001b[0m\u001b[1;36m1\u001b[0m\u001b[1;36m,\u001b[0m\u001b[1;36m539\u001b[0m\u001b[1;36m variants\u001b[0m\n",
       "\u001b[1;36m4\u001b[0m\u001b[1;36m. UBBP4: \u001b[0m\u001b[1;36m1\u001b[0m\u001b[1;36m,\u001b[0m\u001b[1;36m163\u001b[0m\u001b[1;36m variants\u001b[0m\n",
       "\u001b[1;36m5\u001b[0m\u001b[1;36m. SLC39A11: \u001b[0m\u001b[1;36m1\u001b[0m\u001b[1;36m,\u001b[0m\u001b[1;36m082\u001b[0m\u001b[1;36m variants\u001b[0m\n",
       "\u001b[1;36m6\u001b[0m\u001b[1;36m. BCAS3: \u001b[0m\u001b[1;36m956\u001b[0m\u001b[1;36m variants\u001b[0m\n",
       "\u001b[1;36m7\u001b[0m\u001b[1;36m. CA10: \u001b[0m\u001b[1;36m923\u001b[0m\u001b[1;36m variants\u001b[0m\n",
       "\u001b[1;36m8\u001b[0m\u001b[1;36m. RPTOR: \u001b[0m\u001b[1;36m819\u001b[0m\u001b[1;36m variants\u001b[0m\n",
       "\u001b[1;36m9\u001b[0m\u001b[1;36m. PRKCA: \u001b[0m\u001b[1;36m796\u001b[0m\u001b[1;36m variants\u001b[0m\n",
       "\u001b[1;36m10\u001b[0m\u001b[1;36m. ABR: \u001b[0m\u001b[1;36m777\u001b[0m\u001b[1;36m variants\u001b[0m\n",
       "\n",
       "\u001b[1;36m## Clinically Important Genes\u001b[0m\n",
       "\n",
       "\u001b[1;36m### BRCA1 Gene \u001b[0m\u001b[1;36m(\u001b[0m\u001b[1;36m202\u001b[0m\u001b[1;36m variants\u001b[0m\u001b[1;36m)\u001b[0m\n",
       "\u001b[1;36m- **Clinical Classifications**:\u001b[0m\n",
       "\u001b[1;36m  - Benign: \u001b[0m\u001b[1;36m185\u001b[0m\u001b[1;36m variants\u001b[0m\n",
       "\u001b[1;36m  - Benign/Likely benign: \u001b[0m\u001b[1;36m2\u001b[0m\u001b[1;36m variants\u001b[0m\n",
       "\u001b[1;36m  - Uncertain significance: \u001b[0m\u001b[1;36m2\u001b[0m\u001b[1;36m variants\u001b[0m\n",
       "\u001b[1;36m  - No classification: \u001b[0m\u001b[1;36m13\u001b[0m\u001b[1;36m variants\u001b[0m\n",
       "\u001b[1;36m- **Notable variant**: chr\u001b[0m\u001b[1;92m17:4304\u001b[0m\u001b[1;92m4803:C\u001b[0m\u001b[1;36mTT>C \u001b[0m\u001b[1;36m(\u001b[0m\u001b[1;36m3\u001b[0m\u001b[1;36m' UTR variant with uncertain significance\u001b[0m\u001b[1;36m)\u001b[0m\n",
       "\u001b[1;36m- **No pathogenic or likely pathogenic BRCA1 variants** were identified\u001b[0m\n",
       "\n",
       "\u001b[1;36m### TP53 Gene \u001b[0m\u001b[1;36m(\u001b[0m\u001b[1;36m35\u001b[0m\u001b[1;36m variants\u001b[0m\u001b[1;36m)\u001b[0m\n",
       "\u001b[1;36m- **Key variants**:\u001b[0m\n",
       "\u001b[1;36m  - chr\u001b[0m\u001b[1;92m17:7676\u001b[0m\u001b[1;36m153:G>C \u001b[0m\u001b[1;36m(\u001b[0m\u001b[1;36mmissense variant, classified as Benign\u001b[0m\u001b[1;36m)\u001b[0m\n",
       "\u001b[1;36m  - chr\u001b[0m\u001b[1;92m17:7668\u001b[0m\u001b[1;36m835:GA>G \u001b[0m\u001b[1;36m(\u001b[0m\u001b[1;36m3\u001b[0m\u001b[1;36m' UTR variant, uncertain significance\u001b[0m\u001b[1;36m)\u001b[0m\n",
       "\u001b[1;36m- Most variants are intronic or downstream gene variants\u001b[0m\n",
       "\u001b[1;36m- **No pathogenic or likely pathogenic TP53 variants** were identified\u001b[0m\n",
       "\n",
       "\u001b[1;36m## Variants of Uncertain Significance \u001b[0m\u001b[1;36m(\u001b[0m\u001b[1;36mVUS\u001b[0m\u001b[1;36m)\u001b[0m\n",
       "\u001b[1;36mTwo VUS warrant monitoring:\u001b[0m\n",
       "\u001b[1;36m1\u001b[0m\u001b[1;36m. chr\u001b[0m\u001b[1;92m17:7668\u001b[0m\u001b[1;36m835:GA>G in TP53 \u001b[0m\u001b[1;36m(\u001b[0m\u001b[1;36m3\u001b[0m\u001b[1;36m' UTR variant\u001b[0m\u001b[1;36m)\u001b[0m\n",
       "\u001b[1;36m2\u001b[0m\u001b[1;36m. chr\u001b[0m\u001b[1;92m17:4304\u001b[0m\u001b[1;92m4803:C\u001b[0m\u001b[1;36mTT>C in BRCA1 \u001b[0m\u001b[1;36m(\u001b[0m\u001b[1;36m3\u001b[0m\u001b[1;36m' UTR variant\u001b[0m\u001b[1;36m)\u001b[0m\n",
       "\n",
       "\u001b[1;36m## Quality Assessment\u001b[0m\n",
       "\u001b[1;36m- The majority of variants have quality scores above \u001b[0m\u001b[1;36m30\u001b[0m\u001b[1;36m, indicating good confidence in variant calls\u001b[0m\n",
       "\u001b[1;36m- Sequencing depth ranges from 3x to 167x, with most variants having adequate coverage\u001b[0m\n",
       "\n",
       "\u001b[1;36m## Population Context\u001b[0m\n",
       "\u001b[1;36m- Most variants have high allele frequencies in the \u001b[0m\u001b[1;36m1000\u001b[0m\u001b[1;36m Genomes Project data, suggesting they are common \u001b[0m\n",
       "\u001b[1;36mpolymorphisms\u001b[0m\n",
       "\u001b[1;36m- No rare variants of clinical significance were identified in the key cancer-related genes\u001b[0m\n",
       "\n",
       "\u001b[1;36m## Clinical Interpretation\u001b[0m\n",
       "\u001b[1;36mPatient NA21144 does not appear to have any clinically actionable variants in the major cancer predisposition genes\u001b[0m\n",
       "\u001b[1;36mon chromosome \u001b[0m\u001b[1;36m17\u001b[0m\u001b[1;36m \u001b[0m\u001b[1;36m(\u001b[0m\u001b[1;36mBRCA1 and TP53\u001b[0m\u001b[1;36m)\u001b[0m\u001b[1;36m. All identified variants in these genes are either benign or of uncertain \u001b[0m\n",
       "\u001b[1;36msignificance, with most being common polymorphisms in the general population.\u001b[0m\n",
       "\n",
       "\u001b[1;36m## Recommendations\u001b[0m\n",
       "\u001b[1;36m1\u001b[0m\u001b[1;36m. No immediate clinical action is required based on the chromosome \u001b[0m\u001b[1;36m17\u001b[0m\u001b[1;36m variant profile\u001b[0m\n",
       "\u001b[1;36m2\u001b[0m\u001b[1;36m. Consider periodic reassessment of the VUS as knowledge of variant significance evolves\u001b[0m\n",
       "\u001b[1;36m3\u001b[0m\u001b[1;36m. Standard cancer screening protocols should be followed based on the patient's personal and family history\u001b[0m\n",
       "\u001b[1;36m4\u001b[0m\u001b[1;36m. If there is a strong family history of cancer, consider comprehensive genetic counseling and testing for other \u001b[0m\n",
       "\u001b[1;36mcancer predisposition genes\u001b[0m"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\">\n",
       "</pre>\n"
      ],
      "text/plain": [
       "\n"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "invoke_response = agentcore_runtime.invoke({\"prompt\": \"Analyze chromosome 17 variants in patient NA21144\"})"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "<YOUR_JOB_ID>",
   "metadata": {},
   "source": [
    "## Integrate Agentcore Runtime in Streamlite app"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "id": "<YOUR_JOB_ID>",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Requirement already satisfied: streamlit>=1.28.0 in /home/ec2-user/anaconda3/envs/pytorch_p310/lib/python3.10/site-packages (from -r streamlit_requirements.txt (line 1)) (1.49.1)\n",
      "Requirement already satisfied: boto3>=1.34.0 in /home/ec2-user/anaconda3/envs/pytorch_p310/lib/python3.10/site-packages (from -r streamlit_requirements.txt (line 2)) (1.40.27)\n",
      "Requirement already satisfied: botocore>=1.34.0 in /home/ec2-user/anaconda3/envs/pytorch_p310/lib/python3.10/site-packages (from -r streamlit_requirements.txt (line 3)) (1.40.27)\n",
      "Requirement already satisfied: pandas>=2.0.0 in /home/ec2-user/anaconda3/envs/pytorch_p310/lib/python3.10/site-packages (from -r streamlit_requirements.txt (line 4)) (2.3.0)\n",
      "Requirement already satisfied: numpy>=1.24.0 in /home/ec2-user/anaconda3/envs/pytorch_p310/lib/python3.10/site-packages (from -r streamlit_requirements.txt (line 5)) (1.26.4)\n",
      "Requirement already satisfied: requests>=2.31.0 in /home/ec2-user/anaconda3/envs/pytorch_p310/lib/python3.10/site-packages (from -r streamlit_requirements.txt (line 6)) (2.32.4)\n",
      "Requirement already satisfied: altair!=5.4.0,!=5.4.1,<6,>=4.0 in /home/ec2-user/anaconda3/envs/pytorch_p310/lib/python3.10/site-packages (from streamlit>=1.28.0->-r streamlit_requirements.txt (line 1)) (5.5.0)\n",
      "Requirement already satisfied: blinker<2,>=1.5.0 in /home/ec2-user/anaconda3/envs/pytorch_p310/lib/python3.10/site-packages (from streamlit>=1.28.0->-r streamlit_requirements.txt (line 1)) (1.9.0)\n",
      "Requirement already satisfied: cachetools<7,>=4.0 in /home/ec2-user/anaconda3/envs/pytorch_p310/lib/python3.10/site-packages (from streamlit>=1.28.0->-r streamlit_requirements.txt (line 1)) (6.2.0)\n",
      "Requirement already satisfied: click<9,>=7.0 in /home/ec2-user/anaconda3/envs/pytorch_p310/lib/python3.10/site-packages (from streamlit>=1.28.0->-r streamlit_requirements.txt (line 1)) (8.1.8)\n",
      "Requirement already satisfied: packaging<26,>=20 in /home/ec2-user/anaconda3/envs/pytorch_p310/lib/python3.10/site-packages (from streamlit>=1.28.0->-r streamlit_requirements.txt (line 1)) (24.2)\n",
      "Requirement already satisfied: pillow<12,>=7.1.0 in /home/ec2-user/anaconda3/envs/pytorch_p310/lib/python3.10/site-packages (from streamlit>=1.28.0->-r streamlit_requirements.txt (line 1)) (11.2.1)\n",
      "Requirement already satisfied: protobuf<7,>=3.20 in /home/ec2-user/anaconda3/envs/pytorch_p310/lib/python3.10/site-packages (from streamlit>=1.28.0->-r streamlit_requirements.txt (line 1)) (4.25.3)\n",
      "Requirement already satisfied: pyarrow>=7.0 in /home/ec2-user/anaconda3/envs/pytorch_p310/lib/python3.10/site-packages (from streamlit>=1.28.0->-r streamlit_requirements.txt (line 1)) (20.0.0)\n",
      "Requirement already satisfied: tenacity<10,>=8.1.0 in /home/ec2-user/anaconda3/envs/pytorch_p310/lib/python3.10/site-packages (from streamlit>=1.28.0->-r streamlit_requirements.txt (line 1)) (9.1.2)\n",
      "Requirement already satisfied: toml<2,>=0.10.1 in /home/ec2-user/anaconda3/envs/pytorch_p310/lib/python3.10/site-packages (from streamlit>=1.28.0->-r streamlit_requirements.txt (line 1)) (0.10.2)\n",
      "Requirement already satisfied: typing-extensions<5,>=4.4.0 in /home/ec2-user/anaconda3/envs/pytorch_p310/lib/python3.10/site-packages (from streamlit>=1.28.0->-r streamlit_requirements.txt (line 1)) (4.14.0)\n",
      "Requirement already satisfied: watchdog<7,>=2.1.5 in /home/ec2-user/anaconda3/envs/pytorch_p310/lib/python3.10/site-packages (from streamlit>=1.28.0->-r streamlit_requirements.txt (line 1)) (6.0.0)\n",
      "Requirement already satisfied: gitpython!=3.1.19,<4,>=3.0.7 in /home/ec2-user/anaconda3/envs/pytorch_p310/lib/python3.10/site-packages (from streamlit>=1.28.0->-r streamlit_requirements.txt (line 1)) (3.1.45)\n",
      "Requirement already satisfied: pydeck<1,>=0.8.0b4 in /home/ec2-user/anaconda3/envs/pytorch_p310/lib/python3.10/site-packages (from streamlit>=1.28.0->-r streamlit_requirements.txt (line 1)) (0.9.1)\n",
      "Requirement already satisfied: tornado!=6.5.0,<7,>=6.0.3 in /home/ec2-user/anaconda3/envs/pytorch_p310/lib/python3.10/site-packages (from streamlit>=1.28.0->-r streamlit_requirements.txt (line 1)) (6.5.1)\n",
      "Requirement already satisfied: python-dateutil>=2.8.2 in /home/ec2-user/anaconda3/envs/pytorch_p310/lib/python3.10/site-packages (from pandas>=2.0.0->-r streamlit_requirements.txt (line 4)) (2.9.0.post0)\n",
      "Requirement already satisfied: pytz>=2020.1 in /home/ec2-user/anaconda3/envs/pytorch_p310/lib/python3.10/site-packages (from pandas>=2.0.0->-r streamlit_requirements.txt (line 4)) (2025.2)\n",
      "Requirement already satisfied: tzdata>=2022.7 in /home/ec2-user/anaconda3/envs/pytorch_p310/lib/python3.10/site-packages (from pandas>=2.0.0->-r streamlit_requirements.txt (line 4)) (2025.2)\n",
      "Requirement already satisfied: charset_normalizer<4,>=2 in /home/ec2-user/anaconda3/envs/pytorch_p310/lib/python3.10/site-packages (from requests>=2.31.0->-r streamlit_requirements.txt (line 6)) (3.4.2)\n",
      "Requirement already satisfied: idna<4,>=2.5 in /home/ec2-user/anaconda3/envs/pytorch_p310/lib/python3.10/site-packages (from requests>=2.31.0->-r streamlit_requirements.txt (line 6)) (3.10)\n",
      "Requirement already satisfied: urllib3<3,>=1.21.1 in /home/ec2-user/anaconda3/envs/pytorch_p310/lib/python3.10/site-packages (from requests>=2.31.0->-r streamlit_requirements.txt (line 6)) (2.5.0)\n",
      "Requirement already satisfied: certifi>=2017.4.17 in /home/ec2-user/anaconda3/envs/pytorch_p310/lib/python3.10/site-packages (from requests>=2.31.0->-r streamlit_requirements.txt (line 6)) (2025.6.15)\n",
      "Requirement already satisfied: jinja2 in /home/ec2-user/anaconda3/envs/pytorch_p310/lib/python3.10/site-packages (from altair!=5.4.0,!=5.4.1,<6,>=4.0->streamlit>=1.28.0->-r streamlit_requirements.txt (line 1)) (3.1.6)\n",
      "Requirement already satisfied: jsonschema>=3.0 in /home/ec2-user/anaconda3/envs/pytorch_p310/lib/python3.10/site-packages (from altair!=5.4.0,!=5.4.1,<6,>=4.0->streamlit>=1.28.0->-r streamlit_requirements.txt (line 1)) (4.24.0)\n",
      "Requirement already satisfied: narwhals>=1.14.2 in /home/ec2-user/anaconda3/envs/pytorch_p310/lib/python3.10/site-packages (from altair!=5.4.0,!=5.4.1,<6,>=4.0->streamlit>=1.28.0->-r streamlit_requirements.txt (line 1)) (1.43.0)\n",
      "Requirement already satisfied: gitdb<5,>=4.0.1 in /home/ec2-user/anaconda3/envs/pytorch_p310/lib/python3.10/site-packages (from gitpython!=3.1.19,<4,>=3.0.7->streamlit>=1.28.0->-r streamlit_requirements.txt (line 1)) (4.0.12)\n",
      "Requirement already satisfied: smmap<6,>=3.0.1 in /home/ec2-user/anaconda3/envs/pytorch_p310/lib/python3.10/site-packages (from gitdb<5,>=4.0.1->gitpython!=3.1.19,<4,>=3.0.7->streamlit>=1.28.0->-r streamlit_requirements.txt (line 1)) (5.0.2)\n",
      "Requirement already satisfied: jmespath<2.0.0,>=0.7.1 in /home/ec2-user/anaconda3/envs/pytorch_p310/lib/python3.10/site-packages (from boto3>=1.34.0->-r streamlit_requirements.txt (line 2)) (1.0.1)\n",
      "Requirement already satisfied: s3transfer<0.15.0,>=0.14.0 in /home/ec2-user/anaconda3/envs/pytorch_p310/lib/python3.10/site-packages (from boto3>=1.34.0->-r streamlit_requirements.txt (line 2)) (0.14.0)\n",
      "Requirement already satisfied: six>=1.5 in /home/ec2-user/anaconda3/envs/pytorch_p310/lib/python3.10/site-packages (from python-dateutil>=2.8.2->pandas>=2.0.0->-r streamlit_requirements.txt (line 4)) (1.17.0)\n",
      "Requirement already satisfied: MarkupSafe>=2.0 in /home/ec2-user/anaconda3/envs/pytorch_p310/lib/python3.10/site-packages (from jinja2->altair!=5.4.0,!=5.4.1,<6,>=4.0->streamlit>=1.28.0->-r streamlit_requirements.txt (line 1)) (3.0.2)\n",
      "Requirement already satisfied: attrs>=22.2.0 in /home/ec2-user/anaconda3/envs/pytorch_p310/lib/python3.10/site-packages (from jsonschema>=3.0->altair!=5.4.0,!=5.4.1,<6,>=4.0->streamlit>=1.28.0->-r streamlit_requirements.txt (line 1)) (25.3.0)\n",
      "Requirement already satisfied: jsonschema-specifications>=2023.03.6 in /home/ec2-user/anaconda3/envs/pytorch_p310/lib/python3.10/site-packages (from jsonschema>=3.0->altair!=5.4.0,!=5.4.1,<6,>=4.0->streamlit>=1.28.0->-r streamlit_requirements.txt (line 1)) (2025.4.1)\n",
      "Requirement already satisfied: referencing>=0.28.4 in /home/ec2-user/anaconda3/envs/pytorch_p310/lib/python3.10/site-packages (from jsonschema>=3.0->altair!=5.4.0,!=5.4.1,<6,>=4.0->streamlit>=1.28.0->-r streamlit_requirements.txt (line 1)) (0.36.2)\n",
      "Requirement already satisfied: rpds-py>=0.7.1 in /home/ec2-user/anaconda3/envs/pytorch_p310/lib/python3.10/site-packages (from jsonschema>=3.0->altair!=5.4.0,!=5.4.1,<6,>=4.0->streamlit>=1.28.0->-r streamlit_requirements.txt (line 1)) (0.25.1)\n"
     ]
    }
   ],
   "source": [
    "!pip install -r streamlit_requirements.txt"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "<YOUR_JOB_ID>",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Collecting awscli\n",
      "  Downloading awscli-1.42.27-py3-none-any.whl.metadata (11 kB)\n",
      "Collecting botocore==1.40.27 (from awscli)\n",
      "  Using cached botocore-1.40.27-py3-none-any.whl.metadata (5.7 kB)\n",
      "Collecting docutils<=0.19,>=0.18.1 (from awscli)\n",
      "  Using cached docutils-0.19-py3-none-any.whl.metadata (2.7 kB)\n",
      "Collecting s3transfer<0.15.0,>=0.14.0 (from awscli)\n",
      "  Using cached s3transfer-0.14.0-py3-none-any.whl.metadata (1.7 kB)\n",
      "Collecting PyYAML<6.1,>=3.10 (from awscli)\n",
      "  Using cached PyYAML-6.0.2-cp310-cp310-manylinux_2_17_x86_64.manylinux2014_x86_64.whl.metadata (2.1 kB)\n",
      "Collecting colorama<0.4.7,>=0.2.5 (from awscli)\n",
      "  Using cached colorama-0.4.6-py2.py3-none-any.whl.metadata (17 kB)\n",
      "Collecting rsa<4.8,>=3.1.2 (from awscli)\n",
      "  Using cached rsa-4.7.2-py3-none-any.whl.metadata (3.6 kB)\n",
      "Collecting jmespath<2.0.0,>=0.7.1 (from botocore==1.40.27->awscli)\n",
      "  Using cached jmespath-1.0.1-py3-none-any.whl.metadata (7.6 kB)\n",
      "Collecting python-dateutil<3.0.0,>=2.1 (from botocore==1.40.27->awscli)\n",
      "  Using cached python_dateutil-2.9.0.post0-py2.py3-none-any.whl.metadata (8.4 kB)\n",
      "Collecting urllib3!=2.2.0,<3,>=1.25.4 (from botocore==1.40.27->awscli)\n",
      "  Using cached urllib3-2.5.0-py3-none-any.whl.metadata (6.5 kB)\n",
      "Collecting six>=1.5 (from python-dateutil<3.0.0,>=2.1->botocore==1.40.27->awscli)\n",
      "  Using cached six-1.17.0-py2.py3-none-any.whl.metadata (1.7 kB)\n",
      "Collecting pyasn1>=0.1.3 (from rsa<4.8,>=3.1.2->awscli)\n",
      "  Using cached pyasn1-0.6.1-py3-none-any.whl.metadata (8.4 kB)\n",
      "Downloading awscli-1.42.27-py3-none-any.whl (4.7 MB)\n",
      "\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m4.7/4.7 MB\u001b[0m \u001b[31m133.9 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
      "\u001b[?25hUsing cached botocore-1.40.27-py3-none-any.whl (14.0 MB)\n",
      "Using cached colorama-0.4.6-py2.py3-none-any.whl (25 kB)\n",
      "Using cached docutils-0.19-py3-none-any.whl (570 kB)\n",
      "Using cached jmespath-1.0.1-py3-none-any.whl (20 kB)\n",
      "Using cached python_dateutil-2.9.0.post0-py2.py3-none-any.whl (229 kB)\n",
      "Using cached PyYAML-6.0.2-cp310-cp310-manylinux_2_17_x86_64.manylinux2014_x86_64.whl (751 kB)\n",
      "Using cached rsa-4.7.2-py3-none-any.whl (34 kB)\n",
      "Using cached s3transfer-0.14.0-py3-none-any.whl (85 kB)\n",
      "Using cached urllib3-2.5.0-py3-none-any.whl (129 kB)\n",
      "Using cached pyasn1-0.6.1-py3-none-any.whl (83 kB)\n",
      "Using cached six-1.17.0-py2.py3-none-any.whl (11 kB)\n",
      "Installing collected packages: urllib3, six, PyYAML, pyasn1, jmespath, docutils, colorama, rsa, python-dateutil, botocore, s3transfer, awscli\n",
      "\u001b[2K  Attempting uninstall: urllib3\n",
      "\u001b[2K    Found existing installation: urllib3 1.26.19\n",
      "\u001b[2K    Uninstalling urllib3-1.26.19:\n",
      "\u001b[2K      Successfully uninstalled urllib3-1.26.19\n",
      "\u001b[2K  Attempting uninstall: six\n",
      "\u001b[2K    Found existing installation: six 1.17.0\n",
      "\u001b[2K    Uninstalling six-1.17.0:\n",
      "\u001b[2K      Successfully uninstalled six-1.17.0━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m 1/12\u001b[0m [six]\n",
      "\u001b[2K  Attempting uninstall: PyYAML━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m 1/12\u001b[0m [six]\n",
      "\u001b[2K    Found existing installation: PyYAML 6.0.2━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m 1/12\u001b[0m [six]\n",
      "\u001b[2K    Uninstalling PyYAML-6.0.2:━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m 1/12\u001b[0m [six]\n",
      "\u001b[2K      Successfully uninstalled PyYAML-6.0.2━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m 1/12\u001b[0m [six]\n",
      "\u001b[2K  Attempting uninstall: pyasn190m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m 2/12\u001b[0m [PyYAML]\n",
      "\u001b[2K    Found existing installation: pyasn1 0.6.1━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m 2/12\u001b[0m [PyYAML]\n",
      "\u001b[2K    Uninstalling pyasn1-0.6.1:━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m 2/12\u001b[0m [PyYAML]\n",
      "\u001b[2K      Successfully uninstalled pyasn1-0.6.1━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m 2/12\u001b[0m [PyYAML]\n",
      "\u001b[2K  Attempting uninstall: jmespath━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m 2/12\u001b[0m [PyYAML]\n",
      "\u001b[2K    Found existing installation: jmespath 1.0.1━━━━━━━━━━━━━━━\u001b[0m \u001b[32m 2/12\u001b[0m [PyYAML]\n",
      "\u001b[2K    Uninstalling jmespath-1.0.1:━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m 2/12\u001b[0m [PyYAML]\n",
      "\u001b[2K      Successfully uninstalled jmespath-1.0.1━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m 2/12\u001b[0m [PyYAML]\n",
      "\u001b[2K  Attempting uninstall: docutils━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m 2/12\u001b[0m [PyYAML]\n",
      "\u001b[2K    Found existing installation: docutils 0.19━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m 5/12\u001b[0m [docutils]\n",
      "\u001b[2K    Uninstalling docutils-0.19:[0m\u001b[90m━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m 5/12\u001b[0m [docutils]\n",
      "\u001b[2K      Successfully uninstalled docutils-0.19━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m 5/12\u001b[0m [docutils]\n",
      "\u001b[2K  Attempting uninstall: coloramam╸\u001b[0m\u001b[90m━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m 5/12\u001b[0m [docutils]\n",
      "\u001b[2K    Found existing installation: colorama 0.4.6━━━━━━━━━━━━━━━\u001b[0m \u001b[32m 5/12\u001b[0m [docutils]\n",
      "\u001b[2K    Uninstalling colorama-0.4.6:0m\u001b[90m━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m 5/12\u001b[0m [docutils]\n",
      "\u001b[2K      Successfully uninstalled colorama-0.4.6━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m 5/12\u001b[0m [docutils]\n",
      "\u001b[2K  Attempting uninstall: rsa1m╸\u001b[0m\u001b[90m━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m 5/12\u001b[0m [docutils]\n",
      "\u001b[2K    Found existing installation: rsa 4.7.2━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m 5/12\u001b[0m [docutils]\n",
      "\u001b[2K    Uninstalling rsa-4.7.2:1m╸\u001b[0m\u001b[90m━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m 5/12\u001b[0m [docutils]\n",
      "\u001b[2K      Successfully uninstalled rsa-4.7.2━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m 5/12\u001b[0m [docutils]\n",
      "\u001b[2K  Attempting uninstall: python-dateutil━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m 5/12\u001b[0m [docutils]\n",
      "\u001b[2K    Found existing installation: python-dateutil 2.9.0━━━━━━━━\u001b[0m \u001b[32m 5/12\u001b[0m [docutils]\n",
      "\u001b[2K    Uninstalling python-dateutil-2.9.0:━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m 5/12\u001b[0m [docutils]\n",
      "\u001b[2K      Successfully uninstalled python-dateutil-2.9.0━━━━━━━━━━\u001b[0m \u001b[32m 5/12\u001b[0m [docutils]\n",
      "\u001b[2K  Attempting uninstall: botocore0m\u001b[90m━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m 5/12\u001b[0m [docutils]\n",
      "\u001b[2K    Found existing installation: botocore 1.40.27━━━━━━━━━━━━━\u001b[0m \u001b[32m 5/12\u001b[0m [docutils]\n",
      "\u001b[2K    Uninstalling botocore-1.40.27:━━━━\u001b[0m\u001b[90m╺\u001b[0m\u001b[90m━━━━━━━━━\u001b[0m \u001b[32m 9/12\u001b[0m [botocore]\n",
      "\u001b[2K      Successfully uninstalled botocore-1.40.27m\u001b[90m━━━━━━━━━\u001b[0m \u001b[32m 9/12\u001b[0m [botocore]\n",
      "\u001b[2K  Attempting uninstall: s3transfer━━━━\u001b[0m\u001b[90m╺\u001b[0m\u001b[90m━━━━━━━━━\u001b[0m \u001b[32m 9/12\u001b[0m [botocore]\n",
      "\u001b[2K    Found existing installation: s3transfer 0.14.090m━━━━━━━━━\u001b[0m \u001b[32m 9/12\u001b[0m [botocore]\n",
      "\u001b[2K    Uninstalling s3transfer-0.14.0:[0m\u001b[90m╺\u001b[0m\u001b[90m━━━━━━━━━\u001b[0m \u001b[32m 9/12\u001b[0m [botocore]\n",
      "\u001b[2K      Successfully uninstalled s3transfer-0.14.0\u001b[90m━━━━━━━━━\u001b[0m \u001b[32m 9/12\u001b[0m [botocore]\n",
      "\u001b[2K  Attempting uninstall: awscli━━━━\u001b[0m\u001b[90m╺\u001b[0m\u001b[90m━━━━━━━━━\u001b[0m \u001b[32m 9/12\u001b[0m [botocore]\n",
      "\u001b[2K    Found existing installation: awscli 1.40.37m\u001b[90m━━━━━━━━━\u001b[0m \u001b[32m 9/12\u001b[0m [botocore]\n",
      "\u001b[2K    Uninstalling awscli-1.40.37:━━━━━━━━━━━━\u001b[0m\u001b[91m╸\u001b[0m\u001b[90m━━━\u001b[0m \u001b[32m11/12\u001b[0m [awscli]\n",
      "\u001b[2K      Successfully uninstalled awscli-1.40.37[91m╸\u001b[0m\u001b[90m━━━\u001b[0m \u001b[32m11/12\u001b[0m [awscli]\n",
      "\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m12/12\u001b[0m [awscli]11/12\u001b[0m [awscli]\n",
      "\u001b[1A\u001b[2KSuccessfully installed PyYAML-6.0.2 awscli-1.42.27 botocore-1.40.27 colorama-0.4.6 docutils-0.19 jmespath-1.0.1 pyasn1-0.6.1 python-dateutil-2.9.0.post0 rsa-4.7.2 s3transfer-0.14.0 six-1.17.0 urllib3-2.5.0\n"
     ]
    }
   ],
   "source": [
    "# !pip install --upgrade --force-reinstall awscli"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "<YOUR_JOB_ID>",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "aws-cli/1.42.27 Python/3.10.14 Linux/5.10.240-238.959.amzn2.x86_64 awscrt/0.26.1 botocore/1.40.27\n"
     ]
    }
   ],
   "source": [
    "!aws --version"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "<YOUR_JOB_ID>",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Collecting usage statistics. To deactivate, set browser.gatherUsageStats to false.\n",
      "\u001b[0m\n",
      "\u001b[0m\n",
      "\u001b[34m\u001b[1m  You can now view your Streamlit app in your browser.\u001b[0m\n",
      "\u001b[0m\n",
      "\u001b[34m  Local URL: \u001b[0m\u001b[1mhttp://localhost:8501\u001b[0m\n",
      "\u001b[34m  Network URL: \u001b[0m\u001b[1mhttp://172.16.108.147:8501\u001b[0m\n",
      "\u001b[34m  External URL: \u001b[0m\u001b[1mhttp://34.236.202.207:8501\u001b[0m\n",
      "\u001b[0m\n"
     ]
    }
   ],
   "source": [
    "!streamlit run genomics_streamlit_enhanced.py --server.port 8501 --theme.primaryColor \"#667eea\""
   ]
  },
  {
   "cell_type": "markdown",
   "id": "<YOUR_JOB_ID>",
   "metadata": {},
   "source": [
    "## Use your sagemaker link: https://\\<sagemaker-notebook-instance-name\\>.notebook.\\<region_name\\>.sagemaker.aws/proxy/8501/ in the web-browser to chat with your agent"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "<YOUR_JOB_ID>",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "conda_pytorch_p310",
   "language": "python",
   "name": "conda_pytorch_p310"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.10.14"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
